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Thesis abstract 
 
TB remains a major health issue worldwide causing around 1.5 deaths each year. The 
recent phase III clinical trials of shortened TB treatment failed to show superiority 
compared to the current regimen and this mainly because of relapse. Relapse is 
thought to be caused by dormant bacteria. Dormancy in Mycobacterium species has 
been shown to be associated with the accumulation of intracellular lipids, defining 
two phenotypes: the lipid rich (LR) cells (associated with dormancy) and the lipid 
poor (LP) cells (non-dormant). LR cells were shown to have a higher phenotypic 
antibiotic resistance compared to LP cells. Studying these two phenotypes is therefore 
central in tuberculosis research to understand better the disease and also potentially 
start to reveal the bacteriology of relapse. 
We investigated the power of Raman spectroscopy, a label-free and non-destructive 
technique, to discriminate LR and LP bacteria both in-vitro and ex-vivo. This 
represents the first Raman spectroscopy study that tries to discriminate the phenotypes 
of M. tuberculosis and investigate them directly at the site of the disease. 
Using total lipid extract of M. tuberculosis, we showed the location of the main lipid 
bands in the Raman spectrum. The two major lipid peaks were located around 1300 
cm-1 and 1450 cm-1.  
Raman spectroscopy can discriminate LR and LP cells with high sensitivity and 
specificity. The main differences between the two groups are located in the two major 
Raman lipid peaks, the lipid band A (1300 cm-1) and lipid band B (1440 to 1450 cm-
1). The two phenotypes were successfully discriminated in TB infected guinea pig 
lung tissue sections also from in-vitro culture using wavelength modulated Raman 
(WMR) spectroscopy combined with fluorescence imaging. We developed a protocol 
 5 
to perform both Raman spectroscopy and immunohistochemistry on the same tissue 
sample. 
We studied the evolution of LR and LP proportion in mycobacterial population as the 
growth conditions changed and showed that LR cells could rapidly convert to LP cells 
as they face favourable growth conditions. 
The results presented in this thesis showed that LR M. tuberculosis cells could be 
predominant at the site of infection. This would suggest that drug sensitivity testing 
should be performed on culture presenting both LR and LP cells in high proportion. 
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Chapter 1 Introduction 
1.1 General background 
1.1.1 Tuberculosis and humans 
 
Tuberculosis (TB) has long been part of human history; signs of TB infection have 
been found in a 9,000 year old human skeleton (Hershkovitz et al., 2008). Moreover, 
evidence of TB infection has also been observed in Egyptian mummies dating from 
3000 BC (Zink et al., 2001). In Greek antiquity, in describing TB, Hippocrates wrote 
about the symptoms and explained that the disease was usually fatal (Daniel and 
Iversen, 2015). Robert Koch, in 1882, was the first to describe Mycobacterium 
tuberculosis (M. tuberculosis), the causal agent of TB (Koch, 1882, Daniel, 2005b, 
Daniel, 2006). In the early 1900s, Albert Calmette and Camille Guérin developed a 
vaccine from attenuated Mycobacterium bovis; they called it "BCG" for Bacillus of 
Calmette and Guerin. After the First World War, the BCG vaccine was commonly 
used to prevent TB (Daniel, 2005a, Daniel, 2006). It wasn’t until after the Second 
World War that antibiotics, showing activity against M. tuberculosis, were 
discovered. In 1946, the use of streptomycin was found to be an effective treatment 
for TB and later in 1952 isoniazid was found to also be effective in treating TB 
(Schatz et al., 1944, Marshall et al., 1948, Daniel, 2006). Rapidly, resistance to 
antibiotics appeared (Singh and Mitchison, 1955) however, the development of new 
drug combinations led to reduction in mortality due to TB (Fox et al., 1999). The 
emergence of human immunodeficiency virus (HIV) and the reduction of expenses 
spent on controlling TB led to the resurgence of TB. The funding reduction in TB 
control lead to a resurgence of TB, this phenomenon was called the: “The U-shaped 
 23 
curve of concern” (Reichman, 1991). During the global health emergency declaration 
given by the WHO in 1993 (Reichman, 1991, Glaziou et al., 2011), it was declared 
that HIV co-infection and the existence of drug-resistant TB strains participate to the 
global TB burden (WHO, 2016). By 2030 the WHO plans, as part of WHO’s End TB 
Strategy, to reduce the number of deaths due to TB by 90% compared to 2015 (WHO, 
2016). 
 
1.1.2 Mycobacterium tuberculosis 
 
Mycobacterium tuberculosis is the causal agent of tuberculosis (TB) in humans. TB is 
a major health threat and was responsible for the deaths of about 1.4 million people 
around the globe in 2015 (WHO, 2016). The bacillus causing TB is part of the genus 
Mycobacterium that includes several other human pathogens. For example:  
• Mycobacterium leprae, the causal agent of leprosy. 
•  Mycobacterium africanum, causes similar symptoms as TB but the 
pathogenicity is less severe. 
• Mycobacterium bovis, the causative agent of bovine TB.  
Mycobacterium smegmatis is a non-pathogenic, fast-growing Mycobacterium species 
and therefore commonly used in M. tuberculosis research as a surrogate organism. By 
opposition, M. tuberculosis is a slow-growing bacterium with a generation of 16 h 
under optimal culture conditions (Beste et al., 2009). M. tuberculosis is an acid-fast 
bacterium meaning that once the organism is stained the dye used can resist the acid-
alcohol wash (decolourisation step). The high stain retention is due to the high lipid 
content of M. tuberculosis cell wall. Ziehl-Neelsen, Kinyoun or Auramine stains are 
usually used to stain M. tuberculosis. This microorganism possesses a large-sized 
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genome among bacteria of 4.4 Mbp which encodes for approximately 4000 predicted 
proteins. It is an aerobic organism that can produce adenosine triphosphate (ATP) by 
respiration in the presence of oxygen. Aerobic respiration in bacteria is composed of 
three main steps: glycolysis, the Krebs cycle and electron transport chain. All together 
these three steps lead to the production of 38 ATPs for each molecule of glucose used. 
M. tuberculosis can also survive in low oxygen environments as a facultative 
anaerobe. 
 
1.1.3 Tuberculosis 
 
TB is an infectious disease that primarily affects the lungs and causes pulmonary TB 
(PTB). Many types of tissue, other than lung, can be infected by M. tuberculosis 
causing extrapulmonary TB (Noertjojo et al., 2002). Active TB is usually chronic 
with a persistent cough, intermittent fever, loss of appetite, weight loss and chest pain. 
Patients with active PTB can spread the disease to other people through the air when 
coughing, spitting or sneezing. 
TB patients can present active TB or latent TB. Latent TB infection (LTBI) occurs 
when the primary infection is controlled, and no clinical signs of illness can be 
observed (Lipworth et al., 2016). Previous studies suggest that about 5 to 10 % of 
patients with controlled LTBI could develop an active infection during their life. The 
risk of active disease is strongly increased in patients co-infected with HIV (Harries 
and Dye, 2006). Reactivation from LTBI to active TB represents the majority of new 
TB cases (WHO, 2016). 
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1.1.4 Tuberculosis global burden 
 
TB is still one of the leading causes of infectious death in the world. Every year 
around 1.5 million people die from the disease (WHO, 2016). In 2015, around 10.5 
million new TB cases occurred around the globe with around 10% of new cases being 
co-infected with HIV. Approximately 60% of new cases are found in India, China, 
Pakistan, South-Africa, Nigeria and Indonesia. In TB, examples of both multiple 
drug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) can be 
observed. MDR-TB is caused by organisms resistant to at least isoniazid and 
rifampicin. XDR-TB is defined by resistance to rifampicin and isoniazid (first line 
drugs) plus resistance to at least one fluoroquinolone and also resistance to one or 
more second line drug. According to the WHO, around 580,000 patients with multi-
drug resistant TB (MDR-TB) were counted in 2015 mostly in China, India, Russia 
(WHO, 2016). 
 
1.2 Overview of TB diagnosis and treatment 
1.2.1 BCG and prevention 
 
Bacillus Calmette–Guérin (BCG) vaccine continues to be administered to infants in 
many countries, based on the TB epidemiology of the country. In 2015, over 160 
nations were providing BCG vaccine as standard, and over 100 countries showed high 
coverage (superior to 90% of the population) (WHO, 2016). This vaccine is effective 
at preventing the severe form of TB in children but for adult PTB the efficacy is 
limited (WHO, 2016). Moreover, this vaccine is less effective if patients have already 
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been in contact with environmental mycobacteria species, which share similar 
antigens with M. tuberculosis (Andersen and Doherty, 2005). 
 
1.2.2 A diagnostic overview 
 
TB diagnosis is complex and can require several laboratory tests. The diagnosis 
should define if patients have active or latent TB and determine whether drug-
resistant bacteria are present. Populations presenting a high risk of latent infection 
such as people born in regions where TB is endemic and people showing a risk of 
reactivation (HIV positive patients) should be screened for latent TB (Horsburgh and 
Rubin, 2011, Zumla et al., 2013). To diagnose latent TB infection, the tuberculin skin 
test or the interferon-gamma release assay can be used (ECDC, 2011). The tuberculin 
skin test is less expensive than the interferon-gamma release assay showing the same 
sensitivity but less specificity (McNerney et al., 2012). 
To diagnose active TB, the use of sputum microscopy, culture in broth and antibiotic 
susceptibility tests are the standard methods (Zumla et al., 2013). These methods 
could be facilitated by molecular tests, imaging and investigation of biopsied tissue. 
Both the tuberculin test and interferon-gamma release assay are not used to diagnose 
active TB. Xpert MTB/RIF (Cepheid) is a molecular diagnostic tool that can detect M. 
tuberculosis in as little as two hours with high sensitivity (Boehme et al., 2010). The 
Xpert MTB/RIF test is using a PCR-based amplification of a specific region of M. 
tuberculosis involved in drug resistance. 
To diagnose drug-resistant TB, the WHO recommend performing the Xpert MTB/RIF 
at the same time as the drug susceptibility tests in liquid culture (WHO, 2011a). These 
combined tests can confirm the resistance to rifampicin and the susceptibility or 
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resistance to other drugs. The resistance to rifampicin is usually accompanied by 
isoniazid resistance. Other tests can be conducted to diagnose drug-resistant TB such 
as microscopic observation drug susceptibility (MODS), nitrate reductase assay and 
colorimetric reductase methods (Zumla et al., 2013). The diagnosis of multidrug 
resistance remains difficult; it is estimated that only 10% of multidrug-resistant TB 
cases are currently diagnosed worldwide, and only half of those cases receive 
appropriate treatment (Zignol et al., 2012, WHO, 2011b). 
 
1.2.3 Treatment overview 
 
TB treatment depends on diagnosis as a drug-sensitive active TB, a latent infection a 
multidrug resistant or an HIV co-infection can all be detected and would be treated 
differently. The WHO determined the different aims for TB treatment as: 
• “to cure the patient and restore quality of life and productivity 
• to prevent death from active TB or its late effects 
• to prevent relapse of TB 
• to reduce transmission of TB to others 
• to prevent the development and transmission of drug resistance.” (WHO, 
2010). 
Treatment for drug-sensitive active TB is based on rifampicin (RIF), isoniazid (INH), 
ethambutol (EMB), and pyrazinamide (PZA) (Combs et al., 1990). This standard 
treatment takes at least six months and is divided into two steps: the first two months 
includes administration of all four drugs followed by four months of isoniazid and 
rifampicin. The therapy can be extended up to 9 months if the patient presents risks of 
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relapse such as positive sputum culture after eight weeks, immunosuppression, 
extensive disease or cavitation (Zumla et al., 2013). 
In the case of latent TB, patients receive a preventive treatment (WHO, 2012). This 
treatment is isoniazid daily for 6 to 9 months (Zumla et al., 2013). 
 
To treat MDR-TB, a regimen combining several anti-TB drugs has to be designed. 
These drugs are chosen from the first-line and second-line anti-TB drugs. Regimens 
designed to treat MDR-TB are associated with high toxicity (Falzon et al., 2011). 
Treatment for drugs-resistant TB is given for 20 months in patients who have never 
been treated for TB and is extended to 30 months in patients that have previously 
been treated for TB (Zumla et al., 2013). 
For patients co-infected with HIV, TB treatment is combined with antiretroviral 
therapy. The antiretroviral therapy starts within the first eight weeks of TB treatment 
(Zumla et al., 2013). For patients with active TB, the antiretroviral treatment is based 
on efavirenz (Swaminathan et al., 2011). 
 
1.3 Pathogenesis of Tuberculosis 
1.3.1 Overview of the TB cycle 
 
TB infection usually begins with the inhalation of droplets containing M. tuberculosis. 
While coughing, TB infected patients release these droplets that can remain in the air 
for hours, and a single bacterium is enough to infect someone (Russell, 2007). Once 
the bacterium is inhaled, it arrives in the lung where the bacillus is phagocytosed by 
an alveolar macrophage. The phagocytosis initiates a pro-inflammatory response 
allowing recruitment of mononuclear cells from nearby blood vessels (Russell, 2007). 
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Immune cells arrive at the infection site and begin to form a granuloma or tubercle; 
the presence of a granuloma is characteristic of TB. The granuloma is a complex 
structure composed of a core of infected macrophages that have phagocytosed M. 
tuberculosis. Foamy macrophages and mononuclear phagocytes surround the centre, 
and then an outer layer of lymphocytes associated with the extracellular matrix 
(collagen and other components) complete the structure (Russell, 2007, Guirado and 
Schlesinger, 2013). As long as M. tuberculosis is contained inside a granuloma, the 
host cannot infect others. The granuloma however can rupture and release M. 
tuberculosis in the lung. This rupture can be due to a decrease in the immune status of 
the host that can happen in elderly people, immunocompromised patients or someone 
with malnutrition and/or other adverse health conditions (Russell, 2007). Once the 
granuloma caseates (decays into cellular debris) it releases many infectious bacilli 
into the sputum and induces a cough. Coughing leads to expulsion of pathogens into 
the air. 
 
1.3.2 Alveolar macrophages 
 
Macrophages represent the first line of defence against pathogens (Nathan and Shiloh, 
2000, Liu and Modlin, 2008). Once M. tuberculosis arrives in the lung, macrophages 
phagocytose the bacteria leading to the creation of a phagosome (Aderem and 
Underhill, 1999). Macrophages present numerous receptors that can be involved in 
binding to M. tuberculosis leading to the internalisation of the bacilli (Ernst, 1998). 
Once the bacillus is within the phagosome, the host defence system targets the 
pathogen, the pH inside the phagosome decreases and enzymes that attack bacterial 
lipids and proteins are produced (Huynh and Grinstein, 2007). 
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1.3.3 M. tuberculosis strategies to survive inside the macrophage 
 
In the lung, bacilli are phagocytosed by alveolar macrophages in a process, which 
should kill the pathogens. M. tuberculosis succeeds in escaping this process and 
survives in the macrophage (Russell, 2001). Phagosomes containing M. tuberculosis 
cells usually show little acidification and do not have lysosomal hydrolyses as M. 
tuberculosis is able prevent maturation of the phagosome (Huynh and Grinstein, 
2007, Katti et al., 2008, Russell et al., 2009). The acidification inside the phagosome 
is mediated by proton pumps, which reduce the neutral pH to an acidic pH of 5.0 
(Yates et al., 2005). M. tuberculosis can prevent the pH dropping below 6.4, which is 
a lot higher than the phagolysosome normal pH (pH 4.5–5.0) (Yates et al., 2005, 
MacMicking et al., 2003). The phagosome environment is nitrosative, oxidative, 
shows low oxygen level, and low concentration of carbohydrates (Schnappinger et al., 
2003). Once M. tuberculosis is phagocytosed by human macrophages, the bacillus 
metabolism change to adapt and survive to the phagosomal environment. M. 
tuberculosis can access fatty acids while being in the phagosome but there are few 
carbohydrates available. In order to adapt to those conditions the pathogen induces 
fatty acid degradation enzymes (Schnappinger et al., 2003). The extreme phagosomal 
environment inhibits the aerobic respiration and in this environment the main carbon 
source may be derived from fatty acids and their β-oxidation (Schnappinger et al., 
2003). By means of β-oxydation, fatty acids are broken down in smaller molecules 
such as Acetyl-CoA or Propionyl-CoA. The author suggested that such newly 
synthesised products can enter the glyoxylate cycle and the citric acid cycle as icl, 
gltA1 and Rv1130 are induced. The icl gene encodes for the isocitrate lyase (ICL), 
this enzyme is needed for the glyoxylate shunt (Schnappinger et al., 2003). 
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Moreover, it has been shown that ICL is essential for M. tuberculosis persistence 
inside macrophages during the infection (McKinney et al., 2000). When M. 
tuberculosis is deficient in cholesterol transporter Mce4 or ICL, the virulence of the 
bacillus decreases (McKinney et al., 2000, Mohn et al., 2008). Other studies showed 
that M. tuberculosis could utilise the cholesterol from the host cell membrane as a 
carbon source (Pandey and Sassetti, 2008, Chang et al., 2009, Nesbitt et al., 2010). M. 
tuberculosis is able to survive in the hostile phagosomal environment by being 
resistant to the adverse conditions of the phagolysosome compartment of 
macrophages, conditions that are lethal for most microbial pathogens (Huynh and 
Grinstein, 2007). Furthermore, the pathogen is able to survive inside granuloma 
structures (Reece and Kaufmann, 2012). Macrophages containing M. tuberculosis that 
are located in the hypoxic environment of the granuloma are likely to be found in a 
lipid-loaded state. Inside those macrophages, around half of the pathogens become 
tolerant to isoniazid and accumulate intracellular lipid inclusions (Daniel et al., 2011). 
Inside the macrophage M. tuberculosis can import host cell fatty acids, derived from 
triacylglycerols (TAGs), and incorporate them directly. M. tuberculosis can also use 
the host cell fatty acids for its own lipid metabolism. Several genes were found to be 
up regulated, in M. tuberculosis located in macrophages, such as icl, lipY, tgs1, hspX 
and dosR. These genes are known to be involved in lipid metabolism or in dormancy 
in M. tuberculosis (Daniel et al., 2011). The induction if icl is central to be able to use 
the host fatty acids. This induction also suggests that the pathogen uses host fatty 
acids as central energy source while being inside macrophages (Daniel et al., 2011). 
The isocitrate lyase is a critical enzyme in the glyoxylate shunt, which is a short cut in 
the tricarboxylic cycle. This shunt prevents the loss of carbons that occur when CO2 is 
formed. The glyoxylate cycle occurs in organisms that use fatty acids as energy 
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source (Gengenbacher and Kaufmann, 2012). Metabolic pathways occurring in M. 
tuberculosis during the infection such as the glyoxylate cycle are shown in Fig. 1.1. 
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Figure 1.1 Glyoxylate shunt pathway of M. tuberculosis in the macrophage.  
Acetyl-CoA and propionyl-CoA, produced from fatty acids or cholesterol, enter the 
tricarboxylic acid cycle leading to the production of pyruvate. The glyoxylate shunt 
avoids CO2 loss by the bacteria. The pyruvate produced can be used for the 
gluconeogenesis. Acetyl-CoA and C3 molecules coming from the gluconeogenesis or 
glycolysis such as glycerol are needed to produce TAGs. The production of TAGs can 
lead to the accumulation of lipid bodies, in dormant bacteria for example. Figure 
modified from (Gengenbacher and Kaufmann, 2012). 
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1.3.4 Formation of the granuloma 
 
Granulomas are the hallmark of TB. A TB granuloma is an organised structure of 
immune cells composed of infected macrophages, uninfected macrophages, 
epithelioid cells, multinucleated giant cells and T-cells.  It is characterised by a core 
of infected macrophages surrounded by foamy macrophages and lymphocytes (Fig. 
1.2.). The structure is surrounded by fibrous material (Guirado and Schlesinger, 2013, 
Griffiths et al., 2010). The role of a granuloma is to contain M. tuberculosis infection 
leading to a localised immune response. However, M. tuberculosis can survive this 
process and reactivate later under certain conditions. Therefore, granulomatous 
structures are a central and important phenomenon to study. Human macrophages 
produce a strong pro-inflammatory response during TB infection. On the surface of 
host cells, there are Toll-like receptors (TLR), which recognise and bind to the 
bacterial surface. Once alveolar macrophages have phagocytosed M. tuberculosis, the 
innate immune response begins with production by macrophages of cytokines and 
chemokines. This leads to the recruitment of other host immune cells to the site of 
infection such as more macrophages, dendritic cells and lymphocytes (Ulrichs and 
Kaufmann, 2006, Algood et al., 2005, Miranda et al., 2012). The newly recruited 
immune cells also produce chemokines and cytokines to continue the cellular 
recruitment (Algood et al., 2003). The inflammatory response is regulated by the 
production of interferon (IFN)-γ.  For example, IFN-γ-deficient mice are unable to 
stop the pro-inflammatory response, leading to severe lung pathology (Cooper et al., 
1993). TB infection can be contained in a granuloma with the bacilli able to survive 
for decades inside this structure (Miranda et al., 2012). 
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Figure 1.2 Structure of TB Granuloma.  
The granuloma is the hallmark of TB. Infected macrophages are located in the centre 
of the structure surrounded by uninfected macrophages and foamy macrophages. T-
cells (CD4+ and CD8+) and B-cells form a second layer in the granuloma structure. 
Finally, the granuloma is encircled by fibroblasts and collagen. At this stage, TB 
infection is contained. 
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1.3.5 M. tuberculosis inside the granuloma 
 
M. tuberculosis-infected macrophages migrate to the pulmonary epithelium where an 
inflammatory response is induced and immune cells recruited. A granuloma structure 
then appears surrounding the infected macrophages. Three granuloma stages can be 
distinguished including, solid granulomas, necrotic granulomas and caseous 
granulomas (Gengenbacher and Kaufmann, 2012). The solid granuloma is formed 
within a fibrotic wall that separates the tubercle from the surrounding tissue. The solid 
granuloma corresponds to latent TB. At this stage, M. tuberculosis is contained in the 
granuloma. The necrotic granuloma remains structured overall; however the centre is 
necrotic and mainly composed of cell detritus. When the tubercle starts to become 
necrotic M. tuberculosis can resuscitate, become metabolically active and start to 
replicate. In caseous granulomas the centre starts to liquefy creating cavitation. The 
size of the caseous granulomas is reduced compared to the other two types of 
granulomas. The now open cavity allows oxygen to enter the cavity. The presence of 
oxygen and nutrients (caseous material) leads to an important replicating phase. At 
that moment, if the patient coughs there is a possibility of transmission of bacilli to 
other individuals. Finally, M. tuberculosis can access blood vessels and potentially 
start to spread to other organs (Gengenbacher and Kaufmann, 2012). 
 
1.3.6 Models of the TB granuloma 
 
As mentioned previously, the granuloma is the hallmark of TB; its role is to contain 
the infection. However, as previously shown M. tuberculosis can survive in this 
structure and potentially escape and induce active TB. A general granuloma formation 
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process and an overall granuloma structure have been proposed; however, many 
questions and uncertainties remain. For example, the role of M. tuberculosis itself in 
the granuloma formation is not well understood. For a long time granuloma formation 
has been seen as a host driven process, but more recent studies have shown that the 
bacilli can play a major role in this process (Guirado and Schlesinger, 2013, Davis 
and Ramakrishnan, 2009, Ehlers and Schaible, 2013). 
Models to understand granulomas are essential as access to human lung biopsies is 
limited and only gives information of the granuloma structure at one time point. 
Therefore biopsies cannot help understand the process of granuloma formation, 
cellular recruitment, and bacterial influence. The natural host of M. tuberculosis is 
Homo sapiens therefore model organisms are needed to conduct experiments. There 
are several granuloma models, in-vivo, in-vitro and in-silico (Guirado and 
Schlesinger, 2013). 
Animal models can be close to human in term of conditions, but no animal models 
show identical pathology compared to that found in humans. Mouse models show 
different granulomatous structures compared to human pathology and do not present 
latency. The zebrafish model is interesting for observation of the early recruitment of 
immune cells and the initiation of granuloma formation (Davis et al., 2002). 
However, this animal model is limited to study late granuloma or the recruitment of 
lymphocytes (Rubin, 2009, Guirado and Schlesinger, 2013). The guinea-pig model 
presents similar granulomatous structure compared to the human, however, there is no 
latent TB in this in-vivo model. Mini-pig and non-human primates are the closest 
models to human. In in-vivo models, the parameters are not all known and controlled 
but those models are more “realistic” (closer to human). All of these models can be 
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used depending on the experiment, each of them presenting advantages and 
disadvantages (Guirado and Schlesinger, 2013). 
In-vitro models usually use blood mononuclear cells, agarose beads and collagen to 
create a gel. In-vitro models can then be directly challenged with mycobacteria or 
with antigen-coated beads. They provide an understanding about macrophage 
recruitment and differentiation and also show the formation of a granulomatous 
structure with T-cells surrounding the macrophages (Puissegur et al., 2004). This in-
vitro model has been found to be similar to human TB granulomas regarding cell 
morphology and cell differentiation (Lay et al., 2007). The in-vitro models have 
greatly increased our knowledge about granuloma formation and regulation. These 
models are flexible and can be modulated for specific experiments to answer specific 
questions. However, in-vitro models are limited, as their growth conditions remain 
very different to human tissue. They are designed using only known parameters, and 
therefore lack the contribution or role of unknown factors. Both in-vivo and in-vitro 
models generate data that can be combined and used to construct simulations. 
In-silico models can be used to combine data generated by other models or 
experiments. They can simplify very complex systems that are difficult to study only 
by using in-vivo or in-vitro models. In-silico models present important advantages 
including the fact they are inexpensive and all the parameters are known and can be 
controlled. Parameters can be added removed or changed systematically to answer 
very specific questions. In-silico models are limited by known parameters that can be 
used to construct a simulation. They need in-vivo and in-vitro models to generate 
values and parameters to be as close to reality as possible and reduce the number of 
hypothetical values. Combining data and parameters from different models or 
experiments remains a difficulty when creating in-silico models. Several in-silico 
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models of the M. tuberculosis granuloma have been constructed (Segovia-Juarez et 
al., 2004, Gammack et al., 2005, Fallahi-Sichani et al., 2011, Marino et al., 2011). 
The granuloma represents a key structure in TB and its structure is very complex with 
no model alone able to mimic the pathology that occurs in the human. The use of 
several in-vivo, in-vitro and in-silico models is therefore needed to be as close to 
reality as possible. 
 
1.4 Bacterial dormancy 
1.4.1 Bacterial dormancy in the environment  
 
The term dormancy has been used in microbiology for a long time and in the 1920’s 
work was conducted on dormant bacteria (Burke et al., 1925). In the 1970’s 
Stevenson hypothesised that a significant proportion of bacteria in water can be found 
in a dormant state (Stevenson, 1977). Later in the 1980’s Xu et al., (1982) observed 
that a large proportion of Escherichia coli and Vibrio cholerae cells in cultures could 
be non-culturable, but still viable (Xu et al., 1982). More recently, the study of 
dormancy attracted attention as it was suspected to play a role in bacterial infections 
such as tuberculosis, anthrax and cholera (Lennon and Jones, 2011). The term 
dormant could be defined as being asleep or showing reduced activity for a period of 
time referring to a reversible state of the organism. Lennon and Jones proposed a 
general definition for dormancy: “It refers to an organism’s ability to enter a 
reversible state of low metabolic activity when faced with unfavourable 
environmental conditions” (Lennon and Jones, 2011). Many microorganisms can 
show no sign of viability under certain conditions, but not be dead. Up to 80% of the 
bacterial cells in soil samples from the environment appear to be metabolically 
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inactive, many of which can be resuscitated (Lennon and Jones, 2011). 
Microorganisms can become dormant when faced with adverse conditions such as 
starvation (Kaprelyants and Kell, 1993, Kaprelyants et al., 1993) or reduction in 
oxygen concentration (Wayne and Sramek, 1994). Bacteria converting to a dormant 
phenotype can contain specialised structures such as cysts, conidia, spores and 
akinetes. Bacteria can also enter dormancy without showing any of these structures 
but instead have other adaptations to the environment such as reduction of cell size, 
modification of proteins or lipid content, storage of compounds and change in cell 
structure (thickened cell walls, for example) (Lennon and Jones, 2011).  Usually, 
microorganisms exit the dormant state when environmental conditions improve 
(Setlow, 2003, Whitesides and Oliver, 1997, Lennon and Jones, 2011). It has been 
shown that resuscitation-promoting factors (Rpfs) can also induce an exit from a 
dormant state. Rpfs are secreted proteins, first discovered in M. luteus (Mukamolova 
et al., 1998). Very low concentrations (picomolar) of Rpf can induce an increase up to 
a 100 times in the count of viable cells from dormant cultures of M. luteus 
(Mukamolova et al., 1998). Five proteins that are homologous to M. luteus Rpfs have 
been found in M. tuberculosis (Tufariello et al., 2004). 
 
1.4.2 Dormancy in M. tuberculosis 
 
Dormancy in mycobacteria is defined by a combination of phenomena. A definition 
of mycobacterial dormancy has been proposed: “inability to grow on solid medium, 
the presence of low metabolic activity, alteration of gene regulation with the 
accumulation of triacylglycerides in intracellular lipid bodies, loss of acid-fastness, 
tolerance to antibiotics, and the imputation that growth rate is slow.” (Lipworth et 
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al., 2016). Previously published definitions of dormancy in mycobacteria are shown 
in Tab. 1.1. 
 
Table 1.1 Definitions of dormancy in mycobacteria. 
Authors and reference Definitions 
(Voskuil et al., 2004a) Without replication or significant 
metabolism. 
 
(Shleeva et al., 2010) The dormant state is understood here as a 
reversible state of a bacterial cell, when 
the level of metabolic activity is 
decreased and the cell is able to survive 
for a long time without division 
(Gengenbacher and Kaufmann, 2012) Non- replicating bacilli maintaining full 
viability at a very low metabolic rate; 
organisms show minor susceptibility or 
phenotypic drug resistance to antibiotics 
targeting functions required for growth. 
(Mariotti et al., 2013) Dormancy is defined as a stable but 
reversible non-replicating state of 
Mycobacterium tuberculosis. 
 
Recent TB clinical trials were aimed at reducing the treatment duration to four months 
instead of six months for the standard regimen. In these clinical trials the bacterial 
clearance was rapid. However, the tested regimens were not found to be superior to 
the standard regimen, as high relapse rates were observed (Gillespie et al., 2014, 
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Jindani et al., 2014, Merle et al., 2014). Bacteria surviving treatment can induce 
relapse later. These bacteria are thought to exist in a dormant state (Phillips et al., 
2016, Hammond et al., 2015). Investigating dormancy and antibiotic resistance is 
absolutely key to design new TB treatments (Lipworth et al., 2016). 
The existence of mycobacteria in sputum that can grow in the presence of Rpfs but 
not on solid media has been demonstrated. These bacteria however cannot be 
observed by standard culture methodologies. During treatment, the Rpf-dependent  
population does not decrease. This suggests that this bacterial population is 
phenotypically resistant to antibiotics (Mukamolova et al., 2010). These bacteria 
could correspond to dormant cells. Phenotypic antibiotic resistance is arising from the 
reduced or shifted metabolic activity in dormant bacteria, rather than from genetic 
mutations. The importance of dormancy has been reinforced by recent studies 
showing that there is a difference regarding bacterial count between solid and liquid 
media (Bowness et al., 2015). 
 
1.4.3 Terminology and proposed definitions 
 
In TB research there is no standardised definition for dormancy, and also there is a 
misuse of different terms such as dormant, persistent and latent. In 2016, Lipworth et 
al., proposed definitions for these terms in an attempt to generate common 
nomenclature (Lipworth et al., 2016). They proposed that latency corresponds to a 
controlled stage of the TB infection where bacteria can survive in the host for years 
without causing clinical disease. Latent refers to a state of the disease, whereas 
dormant corresponds to a bacterial state. In other words, TB infection can be latent 
(LTBI) or active, and M. tuberculosis can be in a dormant state or active. The 
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dormancy state is harder to define and refers to a hypothetical cell state. There is no 
commonly adopted definition for dormancy, but a recent definition has already been 
described above (Lipworth et al., 2016). Dormancy is a reversible cell state (Lipworth 
et al., 2016). This notion is important to differentiate between a viable but non-
culturable cell and a dead cell. Another term commonly used in TB research is 
persisters which refers to cells that have survived an antibiotic challenge. Fig. 1.3 
presents the differences between the terms latency, dormancy and persistence. 
Persister bacteria can be dormant, or not, and bacteria involved in LTBI can be 
dormant or not. 
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Figure 1.3 proposed definition for the terms latency, dormancy and persistence in a 
TB research context. 
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Cells that resist to an 
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Reversible cellular state 
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the host for years 
without causing clinical 
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1.4.4 M. tuberculosis in-vitro dormancy models 
 
In 1933, Loebel and colleagues observed that carbon starvation induces an important 
metabolic downshift in M. tuberculosis, and that respiration can be restored when the 
carbon source is reintroduced (Loebel et al., 1933). The authors in this study however 
did not use the term dormancy. Since Loebel’s work, many in-vitro dormancy models 
have been developed to try to understand this phenomenon. To generate dormant 
bacteria, different culture conditions to induce stress have been tested including 
oxygen depletion, nutrient poor medium, the presence of antibiotics, high acidity, and 
multiple stress models (Lipworth et al., 2016). Examples of the published dormancy 
models have been reviewed and are listed in the Table 1.2. 
 
Table 1.2 Examples of Dormancy models 
Dormancy model Description Reference 
Oxygen reduction Long term culture in 
liquid medium with 
controlled oxygen 
depletion 
(Wayne and Hayes, 
1996) 
Starvation Bacteria starved in PBS (Betts et al., 2002) 
Acidification pH reduction down to 4.7  (Shleeva et al., 2011) 
Multiple stress Culture condition: low 
oxygen (5%), high CO2 
(10%), nutrient poor 
(10% Dubos medium) 
and acidic (pH 5).  
(Deb et al., 2009) 
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Several models use oxygen depletion to generate dormant population (Wayne and 
Hayes, 1996, Dick et al., 1998, Lim et al., 1999). In the Wayne model, M. 
tuberculosis is cultured in liquid with low agitation, and the oxygen is depleted at a 
controlled rate (Wayne and Hayes, 1996). Two non-replicating persistence (NRP) 
stages have been described: NRP1 and NRP2. NRP1 is a microaerophilic stage and 
displays a high production of glycine dehydrogenase. NRP2 is an anaerobic stage, 
during this stage the concentration of glycine dehydrogenase decreases significantly. 
The authors suggest that the ability of the bacillus to survive anaerobic conditions 
correlates to the time it spends in a transitional stage (NRP1) (Wayne and Hayes, 
1996). Previously Wayne et al. showed that a rapid transfer from aerobic to anaerobic 
culture led to cell death. However, if the oxygen depletion is gradual, the tolerance to 
the anaerobic conditions is higher (Wayne and Lin, 1982). To respond to hypoxia, 
bacteria adapt their metabolism. A shift to the glyoxylate cycle has been described in 
dormant cells with an increased activity of ICL and glycine dehydrogenase (Wayne 
and Lin, 1982). The DosR regulon is highly induced while the microorganisms are 
transiting to an anaerobic state (Voskuil et al., 2004b). 
In 1933, Loebel first observed that carbon starvation induces a significant metabolic 
downshift in M. tuberculosis (Loebel et al., 1933). More recently, using the starvation 
model, it has been shown that M. tuberculosis stop their growth, have reduced 
respiration rate and show resistance to several drugs (rifampicin, isoniazid and 
metronidazole) (Betts et al., 2002). To adapt to starvation, the level of expression of 
many genes changes. Several genes involved in surviving in the host for an extended 
period of time are induced while lipid biosynthesis, cell division, transcription and 
energy metabolism are reduced (Betts et al., 2002). For starved bacilli, ICL and the 
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glyoxylate shunt are central to surviving in a nutrient poor environment 
(Gengenbacher et al., 2010). 
In low pH medium, M. tuberculosis becomes ovoid showing a thickened cell wall. 
These cells are resistant to heat and antibiotics. Moreover, they do not grow on solid 
medium, whereas the addition of Rpfs are required for successful resuscitation 
(Shleeva et al., 2011). 
The Multiple stress model has been designed to be more representative of the 
conditions that M. tuberculosis encounter in-vivo. Deb and colleagues designed a 
multiple stress model as the following: low oxygen (5%), high CO2 (10%), nutrient 
poor (10% Dubos medium) and high acidity (pH 5). In this model, genes involved in 
the glyoxylate cycle were found to be up-regulated, bacteria stored non-polar lipids, 
cells were more resistant to rifampicin and isoniazid, and their buoyant density was 
decreased as the culture aged (Deb et al., 2009). 
 
1.4.5 M. tuberculosis dormancy model and drug testing 
 
The most clinically relevant aspect of dormancy in M. tuberculosis and mycobacteria 
is their phenotypic resistance to antibiotics. Tab. 1.3 presents examples of drug 
sensitivity testing on dormant cells. Many susceptibility tests have been performed in 
different dormancy models (MIC, MBC, % of cell survival after various drug 
exposure times, Alamar blue reduction…). Substantial differences have been 
observed regarding drug concentration for one species in different models. Looking at 
rifampicin in M. tuberculosis, in the in-vitro granuloma model, the MIC was found to 
be over 0.47µg.mL-1 and up to 0.94µg.mL-1; in the Wayne model, using rifampicin at 
0.1µg.mL-1, 4.2% of cells survived after 192 hours (Ackart et al., 2014, Wayne and 
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Hayes, 1996). Direct comparison between “dormancy” models and susceptibility tests 
is therefore difficult. 
 
 
Table 1.3 Dormancy models and associated drug susceptibility.  
Table modified from (Lipworth et al., 2016). 
 
Dormancy 
model 
Methodology Susceptibilities: 
isoniazid Rifampicin Pyrazinamide Ciprofolxacin Metronidozole 
Oxygen shift 
down 
(Wayne 
model) 
(Wayne and 
Hayes, 1996) 
M. 
tuberculosis 
cell survival, 
CFU count 
0.4 µg.mL-
1 
0.1 µg.mL-1  1 µg.mL-1 12 µg.mL-1 in 
NRP2 
Oxygen 
depletion 
(BCG) (Lim 
et al., 1999) 
BCG, CFU 
count 
    BCG viable 
count are 
reduced a 1000 
fold at 
100µg.mL-1 
and 3 fold at 
10 µg.mL-1 
Oxygen 
depletion 
(M. 
smegmatis) 
(Dick et al., 
1998) 
M. smegmatis, 
percentage of 
survival. CFU 
count 24h after 
drug exposure 
    120 µg.mL-1 
20± 10 percent 
survival for 
persistent 
culture (old 
culture) and 
95±9 percent 
survival for 
active culture 
(log aerobic 
culture) 
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Long term 
anaerobic 
cultures 
(Filippini et 
al., 2010) 
7, 14, 21 days 
exposure to 
drugs. CFU 
and MGIT 
(negative: no 
growth after 
100 days) 
 8 µg.mL-1 100 µg.mL-1  8 µg.mL-1 
Nutrient 
starvation 
(Betts et al., 
2002) 
Cell survival 
after 168h of 
drug exposure. 
CFU count 
10 µg.mL-
1 
10 µg.mL-1    
Multiple 
stress model 
(Deb et al., 
2009) 
Cell survival 
after ≥ 96h of 
drug exposure. 
CFU count 
0.8 µg.mL-
1 
5 µg.mL-1   12 µg.mL-1 
Human 
granuloma 
in-vitro 
model 
(Kapoor et 
al., 2013, 
Ackart et al., 
2014) 
M. 
tuberculosis  
MIC 
calculated 
using Alamar 
blue 
MIC: 
1.25_2.5 
µg.mL-1  
MIC: 
0.47_0.94 
µg.mL-1 
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1.4.6 Dormancy theories in TB 
 
Different theories have been proposed to explain dormancy including the Ying/Yang 
theory, spectrum theory and scout theory. 
 
1.4.6.1 Yin/Yang theory 
 
The “Yin-Yang” model describes a mixed bacterial population with growing (Yang) 
and non-growing (Yin) cells that are in several states and present in a continuum. 
During exponential and early stationary phases, there are more growing “Yang” 
bacteria with fewer non-growing “Yin” cells. This changes when the culture enters 
into a stationary phase where more non-growing bacteria appears, and the number of 
growing cells (Yin) decreases. The authors of this model describe the cells as a 
heterogeneous population, appearing as of a continuum of subpopulations exhibiting 
differential gene expression. The authors used this model to explain why M. 
tuberculosis after two months of intensive treatment with the four drugs (isoniazid 
(INH), rifampin (RIF), pyrazinamide (PZA), and ethambutol (EMB) can convert to an 
active form, sensitive to INH and RIF. The authors also used this model to 
demonstrate why isoniazid would be effective in the treatment of latent disease 
(Zhang et al., 2012). 
 
1.4.6.2 Spectrum theory 
 
A theory exposed in 2002 by Shleeva and colleagues proposes a spectrum of 
dormancy where bacteria can be found active, in a transitional phase or dormant 
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(Shleeva et al., 2002) (Fig. 1.4). The transition from actively growing to dormancy 
occurs through a transition phase. The more a culture ages, the less metabolically 
active it becomes. This model suggests that dormancy is a reversible state; bacteria 
can be re-grown or be resuscitated to the active state. “Wayne’s” zone refers to 
transition step to deep dormancy (presence of non-culturable cells). Bacteria in 
“Wayne’s” zone remain viable and metabolically active and those cells can be re-
grown. “Cornell’s zone” corresponds to deep dormancy where cells are described as 
non-culturable and unable to form colonies. This state precedes cell death. These 
bacteria have to be resuscitated before becoming active again. 
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Figure 1.4 M. tuberculosis dormancy spectrum theory.  
The metabolic activity of the cells is represented by the coloured intensity of the 
arrows (in blue); reducing as bacteria enter dormancy. Bacteria become dormant 
through a transition phase (“Wayne’s zone”) in which cells are still culturable; 
entering deep dormancy where bacteria become non-culturable (“Cornell’s zone”). 
Dormancy is reversible, and bacteria can be re-grown or resuscitated to an active 
state. Figure modified from (Shleeva et al., 2002). 
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1.4.6.3 The scout theory 
 
One of the proposed theories to explain resuscitation from dormancy is the “scout” 
theory. In this theory, a few of the M. tuberculosis dormant cells randomly awaken.  
These cells are termed the ‘scouts’. These cells assess their environmental conditions 
and if suitable for growth they start replicating. The replicating scout cells potentially 
send activation signals to the dormant bacteria awakening them (Epstein, 2009, Chao 
and Rubin, 2010). In the opposite case if conditions are unsuitable for growth, the 
scout cells die, leaving the rest of the cells dormant and alive. When scouts 
successfully replicate and survive antibiotic treatment and the immune system, they 
may induce relapse (Lipworth et al., 2016, Epstein, 2009). 
 
1.4.7 Mycobacterial lipids  
 
In 2011, Sartain et al, studied M. tuberculosis lipids using a liquid chromatography 
and mass-spectrometry (LC/MS) approach (Sartain et al., 2011). The authors 
designed a lipid dataset containing about 2,500 lipid entities. The lipid profile of M. 
tuberculosis was found to be highly complex. Lipids in M. tuberculosis can represent 
up to 60% of the cellular dry weight with many lipids present M. tuberculosis being 
specific to this species or to its genus (Sartain et al., 2011). The authors compared the 
changes in the lipid composition that occur as M. tuberculosis cultures age. Important 
differences in the abundance of TAGs and fatty acyl composition were observed. 
TAGs represented 35.8% of the detected molecules in logarithmic phase cultures, 
while they represented 77.3% in stationary phase cultures. It was shown that the 
concentration of TAGs and the mass of TAGs increase in stationary phase cultures 
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compared to logarithmic phase cultures (Sartain et al., 2011). For example, TAGs, in 
logarithmic phase cultures, were found to be mainly esterified by C16:1 and C18:1 
fatty acids (with one unsaturated bond). In stationary phase cultures, C16:0, C18:0 
and C26:0 (no unsaturation) fatty acids were predominantly observed to be esterified 
to TAGs. In stationary phase cultures as compared to logarithmic phase cultures, there 
was an increase in saturated bonds in other lipid groups such as phospholipids, 
phosphatidylethanolamine, phosphatidylinositol and cardiolipin (Sartain et al., 2011). 
 
1.4.7.1 Mycobacterial cell envelope 
 
Mycobacteria display a specific and very complex cellular envelope (Fig. 1.5). The 
cell wall of mycobacteria presents a thin layer of peptidoglycan surrounded by a layer 
of arabinoglycan and a thick layer of mycolic acids. Intercalating with the distal end 
of the mycolate chains are a range of complex lipids of varying polarities, to form a 
mycobacterial outer membrane. These complex lipids include non-polar waxes 
phthiocerol dimycocerosates (PDIMs) and polar glycolipids such as acyl trehaloses 
and sulpholipid. In addition, very long lipoarabinomannan (LAM) molecules that are 
anchored in the cytoplasmic membrane traverse the cell wall. Porins are found in the 
mycobacterial outer membrane and allow the passage of hydrophilic molecules. The 
cell envelope of mycobacteria is very rich in lipid content (Rajni et al., 2011, Brown 
et al., 2015, Jackson, 2014). Growth conditions can impact M. tuberculosis cell wall. 
M. tuberculosis cultured microaerobically and anaerobically present thickened cell 
wall outer layer (Cunningham and Spreadbury, 1998). In M. tuberculosis, there is an 
increased synthesis of PDIM when the bacteria are grown on odd-chain fatty acids 
and also during infection (Jain et al., 2007). 
 55 
 
 
  
 
  
Figure 1.5 Cellular envelope of mycobacterium species.  
A thin layer of peptidoglycan covers the cytoplasmic membrane followed by a layer of 
arabinoglycan and a thick layer of mycolic acids. In the cell wall several other 
molecules or structures can be observed such as lipoproteins, glycolipids, PDIMs 
very long LAM molecules and porins. 
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1.4.7.2 The lipid bodies in mycobacteria 
 
Dormancy is associated with intracellular storage of lipids (lipid rich (LR) bacteria). 
The accumulation of intracellular lipids could be useful for the identification of 
dormant mycobacteria, which can then be detected by different technologies such as 
fluorescence microscopy. In M. tuberculosis and M. smegmatis, lipid bodies can be 
observed in cells (Garton et al., 2002). Dormant cells from hypoxic or nutrient 
starvation models show a decrease in intracellular ATP levels (Rao et al., 2008, 
Gengenbacher et al., 2010). ICL knockout mycobacteria grown in nutrient poor 
conditions cannot reduce their ATP level and die as a result. As mentioned in 
Chapter 1 Introduction section 1.3.3 above, the ICL enzyme is involved in the 
glyoxylate shunt which avoids CO2 losses that would occur during the complete 
tricarboxylic cycle. This enzyme is essential for M. tuberculosis in a nutrient poor 
environment (Gengenbacher et al., 2010). In low oxygen conditions, a shift to the 
glyoxylate shunt has been described in dormant cells with increased activity of ICL 
(Wayne and Lin, 1982). There is a global up-regulation of mycobacterial lipid 
metabolism genes in a low oxygen environment. This up-regulation leads to an 
accumulation of lipids, stored in intracellular bodies (lipid bodies) (Gengenbacher and 
Kaufmann, 2012). The presence of lipid bodies would be interesting to identify 
dormant cells. 
 
In 1946, Burdon studied lipid bodies in several bacteria including mycobacteria. 
Bacteria were stained using Sudan Black and lipid bodies as “distinct fat droplets” 
were described. The droplets were present in many mycobacteria but not all (see Fig. 
1.6) (Burdon, 1946a, Burdon, 1946b). 
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Figure 1.6 Lipid inclusions in mycobacteria.  
This figure shows the drawing of Sudan Black stained mycobacteria. Some 
mycobacteria do not have any lipid droplets, while others contain one or more lipid 
droplets. Importantly, the size of the lipid inclusions varies from small to very large. 
Drawing modified from (Burdon, 1946b). 
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Other bacteria outside the Mycobacterium genus also have the capacity to store lipids 
in intracellular inclusions (Burdon, 1946b, Waltermann and Steinbüchel, 2005, Wang 
and Bakken, 1998). For example in Rhodococcus opacus, it was shown that PD630 
fatty acids represent up to 87% of the dry weight of the bacterium (Alvarez and 
Steinbüchel, 2002). 
More recently, in 2002 Garton and colleagues demonstrated that lipid bodies in 
mycobacteria could be formed using fatty acids or a simple carbon source. The 
authors used staining methods and microscopy to study lipid inclusions, and 
investigated their composition. TAGs were found to be the major component of the 
lipid bodies (Garton et al., 2002). Using an in-vitro multiple stress model, it was 
shown that phenotypic antibiotic tolerance and accumulation of TAGs were highly 
correlated (Deb et al., 2009). The mycobacterial protein perilipin-1 (MPER1), up-
regulated in dormant cells, has been found to play a crucial role in the formation of 
lipid inclusions (containing TAGs) in M. tuberculosis. The M. tuberculosis mper1 
knockout strain presents a lower accumulation of lipid bodies and also a reduction in 
rifampicin tolerance in in-vitro dormancy models (Daniel et al., 2016). Mycobacteria 
with lipid bodies can be defined as lipid rich (LR) cells as opposed to lipid poor (LP) 
bacteria that do not present any intracellular lipid bodies. LR mycobacteria display 
higher tolerance to antibiotics used in TB treatment; for example, M.smegmatis LR 
bacteria were found up to 40 times more tolerant to Rifampicin in comparison to LP 
bacteria (Hammond et al., 2015). 
Bacilli containing lipid bodies have been found to be dominant in sputum treated 
patients (Garton et al., 2008). This could mean that the transmissible phenotypes 
could be lipid body positive and possibly slow-growing or dormant. This group also 
showed that an increase in lipid body count in M. tuberculosis in sputum correlated 
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with an increase in time to positivity of the cognate M. tuberculosis isolate in 
BACTEC system. Moreover, when they analysed the sputum transcriptome using 
microarray, they found a strong correlation of transcriptional signatures with slow 
growing mycobacteria, finding an upregulation of the DosR regulon and a 
downregulation of genes linked with aerobic metabolism. Ribosomal protein genes 
were also downregulated, which suggests that growth is reduced within this 
population (Garton et al., 2008). This work led to a new vision for the role of 
dormancy in TB, revealing that lipid body positive cells can predominate in sputum of 
treated patients. More recently, Sloan and colleagues showed that only few patients 
with unfavourable outcomes were infected with bacteria with resistance-associated 
mutations. Moreover, in patients that had an unfavourable outcome, the authors 
observed a higher percentage of lipid body positive M. tuberculosis cells in sputum at 
around three and four weeks of treatment. These findings support the hypothesis that 
dormant bacteria are the leading cause of relapse (Sloan et al., 2015). 
 
1.5 Introduction to Raman spectroscopy 
1.5.1 History of Raman spectroscopy 
 
The inelastic scattering of light has been first suggested by Smekal in 1923 (Smekal, 
1923). Five years later Sir Raman observed for the first time the phenomenon 
hypothesised a few years earlier by Smekal (Raman and Krishnan, 1928). In 1928 Sir 
Raman used sunlight as a source focused on a sample by a telescope and observed the 
output with his eyes. He succeeded to show the presence of light scattering with a 
different frequency compared to the original light; this is the principle of Raman 
spectroscopy. To demonstrate this, the authors used two light filters: a blue/violet one 
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and a yellow/green one, while examining light scattering through a liquid medium. 
When the two filters were placed in series in the incident light, no light would enter 
the observer’s eyes. However, when the yellow/green filter was placed between the 
liquid and the experimentalist’s eye, light could be observed. This proved the 
existence of light scattering presenting a different frequency compared to the incident 
light. 
 
1.5.2 Raman spectroscopy principle 
 
When photons reach a sample, they can go through without any interaction, or they 
can scattered, or be absorbed. The light scattering can be elastic or inelastic. Elastic 
scattering occurs when photons only interact with electrons of the molecule, the 
frequency of the photon is nearly unmodified and there is no shift in the energy level. 
This scattering event is the dominant process and is referred to as Rayleigh scattering. 
The inelastic scattering occurs when the photons interact with the nuclei of the 
molecule. In this case, there is a transfer of energy to the molecule from the photon or 
vice versa. The energy of the scattered photons is different compared to their initial 
energy level (incident photons). Those photons are Raman photons. The inelastic 
scattering is a rare event and only occurs in one photon every 106-108 photons. Raman 
spectroscopy is a technique using the inelastic scattering of monochromatic light, 
generated by a laser. Lasers are used in Raman spectroscopy as they produce intense 
monochromatic beam. This is necessary to improve the yield of the rare Raman 
photons. The frequencies of photons in monochromatic light can change after entering 
into contact with a sample in case of an inelastic scattering. In this case, photons are 
absorbed by the sample and re-emitted with a shifted frequency that could be shifted 
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up or down compared with original monochromatic frequency. This shift is measured 
and gives information about vibrational, rotational and other low-frequency 
transitions in molecules. 
When photons interact with the sample they can scatter in several ways (Fig. 1.7) 
Rayleigh scattering is how most photons scatter. Scattered photons have the same 
energy as the incident photons and is referred to as elastic scattering. Raman 
scattering occurs when the energy level of the scattered photon changes compared to 
the incident photon, this is inelastic scattering.  Examples of which include:  
• Stokes scattering corresponds to a photon that excites a chemical bond that 
was in a non-excited state. During Stokes scattering, the photon will lose 
some energy that is absorbed by the atoms of the molecule. 
• Alternatively, Anti-Stokes scattering corresponds to a gain of energy by the 
scattered photon. In this case, the atoms of a molecule are already in a 
vibrational state, and some energy is transferred from the molecule to the 
photon. 
There is more Stokes scattering compared to Anti-Stokes scattering under normal 
conditions because at room temperature molecules are predominantly in the lowest 
vibrational energy level. With an increase in temperature anti-stokes events increase 
(Smith and Dent, 2005). 
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Figure 1.7 Rayleigh and Raman scattering. 
Raman photons can either show a Stokes or an anti-Stokes scattering. Anti-Stokes 
scattering corresponds to a gain of energy by the scattered photon compared to the 
incident photon. To the contrary, Stokes scattering is the result of energy loss by the 
scattered photon. Rayleigh scattering corresponds to elastic scattering (no changes in 
the energy level between the incident photon and the scattered photon). In the figure, 
each type of scattering presents an arrow going up or coming back down 
corresponding to changes in the energy level of the scattered photon. The arrow can 
depart from either an excited vibrational state or a ground vibrational state. In the 
case of the anti-Stokes Raman scattering the arrow departs from an excited 
vibrational state and the scattered photons comes back to a ground vibrational state 
(with higher energy). The opposite is observed for the Stokes Raman scattering. And 
identical energy levels, between the incident photons and the emitted photons, are 
found in the case of Rayleigh scattering. 
 
 
En
er
gy
 
Ground 
vibrational 
state  
Excited 
vibrational state 
Stokes Raman 
scattering 
Anti-Stokes Raman 
scattering 
Rayleigh 
scattering 
Virtual states 
 63 
In Raman spectroscopy, mainly Stokes Raman scattering is used. The shift in energy 
level is measured by subtracting the energy of the scattered photon from the initial 
photon. This is the reason why Raman scattering is expressed in energy shift delta cm-
1 or simply cm-1 (wavenumber, number of wave per unit of length). The wavenumber 
is directly related to the wavelength, the frequency and the energy of the photon. 
Knowing one of these parameters and using Planck’s constant and the speed of light, 
it is easy to calculate any of the other related parameters (wavenumber, wavelength, 
frequency and the energy of the photon). The corresponding equations are shown 
below: 
 
! = ℎ!!  
 
! = 1! = !! 
Where: 
 h is the Planck’s constant h = 6.626 × 10-34 J.s (unit is Joules × seconds) 
c is the speed of light c=3 × 108 m.s-1 
E is the energy in Joules 
λ is the wavelengths in nm 
v is the frequency in s-1 
v ̃ is wavenumber in cm-1 
When the wavenumber is calculated from the wavelength, the wavelength needs to be 
in cm (107 nm). 
! = 1! = 1785 × 10!! = 12738.9!"!! 
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1.5.3 Vibrational modes 
 
There are three molecular vibration modes in Raman spectroscopy: symmetric stretch, 
bend and asymmetrical stretch. In Fig. 1.8, water (H2O) is shown in the three different 
vibrational modes. A Raman spectrum corresponds to all the vibrations that occur in 
the sample studied; one peak corresponds to one vibration of one specific bond, and 
gives a unique feature for each molecule. By extension, the Raman spectrum 
corresponds to all the energies (frequencies) of scattered light plotted on the x-axis 
and the corresponding intensities are plotted on the y-axis (see Fig. 1.10).  
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Figure 1.8 Vibrational modes of water.  
Any molecule can vibrate in different modes. The figure illustrates the different 
vibrational modes of water: symmetrical, bend and asymmetrical. The arrows 
indicate the movement of the atoms at one moment. To be called a vibration, this 
movement needs to be repeated several times. In the case of a symmetrical stretch of 
H2O the two bonds are elongated then compressed at the same time. In the case of an 
asymmetrical stretch, one bond is compressed while the other is elongated, and vice 
versa. In the case of H2O bending vibration mode, the two atoms of hydrogen are 
coming closer to each other and then they separate while the length of the bonds 
between the atoms hydrogen and the atom of oxygen do not change. 
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1.5.4 Raman spectroscopy methodologies 
 
Raman scattering is a very weak process since only a small percentage of incident 
photons are scattered inelastically. The Raman spectra of biological samples exhibit 
high fluorescence background commonly due to the presence of fluorophore 
molecules in biological samples. There are several possible methods to reduce this 
fluorescence, for example, choosing the laser wavelength in the ultraviolet (UV) or 
infrared (IR) regions (Sengupta et al., 2007). However, the UV laser generates high 
energy which could damage the biological samples. 
 
1.5.4.1 Conventional Raman spectroscopy  
 
Conventional Raman spectroscopy has been used in this study. For this type of 
Raman spectroscopy, first the background signal is taken (near the bacterium) then 
the reference signal is acquired (on the bacterium). This permits us to subtract the 
background mathematically. However, the auto-fluorescence coming from the 
biological sample (the bacterium) is not subtracted, as it is only coming from the cell. 
This technique can be used when the background is homogeneous, as it assumes that 
the background near the cell is the same as the background at the location of the cell. 
 
1.5.4.2 Wavelength modulated Raman spectroscopy 
 
In wavelength modulation Raman (WMR) spectroscopy, the laser wavelength is tuned 
during the acquisition and the Raman peaks are shifted according to the laser 
wavelength, while the fluorescence background is not. Several original spectra, at 
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different laser wavelengths, are taken during the acquisition time. This makes it 
possible to subtract the fluorescence background mathematically. The optimal 
processing algorithm to generate WMR spectra was shown to be Principal component 
analysis (PCA) showing high signal to noise ratio and efficient background 
subtraction (De Luca et al., 2010, Mazilu et al., 2010, Chen et al., 2015). In this 
study, we used continuous modulation meaning that the laser was tuned continuously 
at a constant rate during the acquisition time. 
 
1.5.5 Raman spectroscopy and instrumentation 
 
Raman spectroscopy systems are composed of four main components (see Fig. 1.9): 
• The excitation source (the laser) 
• The sample illumination and the optics to collect light 
• The spectrometer (the wavelength selector) 
• The detector 
 
Different lasers can be used depending on the experiment with distinct wavelengths 
(UV, visible light or in the infrared). The laser wavelength will have a great impact on 
the results as the scattering depends directly on the laser wavelength. For example, a 
high-frequency laser (UV) will generate higher peak intensity and therefore increase 
the sensitivity of Raman spectroscopy. Working in the UV wavelength also has the 
advantage of low levels of fluorescence compared to lower frequencies. The biggest 
problem encountered when working in the UV wavelength is the high energy of the 
photon and radiation that can be absorbed by the samples. This can lead to sample 
degradation and also direct burning of the sample due to increased temperature. Using 
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an infrared laser will allow working with a higher laser power as the photon generated 
presents a lower frequency. This type of laser is much less damaging for the sample 
compared to the UV, but the peak intensity will be lower thus requiring longer 
acquisition time.  
The incident light usually reaches the sample through a microscope objective. The 
difficulty is to remove as much Rayleigh scattering as possible as Raman scattering is 
a rare event. The use of filters such as notch filters will remove the light with a 
wavelength equal to the incident laser light ± 100 cm-1 but the use of those filters 
makes it impossible to study low-frequency Raman scattering events. Raman 
spectrometers usually use diffraction gratings for wavelength selection. In order to 
detect Raman scattered light, multi-channel detectors such as charged couple devices 
(CCD) are used. A basic schematic of a Raman spectroscopy system is shown in Fig. 
1.9. 
In this study, two Raman spectroscopy systems have been used. The first one is 
presented in Chapter 2 General methods Fig. 2.5 was used to do both standard and 
WMR spectroscopy. The second system is shown in Chapter 2 General methods 
Fig. 2.6 and is a very similar system for the Raman spectroscopy part, however, it was 
designed to additionally investigate fluorescence (therefore, combining Raman 
spectroscopy and fluorescence imaging). 
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Figure 1.9 Basic schematic of a possible Raman spectroscopy set up. 
The system is composed of a light source (laser), different optics (lenses and fibres), a 
sample holder, filters (to remove a maximum of Rayleigh light), a spectrometer or 
wavelength selector and a detector. Any system also requires the use of a computer to 
display and analyse the data. The arrows represent the light propagation. 
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1.5.6 Principal component analysis 
 
Principal Component Analysis (PCA) is a multivariate statistical analysis used in this 
thesis to compare the different datasets generated by Raman spectroscopy.  
PCA was also the method chosen to generate WMR spectra from the original spectra 
(acquired at different laser wavelengths). PCA was shown to be the optimal algorithm 
to generate WMR spectra presenting high signal to noise ratio and good subtraction of 
the fluorescence background (Mazilu et al., 2010). 
PCA is used to study data allowing many more parameters per sample than sample 
number (data with high dimensionality). This mathematical process is used to reduce 
the dimensionality of the dataset and retain most of the variance. The PCA determines 
new variables called principal components (PCs) that are linear and extracted from 
the previous variables; in simple terms, it corresponds to a direction. Using only 
several PCs, the complex dataset can be expressed by a few numbers. The first PCs 
correspond to the direction in which most of the variation is observed in the dataset. 
The second PCs are not correlated to the first one, but instead corresponds to the 
direction in which most of the variation is observed in the dataset after the first PCs 
(Ringner, 2008). The PCA determines the direction or PCs that show the highest 
variation in the dataset. All PCs are orthogonal to each other and listed in a decreasing 
order accounting for the variability in the dataset. 
 
1.5.7 Calculation of sensitivity and specificity 
 
To estimate the difference between two datasets the ‘leave one out cross validation’ 
(LOOCV) technique can be applied. The PCA creates a multi-dimensional space 
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using the datasets where one Raman spectrum is then taken out (the ‘left out’ 
spectrum), and all the other spectra from the datasets are used as training sets. The 
‘left out’ spectrum is then placed in the multi-dimensional space and classified to 
either datasets. The classification is realised using the nearest neighbour algorithm. 
This process is then repeated for each spectrum from both datasets. Ultimately the 
user obtains a correct or an incorrect prediction of each spectrum, which permits the 
user to draw a confusion matrix and calculate the sensitivity and the specificity. 
 
1.5.8 Raman spectroscopy in biological features 
 
Cellular compounds and molecules (DNA, RNA, proteins, lipids, sugars) give a 
distinct Raman spectrum (De Gelder et al., 2007a). Once the Raman spectrum is 
obtained, it is crucial to be able to assign the observed peaks correctly as there is a 
high need of database recording information about biological features. In 2007 
Movasaghi and colleagues attempted to collect the assigned peaks already existing in 
the literature and group them in one review. This work represents a database where 
most of the biological features are included (Movasaghi et al., 2007). 
 
1.5.8.1 Nucleic acids 
Nitrogenous bases are the components of nucleotides and nucleic acids. There are five 
nitrogenous bases: adenine (A), cytosine (C), guanine (G), thymine (T) and uracil (U). 
In DNA there is no uracil and in RNA thymine is replaced by uracil. Nitrogenous 
bases are complex structures composed of carbon, oxygen, hydrogen and nitrogen 
with single and double bonds. All of the different atoms and bonds will result in a 
specific Raman spectrum. Using Raman spectroscopy, it is possible to differentiate 
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DNA and RNA bases (De Gelder et al., 2007a). In Raman spectra of nucleic acids, 
most Raman peaks are located between 400 and 1800 cm-1. Raman peaks in DNA 
spectra are mainly originate from the bases. For example, the peaks located at 666, 
729, 783, 1243, 1335, 1372, 1484 and 1577 cm-1 are related to the bases (A, T, C, G). 
The peak around 1060 cm-1 comes from the carbon-oxygen single bond vibration, at 
1100 cm-1 it is the phosphodioxy groups (PO2-). The peaks around 1460 cm-1 are 
linked to CH2 deformation, and the peak at 1664 cm-1 comes from C=O bond that 
occurs in T and G bases (Gorelik et al., 2014). 
 
1.5.8.2 Amino acids and proteins 
 
Proteins are composed of one or several chains of amino acids. Different amino acids 
present distinct Raman spectra (Candeloro et al., 2013). Many Raman peaks between 
600 cm-1 and 1700 cm-1 correspond to the different amino acids. The most intense 
peak can be observed around 1450 cm-1 and represents the CH bond deformation. This 
peak becomes more intense in the Raman spectrum of proteins as the number of CH 
bonds increases with the number of amino acids. Around 1655 cm-1, the amide I band 
(polypeptide backbone) can be found, which is mainly due to the C=O stretching. The 
amide III band, located between 1240-1280 cm-1, also corresponds to the polypeptide 
backbone and comes from N–H bending and C–N stretching (Tuma, 2005). 
 
1.5.8.3 Saccharides 
Raman spectra of saccharides and polysaccharides show peaks related to CCH, COH 
and OCH deformation between 800 and 950 cm-1. From 1000 to 1200 cm-1 the bands 
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observed correspond to C–C and C–O stretches; CH2 and CH2OH deformations are 
located between 1250 and 1500 cm-1 (De Gelder et al., 2007a). 
 
1.5.8.4 Lipids 
 
Lipids and especially intracellular lipid inclusions could represent a possible marker 
to identify dormant bacteria. Knowing where the main lipid peaks are present in the 
Raman spectrum is therefore crucial.  In 2002, Garton and colleagues studied the 
composition of lipid bodies and found that they mainly contain TAGs (Garton et al., 
2002). The positions of the major peaks for lipids are at 1296 cm-1 assigned for CH2 
twisting vibration, 1050-1150 cm-1 attributed to C–C stretching vibration, and around 
1450 cm-1 due to CH2 or CH3 deformations. Raman spectra of unsaturated fatty acids 
show an intense and sharp peak at 1655 cm-1 due to C=C stretching vibrations (De 
Gelder et al., 2007a, Wu et al., 2011). 
 
1.5.9 Raman spectroscopy on bacteria 
 
Raman spectra of individual molecules are helpful to understand the Raman spectrum 
of bacteria or other cells. The Raman spectrum of a whole bacterium is very complex 
as many different molecules compose the cell. To extract information about the 
chemistry of bacteria from its spectra, it is important to have access to a reliable 
reference database. Most biological information in a Raman spectrum are found 
between 400 and 4000 cm-1 (nucleic acids, proteins, polysaccharides, carbohydrate 
and lipids) (Movasaghi et al., 2007). In a complex sample such as bacteria, a Raman 
peak can represent several molecules. For example, the intensity of the lipid peak 
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around 1450 cm-1 is due to all the lipids present in the bacteria. It is possible to assign 
peaks to a group of molecules such as lipid or nucleic acid for example. In some 
cases, it is reasonable to assign a Raman peak to one molecule, the phenylalanine for 
example around 1000 cm-1 (Movasaghi et al., 2007). Huang and colleagues in 2004 
interrogated single bacteria (Pseudomonas putida NCIMB 11764) using Raman 
spectroscopy. They characterised the different main Raman peaks, indicated the 
location of the lipids, the nucleic acids, proteins, and carbohydrates (see Fig. 1.10) 
(Huang et al., 2004). 
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Figure 1.10 Analysis of a single bacterium using Raman spectroscopy. 
The bacterium investigated in Huang et al., 2004 was: Pseudomonas putida NCIMB 
11764. The figure shows the assignment of the major Raman peaks. The main lipid 
associated Raman band is present around 1450 cm-1. In the Raman spectrum of a 
complex entity, such as a cell, information regarding specific molecules can only be 
obtained if there is a specific Raman peak for this molecule, such as phenylalanine 
(around 1000 cm-1). Otherwise, the Raman spectrum provides information about 
large groups of molecules (lipids, proteins…etc) by giving their peak location and 
intensity. Figure modified from (Huang et al., 2004). 
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1.5.10 Table of assignment  
 
The peak assignment is crucial for extracting information out of the Raman spectra 
and understanding the biological meaning of a spectral change. Tab. 1.4 presents an 
overview of possible Raman peak assignment. 
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Table 1.4 Chemical bond assignment for Raman shifts. 
Peak cm-1 Assign bond Chemical 
association 
Reference 
490  Glycogen (Stone et al., 2004) 
666 Ring breathing 
G,T 
Guanine, Thymine 
(DNA base) 
(Movasaghi et al., 2007, Chan et al., 2006) 
723-725 Ring breathing A Adenine (DNA 
base) 
(De Gelder et al., 2007a, Movasaghi et al., 2007) 
780-790  DNA (Gorelik et al., 2014) 
865 O—C—C—N Phospholipid (Wu et al., 2011) 
 C—C  Backbone (Chan et al., 2006) 
930-935 C—C  Proline, valine 
protein backbone, 
glycogen 
(Kendall et al., 2011, Huang et al., 2003) 
1000-1005 C—C  Phenylalanine, 
proteins 
(Kendall et al., 2011, Huang et al., 2003, Cheng et al., 
2005, Lakshmi et al., 2002, Chan et al., 2006) 
1060-1100 C—C, 
COC, PO2- 
Lipids, 
Carbohydrates, 
DNA/RNA 
(De Gelder et al., 2007b, Chiriboga et al., 1998) (Gallier 
et al., 2011, Silveira et al., 2002) (Wu et al., 2011, 
Gallier et al., 2011) 
1126 C—C and    C—
N  
Lipids and proteins (De Gelder et al., 2007b, Cheng et al., 2005, Lakshmi et 
al., 2002, Chan et al., 2006) 
1245 Amide III Protein (beta strand) (Rusciano et al., 2013) 
1300 CH2 twist Lipids (Wu et al., 2011, Huang et al., 2003, De Gelder et al., 
2007b, Gallier et al., 2011, Lakshmi et al., 2002) 
1440 to 
1450 
CH2, CH3  
(bend) 
Lipids, fatty acids, 
proteins 
(Huang et al., 2003, Wu et al., 2011, Kendall et al., 
2011, De Gelder et al., 2007b, Gallier et al., 2011, 
Lakshmi et al., 2002, Chan et al., 2006) 
1650-1660 C=C Lipids (De Gelder et al., 2007b, Gallier et al., 2011, Lakshmi et 
al., 2002, Wu et al., 2011) 
1667 Amide I Protein (Rusciano et al., 2013) 
1740 C=O Lipids (Wu et al., 2011) 
2850-2930 C-H2, C-H3 Lipids, carbohydrate (Wu et al., 2011) 
3020 =C-H Lipid (Wu et al., 2011) 
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1.5.11 Raman spectroscopy studies on bacteria: a short review 
 
In microbiology, Raman spectroscopy studies began to generate data in the 1980s, 
thanks to significant improvement in laser technology during the previous decade. In 
1986 and 1987 Dalterio and colleagues demonstrated that Raman spectroscopy had 
the potential for microbiological identification as they succeeded in obtaining spectra 
of single bacteria (Dalterio et al., 1986, Dalterio et al., 1987). Since then, Raman 
spectroscopy has been widely used to study microorganisms in many fields including 
medicine and clinical applications, water quality, food quality… (Yang and 
Irudayaraj, 2003, Maquelin et al., 2002b, Fan et al., 2011, Nicolaou et al., 2011). For 
many applications, being able to target a single bacteria and obtain information is 
crucial. Raman spectroscopy has the ability to target and identify bacteria at the single 
cell level (Huang et al., 2004, Harz et al., 2009, Schuster et al., 2000). 
In medicine, it is crucial to be able to identify the infectious agent causing a disease, 
where a fast diagnosis could lead to rapid and appropriate treatment. Many in-vitro 
studies using Raman spectroscopy have been carried out on medically relevant 
microorganisms (Ibelings et al., 2005, Jarvis and Goodacre, 2004, Culha et al., 2010, 
Buijtels et al., 2008, Maquelin et al., 2002a). For example, Raman spectroscopy has 
already been applied to mycobacteria for discrimination at a species level (Stockel et 
al., 2016, Buijtels et al., 2008). Using Raman spectroscopy it was shown that M. 
smegmatis presents an enhanced production of carotenoid when cultured on glucose 
compared to acetate or glycerol (Kumar et al., 2015). In 2015, Stockel et al. showed 
that the Raman profile of M.smegmatis changes during the course of growth. In 
stationary phase cultures, M. smegmatis displays enhanced Raman lipid bands at 1081 
cm-1, 1305 cm-1, 1446 cm-1 and 1748 cm-1 (Stockel et al., 2015). 
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Samples obtained from TB patients and used for diagnosis and treatment management 
is usually sputum. Two studies investigating bacteria have been conducted using 
sputum samples (Rusciano et al., 2013, Kloss et al., 2015). Both studies showed that 
Raman spectroscopy could be applied to sputum samples, to identify bacteria. 
The dormant phenotype in TB is associated with the presence of intracellular lipid 
bodies as opposed to active cells. Being able to identify both phenotypes could lead to 
substantial improvement in terms of understanding the disease and treatment 
management. Lipid content can be studied by Raman spectroscopy (van Manen et al., 
2005, Wu et al., 2011). This technique requires minimal sample preparation, is non-
destructive, label-free and can differentiate closely related single bacteria. 
Thus, given the important role that dormant cells play in TB treatment, we sought to 
harness the discriminatory power of Raman spectroscopy to differentiate dormant 
(LR) from active (LP) mycobacterial cells. 
 
1.6 Thesis aims 
 
Dormancy in TB is a crucial area of research that could lead to a better understanding 
of the pathology of relapse which remains largely uncharacterised to date. Relapse is 
the major issue needing to be addressed to shorten TB treatment. The principal 
objective of this thesis project is to investigate the capacity of an all-optical, non-
destructive technique, Raman spectroscopy, to differentiate dormant (LR) cells from 
active (LP) cells in in-vitro and ex-vivo samples. The presence (LR bacterium) or 
absence (LP bacterium) of intracellular lipid bodies could be used to define the two 
phenotypes. Up to now phenotypic discrimination has been achieved on sputum 
samples but never directly in TB infected lung tissue sections. This is highly 
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challenging, as other material could surround bacteria in tissue sections. Thus, the 
central aim of this thesis is to design a method and protocols using Raman 
spectroscopy (a non-destructive and label-free technique), to investigate and 
discriminate LR and LP cells, both in in-vitro and in ex-vivo samples (Chapter 4 and 
5). 
 
In Chapter 3 we will investigate lipid extracts of M. tuberculosis using Raman 
spectroscopy. The aim of this chapter is to understand the changes in lipid content that 
occur in M. tuberculosis as the population ages and between LR and LP populations 
(the LR proportion increases as cultures age). The objective of the chapter will 
include investigation of the ability of WMR spectroscopy to study lipid extraction 
from bacteria, and evaluation of the relationship between lipid concentration and 
Raman peak intensity. 
 
In Chapter 6 we will investigate the growth dynamics of a mycobacterial population. 
This study will use M. smegmatis as a surrogate organism. The aim of this chapter is 
to understand the conversion from LR to LP cells when the environmental conditions 
are improving. Stationary phase and 24 hours old cultures will be investigated and 
their LR/LP proportion compared. If differences in phenotypic proportion are 
observed, further experiments will be conducted to try to understand the rate of 
conversion from LR to LP. Two methods will be used first: Nile red staining and 
Raman microscopy. 
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Chapter 2 General methods 
2.1 Bacterial cultures 
 
Three mycobacterial species were investigated in this work: M. smegmatis (NCTC 
8159), M. bovis (BCG, NCTC 5692), M. tuberculosis (NCTC 7416; H37Rv). All 
mycobacteria were grown at 37°C in Middlebrook 7H9 medium (Sigma-Aldrich, 
UK), supplemented with two mL of glycerol (Sigma-Aldrich, UK) for 450 mL of 
media and with 0.05% (v/v) Tween80 (Fisher Scientific, Fisher BioReagents, UK, 
BP338-500). M. bovis and M. tuberculosis were grown in this medium with the 
addition 1 vial (50 mL; For 450 mL of medium) of Middlebrook ADC enrichment 
(Sigma-Aldrich, UK). 
 
2.2 Glycerol stock 
 
M. smegmatis and BCG bought from NCTC were cultured as described above. Then 
500 µL of bacterial culture were mixed with 500 µL of 80% (v/v) glycerol solution 
(diluted with MiliQ water). The bacterial suspension was left at room temperature for 
half an hour in order to let the glycerol penetrate the cells. Then the stock tubes of M. 
smegmatis and BCG were stored at -80°C in 40% (v/v) glycerol. To start a new 
culture, the stock tube was taken and left to defrost at room temperature. Once 
defrosted, 10 µL of the bacterial suspension were plated on brain hart infusion (BHI; 
Oxoid, UK) agar. Then one colony was picked up, using a disposable plastic loop, to 
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start the new liquid culture. Every five to ten passages a new culture was started from 
the glycerol stock. 
 
2.3 Deuterium separation 
 
The bacteria were separated using a density based separation technique as described 
previously by Hammond et al in 2015 (Hammond et al., 2015). This method was used 
to obtain over 90% pure fractions of LR cells and LP cells. To perform this 
separation, two mL of bacterial culture were heat inactivated at 80°C for 20 minutes 
(see Chapter 2 General methods section 2.7 for more detail). M. tuberculosis has to 
be heat inactivated to be taken out the Cat 3 laboratory. The heat inactivation 
procedure does not induce a significant modification in the Raman spectra (Buijtels et 
al., 2008). The bacteria were resuspended in a mixed solution of D2O (Sigma-Aldrich, 
UK) and water at a known density. The density of pure D2O is 1.107 g.mL-1and the 
density of water is 1 g.mL-1. The bacteria were separated over night, in a plastic 
cuvette covered with PARAFILM® M (Sigma-Aldrich, UK, P7793), in D2O/H2O 
solution at a known density (1.04 g.mL-1). 100 microliters were removed from the top 
(LR) and the bottom (LP) of the D2O/H2O solution. The bacteria were spun down for 
three minutes at 20,000 x g and the supernatant slowly removed. The bacterial pellets 
were resuspended in 100 µL of PBS (Thermo Fisher Scientific, US). The two 
fractions were stained using Nile red (Sigma-Aldrich, UK, 19123)(see Chapter 2 
General methods Section 2.5 for more detail) and analysed by fluorescence 
microscopy (Leica DM5500; using an oil immersion objective x100). The fraction 
was used if the purity was greater than 90% (counted by eye). 
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2.4 Nile red stock 
 
1 mg of Nile red (Sigma-Aldrich, UK) was weighed using a precise balance. The 1 
mg of Nile red was dissolved in 4 mL of dimethyl-sulfoxide (DMSO; Sigma-Aldrich, 
UK) to create a 0.25 mg.mL-1 stock solution. This solution was kept in a sealed glass 
vial covered with aluminium foil and tape and stored in the dark at 4°C. 
 
2.5 Nile red staining of bacteria 
 
From the Nile red (Sigma-Aldrich, UK) stock solution (250 µg.mL-1) one µL was 
added to a 100 µL of bacterial suspension. The bacterial suspension was then vortexed 
and left at room temperature in the dark, usually covered with aluminium foil, for 10 
minutes. Then the tube was centrifuged for three minutes at 20,000 x g and the 
supernatant discarded. The bacterial pellet was resuspended in a 100 µL of PBS 
(Thermo Fisher Scientific, US). These washing steps were repeated twice. Finally, the 
bacterial pellet was resuspended in 20 µL of PBS (Thermo Fisher Scientific, USA) 
and 10 µL were heat fixed on a microscopic glass slide for microscopy or on a quartz 
slide (SPI Supplies, PA, USA) for Raman spectroscopy. 
 
2.6 Fluorescence microscopy 
 
The slides with heat fixed Nile red (Sigma-Aldrich, UK) stained bacteria were 
covered with aluminium foil to protect them from light. The microscope used was a 
Leica DM5500; a 100X-magnification oil immersion objective was used (Leica). 
Specific Leica immersion oil (ISO8036) was added and a Leica camera DFC 3000 G 
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captured the images. It was shown that Nile red is an excellent stain to observe 
intracellular lipid droplets composed of neutral lipids such as TAGs or cholesterol 
esters (Greenspan et al., 1985). These authors explain that the lipid droplets could be 
well observed using excitation ranging from 450 nm to 500 nm and observing the 
fluorescence emission > 528 nm. Nile red is highly fluorescent when in contact with a 
hydrophobic environment (Greenspan et al., 1985). Nile red is soluble in organic 
solvent. When the polarity of the solvent decreases the excitation and emission of 
Nile red spectra display a shorter wavelength (Greenspan and Fowler, 1985). The 
fluorescent properties of Nile red change depending on whether the fluorophore is in a 
relative polar or non-polar lipid environment. The polarity of the lipid environment 
impacts the maximal wavelength of excitation and emission fluorescence of Nile red. 
However, the spectra of Nile red in different lipid environments do overlap 
(Greenspan and Fowler, 1985). 
In order to observe both polar lipid environment and non-polar lipid environment, on 
Nile red stained samples, two filter cubes were used: L5 and TX2. In the L5 filter, the 
excitation light used was 480/40 nm meaning that the light going through the filter 
cube ranged from 460 nm to 500 nm. The emission light collected ranged from 512 
nm to 542nm (527/30 nm). The L5 filter was used to detect the fluorescence of the 
fluorophore located in a non-polar environment. In the TX2 filter, the excitation light 
used was 560/40 nm meaning that the light going through the filter cube ranged from 
540 nm to 580 nm. The light collected ranged from 608 nm to 683 nm (645/75 nm). 
The TX2 filter was used to detect the fluorescence of the fluorophore present in a 
polar lipid environment. The microscope’s software used was LAS AF 3.bu1.0 
(Leica). An example showing Nile red stained mycobacteria is presented in Fig. 2.1. 
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Figure 2.1 Example of Nile red labelled M. smegmatis. 
The final concentration of Nile red used was 2.5 µg.mL-1. The image showing the 
polar lipids (red channel) was taken using a TX2 filter cube; while the picture 
presenting the non-polar lipids (green channel) was taken with a L5 filter cube. The 
bottom left picture is the combined picture of the previous two, and one LR cell next 
to a LP cell can be observed. The picture was acquired using a one week old M. 
smegmatis culture (stationary phase). The scale bar represents 5µm. 
 
LR	cell LP	cell 
Green	channel Red	channel 
Overlay	picture 
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2.7 Heat inactivation 
 
In order to heat kill mycobacteria, one mL of cell culture was placed in a heat block 
for 20 minutes at 80°C. The heat killing protocol was validated (by the research 
group) on M. tuberculosis. This protocol permitted M. tuberculosis to be taken out of 
the containment level 3 (CL3) laboratory. After heat killing, the mycobacteria were 
plated on 7H10 (Sigma-Aldrich, UK) supplemented with 0.05% (v/v) glycerol 
(Sigma-Aldrich, UK) and 10% (v/v) OADC (Sigma-Aldrich, UK) and no growth was 
observed after four weeks. The same protocol was applied to M. smegmatis and BCG 
to work with the condition. 
 
2.8 Standard Raman spectroscopy and WMR spectroscopy 
 
In this work, both Standard Raman spectroscopy and WMR spectroscopy were 
applied to single bacteria. In the standard Raman spectroscopy, an individual 
spectrum was acquired over 30 seconds, the laser wavelength was fixed (784.6 nm) 
during the integration time. A spectrum of the background nearby the bacterium was 
taken and then subtracted from the spectrum of the bacterium to generate the standard 
spectrum. A flow chart (Fig. 2.2) shows how standard Raman spectra were acquired. 
In WMR spectroscopy a spectrum from a single bacterium was obtained using five 
spectra, of 30 seconds each, taken continuously (2.5 minutes in total). The laser line 
was tuned continuously during the acquisition; the modulation range was Δλ=1 nm. A 
WMR spectrum was generated with the five original spectra using PCA; in the 
process, most of the fluorescence background was removed, as it is identical in the 
five original spectra. PCA was explained in detail in Chapter 1 Introduction, 
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section 1.5.6. In WMR spectra the peaks are represented by the zero-crossing and the 
peak intensity by the peak-to-valley value. A flow chart (Fig. 2.3) shows how WMR 
Raman spectra were acquired. For each preparation 40 to 60 spectra of single cells 
were acquired. 
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Figure 2.2 Flow chart describing the acquisition of a standard Raman spectrum of a 
single bacterium. For each standard Raman spectroscopy spectrum one background 
and one reference were taken.  
 
Figure 2.3 Flow chart representing the acquisition of a WMR spectrum of a single 
bacterium. 
 
 
 
 
Acquisition	of	the	background	~1μm	away	from	the	bacterium	to	interrogate	(30	seconds)	
Move	from	the	the	background	to	the	single	bacterium	(few	seconds)	
Acquisition	of	the	signal	from	the	single	bacterium	with	subtraction	of	the	background	taken	previously(30	seonds)	
Acquisition	of	the	Iirst	spectrum	(30	seconds)	
Acquisition	of	the	second	spectrum	(30	seconds)	
Acquisition	of	the	third	spectrum	(30	seconds)	
Acquisition	of	the	fourth	spectrum	(30	seconds)	
Acquisition	of	the	Iifth	spectrum	(30	seconds)	
The	Iive	spectra	with	PCA	are	used	to	create	the	WMR	spectrum	
The	Iluorescence	background	can	be	removed		by	combining	the	modulation	and	PCA	
The laser wavelength is tuned continuously (Δλ=1 nm over 2.5 
minutes) 
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2.9 Laser Calibration using polystyrene 
 
Polystyrene beads (1 µm in diameter) were used to calibrate the Raman spectra. The 
known peak position (1001.4 cm-1, see Fig. 2.4) of a polystyrene bead was measured 
by our system in order to monitor drifts of the laser. Each Raman spectrum was 
calibrated with the nearest laser line that was calculated from the spectra of the 
polystyrene beads. To calculate the laser wavelength, using the known the position of 
the main polystyrene peak (∆ω = 1001.4 cm-1), the following equation was used: 
 
∆! !"!! = 1!!(!")− 1!!(!") × (10!!")(!")  
Where ∆ω corresponds to the Raman shift, λ0 (nm) is the laser wavelength to 
calculate and λ1 (nm) the measured wavelength of the main polystyrene peak in the 
Raman spectrum. 
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Figure 2.4 WMR spectrum of a Polystyrene bead. 
The spectrum was acquired on a 1 µm polystyrene bead. The x-axis shows the Raman 
shift in cm-1 and the y-axis presents the differential intensity in arbitrary units. In a 
WMR spectrum, the peaks are located at the zero crossing; the zero is represented by 
the black dash dotted line. The main Raman peak of the polystyrene is visible at 
1001.4 cm-1. The main peak at 1001.4 4 cm-1 is a result of the C-C aromatic ring 
stretching (Winkler et al., 2003). 
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Each spectrum was also normalised by its total intensity (using the integration over 
the area covered by the spectrum) in order to avoid the influence of any fluctuation in 
the laser power during wavelength modulation. Raman spectra in the region of 600 
cm-1 to 1800 cm-1 were taken into account for the later data analysis. 
 
2.10 Discrimination between datasets using Principal component 
analysis (PCA) 
 
PCA was explained in detail previously (see Chapter 1 Introduction, section 1.5.6 
for more detail). The PCA was run in MATLAB® (MathWorks, UK, version 
R2014b). Datasets (40 to 100 spectra) acquired using conventional Raman 
spectroscopy or WMR spectroscopy were investigated using PCA. In order to 
discriminate the data sets, usually LR and LP, the first seven PCs were used. The first 
seven PCs represented more than 70% of the variances between the datasets. 
 
2.11 Leave one out cross validation (LOOCV) 
 
The leave-one-out cross validation method was used to evaluate the ability to 
discriminate datasets. Using the LOOCV method the correct or an incorrect prediction 
of each spectrum were obtained and used to inform the confusion matrix and calculate 
the sensitivity and the specificity (see Chapter 1 Introduction, section 1.5.7 for 
more detail). The LOOCV was run in MATLAB® (MathWorks, UK, version 
R2014b). 
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2.12 First Raman spectroscopy system 
 
Raman spectra were acquired by a confocal Raman spectroscopy system shown in 
Fig. 2.5. Pumped by a green laser (Verdi V6, 532 nm, 5W), a tunable Ti:Sapphire 
laser (Spectra-Physics 3900s,  785 nm, 1W) was focused by a microscope objective 
(Nikon, 50x, oil immersion) onto a single cell. The objective numerical aperture (NA) 
was 0.9, the confocal diameter was 2.63 µm, and confocal depth was 2.86 µm. 
Excited Raman photons were then collected by a spectrometer formed with a 
monochromator (Andor Shamrock SR303i, 400lines/mm grating @850 nm) and a 
cooled CCD camera (Andor Newton). In order to get strong Raman signal from a 
single cell, a power of 150 mW was applied onto the sample plane. We designed an 
experiment to assess the impact of the laser to the bacteria. This experiment was 
carried out, using a stationary phase culture of M. smegmatis, on 3 individual bacteria 
(N=3). We took 10 spectra in a row on the same bacteria. This represents 1500 
seconds of exposure to the laser. No spectral differences were observed between the 
first spectrum and the last one in the three experiments. The results for one bacterium 
are shown in the Appendices section 7. This focused laser power did not induce any 
damage to the cell during the acquisition of spectra. 
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Figure 2.5 Diagram of the initial experimental setup. First Raman system. 
The design used a tunable Ti:Sapphire laser (Spectra-Physics 3900s,  785 nm, 1W) 
that was Pumped by a green laser (Verdi V6, 532 nm, 5W). The laser used a 
microscope objective (Nikon, 50x, oil) to focus on the sample plane. EF stands for 
edge filter, NF corresponds to notch filter, L1, L2 and L3 are lenses and LF stands for 
line filter. Finally, the spectrometer was made of a monochromator (Andor Shamrock 
SR303i, 400lines/mm grating @850 nm) and a cooled CCD camera (Andor Newton).  
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2.13 Second Raman spectroscopy system 
 
This combined Raman spectroscopy and fluorescence system (Fig. 2.6) was built up 
based on a Nikon microscope (Nikon TE2000-E). A tunable Ti:Sapphire laser (Solstis 
M squared, 1W @785 nm) was used as an excitation source which was focused by a 
microscope objective (Nikon Plano, 40X, oil immersion) onto a single bacteria cell. 
The objective NA was 1.3, the confocal diameter was 5 µm, and the confocal depth of 
the system was 4.68 µm. As shown in Fig. 2.6, excited Raman photons from the 
sample were dispersed by a monochromator (Andor Shamrock SR303i, 400 lines/mm 
grating @850 nm) and finally formed a spectrum on a cooled CCD camera (Andor 
Newton). A laser dosage at 150 mW at the sample plane was used in order to excite 
enough Raman photons. This laser dosage was tested and didn’t show any damage to 
the cells. 
The system is able to switch from Raman spectroscopy to fluorescence imaging by 
inserting FITC/TRITC cubes into the microscope and directing the flip mirror (FM) to 
CCD1 (Hamamatsu ORCA-ER). Using a standard Nikon fluorescence white light 
source (Lamp2) together with FITC/TRITC cubes, a green excitation light (545~565 
nm) will excite red fluorescence emission (580~620 nm) from a polar lipid 
environment in the Nile red stained samples while a blue excitation light (475~490 
nm) will excite green fluorescence emission (500~540 nm) from a non-polar lipid 
environment (lipid bodies). 
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Figure 2.6 Raman spectroscopy and fluorescence combined system. Second Raman 
system.  
The excitation source used is a tunable Ti:Sapphire laser (Solstis M squared, 1W 
@785 nm). The components used to build the system are: SF (single-mode fibre), MF 
(multi-mode fibre, 200um core diameter), LF (Laser line filter (Semrock LL01-785)), 
EF (Edge filter (Semrock LPD02-785RU)), NF (Notch filter (Semrock NF03-785E)), 
FM (flip mirror). For the fluorescence: TRITC/FITC: Fluorescence Filter cubes  
(FITC: excitation 475-490 nm/emission 500-540 nm, TRITC: excitation 545-565 
nm/emission 580-620 nm). The different cameras used were: CCD1: Hamamatsu 
ORCA_ER; CCD2:Imaging Source USB camera (DFK 42AUC03); CCD3:Andor 
Newton Camera (cooled at -70oC); L1~L6: lenses; F/#: F number matcher. 
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Chapter 3 Investigation of Mycobacterium 
tuberculosis total lipid extracts using Raman 
spectroscopy. 
3.1 Introduction 
 
We define, based on Nile red staining and microscopic observation, the Lipid rich 
(LR) cells as bacteria that have one or more intracellular non-polar lipid bodies or 
detectable forming lipid bodies whereas lipid poor cells (LP) correspond to bacteria 
that have no detectable intracellular lipid bodies. The intracellular lipid bodies present 
in mycobacteria are mainly composed of TAGs (Garton et al., 2002). The lipid 
composition of mycobacteria is very complex, and a lot of those lipids are unique to 
the Mycobacterium genus (Sartain et al., 2011). A lipidomic study of M. tuberculosis 
has been conducted using mass spectrometry showing that the lipid content changes 
between a young and old culture. As the culture ages, various lipid classes contain 
enhanced proportion of homologues with long acyl substituents (Sartain et al., 2011). 
This group developed a lipid database of M. tuberculosis using mass spectrometry 
(“Mtb LipidDB”). This lipid database presents the exact mass of over 2,500 entities. 
As a mycobacterial culture ages the proportion of LR cells increases (See Chapter 6 
result section 6.3.1 for more detail). It has been demonstrated that LR cells exhibit a 
much higher level of tolerance to antibiotic treatment (Hammond et al., 2015). Thus, 
the presence of intracellular lipid bodies can be seen as a potential marker of higher 
antibiotic tolerance and lower metabolic activity. This is clinically important as a high 
percentage of lipid body positive bacilli in patients at 21-28 days into treatment have 
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been linked to an unfavourable outcome (Sloan et al., 2015). The presence or absence 
of lipid bodies could be used to discriminate phenotypically antibiotic tolerant from 
sensitive bacteria. In this study, we investigated total lipid extracts from bacteria 
using Raman spectroscopy. This chapter aims to: first, identify the lipid peak location 
in the Raman spectrum. Secondly, to evaluate the relationship between the lipid 
concentration and the Raman peak intensity. Finally, to investigate the changes in 
lipid content that occurs in LR and LP population of M. tuberculosis as the population 
ages. 
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3.2 Methods 
3.2.1 Lipid extraction 
 
In order to extract the total lipids, the Bligh & Dyer lipid extraction protocol was 
used. (Bligh and Dyer, 1959). All steps concerning the lipid extraction were 
performed using glass vials (Camlab, UK; 1.75 mL). All vortex steps were done at 
max speed for 15 to 20 seconds on a peqTWIST (Peqlab) vortex. Firstly, at room 
temperature, one mL of bacterial culture (≈1.107 bacteria per ml) was spun down at 
20,000 x g for three minutes. The cell pellet was washed with 200 µL PBS three 
times. The bacterial suspension (200 µL) was transferred into a small glass screw cap 
vial, 250 µL of chloroform and 500 µL of methanol were added to the glass vial. 
Samples were thoroughly vortexed to ensure that bacteria were completely 
delipidated and lipids solubilised (up to this point, all steps were conducted at room 
temperature). The samples were placed in continuous agitation at 1000 rpm for at 
least one hour to ensure efficient extraction. This was performed at 4°C to prevent the 
evaporation of the solvents. Then 250 µL of chloroform were added, and the tubes 
were vortexed well. 250 µL of water were added, and the tubes were vortexed well 
again. After this step, all the procedures were conducted at room temperature. The 
glass vials were inserted in 15 mL Falcon tubes (CELLSTAR) that were half-filled 
with tissue or paper. The samples were centrifuged for 10 minutes at 3500 x g (J6-
M1, Beckman Coulter centrifuge), a clear phase separation was observed with a sharp 
interphase (containing the cellular debris). The bottom organic phase (lipid 
containing) was harvested by inserting a long and thin pipette tip (Fisher Scientific, 
Pipettor tip SureOne, 12982571) and as much volume as possible was pipetted from 
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the bottom phase. The bottom phase has been placed into a new glass vial and dried in 
a fume cabinet. The samples were then stored at 4°C. 
 
3.2.2 Sample preparation for Raman spectroscopy investigation 
 
Total lipids, from the glass vial, were resuspended in chloroform (20 µL). Then a 5 
µL drop was placed on a thin quartz coverslip (01015T-AB, SPI Supplies, USA; 
Quartz coverslip 25,4 x 25,4 mm, 0.15-0.18 mm thick) and left to air dry in the hood. 
The dry lipids were covered using a thick quartz slide (01016-AB, SPI Supplies, 
USA; Quartz microscope slide 25,4 x 25,4 mm, 1 mm thick) presenting a vinyl 
spacer. The mount was sealed with a transparent Nail polish; this preparation was 
interrogated using Raman spectroscopy. 
 
3.2.3 Raman spectroscopy and acquisition time for extracted lipids 
 
WMR spectroscopy acquisition was 2 seconds x5x5 (meaning that five 2 second 
spectra were accumulated and this was reproduced five times) 50 seconds total per 
WMR spectrum, for all dried total lipid extract samples. The standard Raman 
spectroscopy acquisition time was 10 seconds per spectrum. These results were 
acquired using the second Raman spectroscopy system (see Chapter 2 General 
methods, section 2.13 for more details). 
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3.2.4 Lipid concentration and WMR spectroscopy 
 
A commercial lipid standard (Mono-, Di-, and Triglyceride mix) (1787-1AMP, 
Sigma-Aldrich, UK) was diluted to the required concentration in DMSO (Sigma-
Aldrich, UK). A small spacer was placed on a quartz slide and filled with 5 µL of 
lipids diluted in DMSO. The quartz slide was then covered with a quartz coverslip 
and sealed with transparent nail polish. The sample was then interrogated using WMR 
spectroscopy. The acquisition time was 150 seconds in total (6x5x5 seconds). These 
results were acquired using the first Raman spectroscopy system (see Chapter 2 
General methods, section 2.12 for more details). 
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3.3 Results 
3.3.1 Standard Raman spectroscopy 
 
Total lipids were extracted from M. tuberculosis cultures of different age: one month, 
three months and four months old (initial time points tested). The dried lipid extracts 
were investigated by Raman spectroscopy. Examples of lipid aggregates observed 
under the Raman spectroscopy system from the three time points are presented in Fig. 
3.1. The standard Raman signals of the lipid extracts are shown in Fig. 3.2. The 
intensity of the Raman signal depends directly on the size of the lipid aggregate 
interrogated. In this study pure lipid extract were investigated. Therefore, differences 
in terms of absolute intensity are not relevant. However, changes in peak position or 
ratios between Raman peaks can be related to a change in composition. 
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Figure 3.1 Lipid aggregates dried out from of chloroform suspension (M. 
tuberculosis). 
Total lipids were extracted from one month, three months and four months old M. 
tuberculosis cultures. An arrow shows the lipid aggregates. The total lipid extract 
was left to dry on the quartz slide. Total lipid aggregates were quite rare on the 
slides, only several were targeted for each condition and several WMR spectra were 
taken on every aggregate. The scale bars correspond to 5 µm. 
1 month old 
3 months old 
4 months old 
5 µm 
5 µm 
5 µm 
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Five main peaks can be observed in the fingerprint region (1000-1800 cm-1) and one 
double-headed peak in the 2800-3000 cm-1 region. Those seven peaks are named 
bands 1 to 7 from left to right (Fig. 3.2). For the three time points, the peak at 1449 
cm-1 is showing a clear shoulder located at 1465 cm-1. 
The exact peak position for each condition is presented in Tab. 3.1. The peak 
positions of the total lipid extract do not change between the different time points. 
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Figure 3.2 Mean standard Raman spectra of M. tuberculosis total lipid extract of one 
month old (a), three month old (b) and four month old (c).  
The colour-shaded area represents the associated single standard deviation. The x-
coordinate in (Fig. 3.2 a, b, c) corresponds to the Raman shift (in wavenumber, cm-1) 
and the y-coordinate corresponds to the differential Raman intensity in arbitrary 
units. The acquisition time is 10 seconds per spectrum in total (see Chapter 3 section 
3.2.3 for more details). Around 60 to 65 spectra were taken for each condition. 
 
 
 
 
 
 
 
 
Raman shift (cm-1)
1000 1500 2000 2500 3000
Ra
m
an
 in
te
ns
ity
 (a
rb
. u
nit
s)
 M. tuberculosis 1 month old total lipid extraction
Raman shift (cm-1)
1000 1500 2000 2500 3000
Ra
m
an
 in
te
ns
ity
 (a
rb
. u
nit
s)
 M. tuberculosis 3 months old total lipid extraction
Raman shift (cm-1)
1000 1500 2000 2500 3000
Ra
m
an
 in
te
ns
ity
 (a
rb
. u
nit
s)
 M. tuberculosis 4 months old total lipid extraction
(a) 
(b) 
(c) 
1 
2 
3 5 
4 
6 
7 
1 
2 
2 1 
3 
4 
5 
6 
7 
3 
4 
5 
6 
7 
 105 
Table 3.1 Exact position of the main Raman band present in the total lipid extract 
standard spectra of M. tuberculosis. 
Main Raman 
bands 
One month (peak 
position in cm-1) 
n=1 
3 months (peak 
position in cm-1) 
n=1 
4 months (peak 
position in cm-1) 
n=1 
Band 1 1063 1063 1063 
Band 2 1131 1131 1131 
Band 3 1300 1300 1300 
Band4 1449 1449 1449 
Band 5 1465 1465 1465 
Band 6 2875 2875 2875 
Band 7 2908 2908 2908 
 
Using the standard Raman spectra taken from the total lipid extract of M. tuberculosis 
no changes could be found in peak positions between the three time points. 
 
3.3.2 WMR spectroscopy 
 
The spectra were obtained using WMR spectroscopy meaning that the laser 
wavelength was tuned during the acquisition. To create each WMR spectrum; five 
original spectra were taken while the laser wavelength was changing. In Fig. 3.3 a 
clear shift in Raman peak position can be observed between the five individual 
spectra due to the modulation. As seen in the introduction, WMR spectroscopy can 
remove the fluorescence background entirely as only the position of Raman peaks 
changes during the modulation; the fluorescence remains unchanged. After data 
processing, using PCA, a modulated Raman spectrum is obtained (Fig. 3.4) in which 
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all fluorescence background has been removed and where the zero crossing 
corresponds to the Raman peak. PCA was previously shown to be the optimal 
algorithm for fluorescence subtraction in WMR spectroscopy (Mazilu et al., 2010). 
WMR spectra show clear and distinct peaks. For example, around 1465 cm-1 there is a 
shoulder in the standard Raman spectrum and after processing a clear peak can be 
observed, and its intensity measured accurately. 
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Figure 3.3 the five initial spectra acquired during modulation. 
Each coloured line represents a different spectrum (five in total). The Raman peaks in 
the five spectra are shifted as the laser was tuned during the acquisition. The x-
coordinate corresponds to the Raman shift (in wavenumber, cm-1) and the y-
coordinate corresponds to Raman intensity in counts. The acquisition time for each 
spectrum is 50 seconds in total (see Chapter 3 section 3.2.3 for more details). 
 
 
Figure 3.4 Example of WMR spectrum after processing. 
The WMR spectrum is generated using the five original spectra presented in Fig. 3.3 
and the PCA algorithm. The x-coordinate corresponds to the Raman shift (in 
wavenumber, cm-1) and the y-coordinate corresponds to Raman intensity in counts. In 
a WMR spectrum, a Raman peak is located at the zero crossing point (denoted by the 
red line) while the Raman peak intensity is represented by the peak-to-valley value 
around that point. The acquisition time for each spectrum is 50 seconds in total (see 
Chapter 3 section 3.2.3 for more details). 
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The WMR spectra of the total lipid extract of M. tuberculosis are shown in Fig 3.5. 
Comparing the result from standard and modulated Raman spectroscopy, manifest 
differences regarding peak ratios can be observed. For example, in the standard 
Raman spectrum, the 1300 cm-1 peak is less intense compared to the 1449 cm-1, and it 
is the opposite in the WMR spectrum. Moreover, the WMR spectrum presents more 
detail around 1465 cm-1 where a clear peak can be identified whereas this was only a 
shoulder in the standard Raman spectrum. The WMR spectrum allows accurate 
determination of the peak value and its intensity. The peak positions in all the WMR 
spectra are shown in Tab. 3.2. 
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Figure 3.5 Mean WMR spectra of M. tuberculosis total lipid extract of one month old 
(a), three month old (b) and four month old (c). 
The colour-shaded area represents the associated single standard deviation. The x-
coordinate in (Fig. 3.5 a, b, c) corresponds to the Raman shift (in wavenumber, cm-1) 
and the y-coordinate corresponds to the differential Raman intensity in arbitrary 
units. In a WMR spectrum, a Raman peak is located at the zero crossing point 
(denoted by the dash-dotted line) while the Raman peak intensity is represented by the 
peak-to-valley value around that point. The acquisition time for each spectrum is 50 
seconds in total (see Chapter 3 section 3.2.3 for more details). Around 60 to 65  
WMR spectra were taken for each condition. 
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Table 3.2 Exact position of the main Raman band present in the WMR spectra of M. 
tuberculosis total lipid extract.  
Main Raman 
bands  
One month (peak 
position in cm-1) 
n=1 
3 months (peak 
position in cm-1) 
n=1 
4 months (peak 
position in cm-1) 
n=1 
Band 1 1063 1063 1063 
Band 2 1131 1131 1131 
Band 3 1300 1300 1300 
Band4 1449 1449 1449 
Band 5 1465 1465 1465 
Band 6 2875 2875 2875 
Band 7 2908 2908 2908 
 
The Raman peak positions are the same before and after the data processing and 
fluorescence background removal. The peak-to-peak ratios between the main Raman 
peaks present in the fingerprint region were calculated using the WMR spectra A 
table showing all possible ratios, between the main bands, is shown in the 
Appendices section 1. Differences in peak-to-peak ratio can be observed between 
time points; however high variability among each condition is also observed. The 
Tab. 3.3 displays examples of peak-to-peak ratios. 
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Table 3.3 Peak-to-peak ratios calculated using Raman spectra of M. tuberculosis lipid 
extracts for the different culture ages with the corresponding single standard 
deviation. 
  1 month 3 months 4 months 
Ratios Average Standard 
deviation 
Average Standard 
deviation 
Average Standard 
deviation 
1060/1131 1.06 0.02 1.07 0.10 1.08 0.03 
1060/1300 0.67 0.02 0.67 0.03 0.67 0.01 
1060/1449 0.76 0.04 0.95 0.16 0.96 0.12 
1060/1465 1.89 0.13 1.92 0.15 2.53 0.25 
1060/2876 1.43 0.09 1.64 0.20 1.72 0.26 
1060/2908 1.04 0.04 1.34 0.28 1.14 0.13 
 
Before comparing peak-to-peak ratios between time points, it is important to observe 
the variability among each data set. For each time point, 60 to 65 spectra were taken 
from several lipid aggregates of various sizes and volume. The lipid samples were 
homogenised. However, important variation can be observed within one dataset. This 
variation between items can also be observed in the 3D PCA plot where for each 
condition distinct groups of spectra can be observed corresponding to different lipid 
aggregates Fig. 3.6. The exact composition of lipids can change between aggregates 
and also the orientation of the molecules, changing the vibrational profile and 
therefore the peak-to-peak ratio even if the composition remains unchanged. A study 
showed that pure lipid could give different relative peak intensity depending on the 
lipid aggregate targeted (Czamara et al., 2015). 
Within one time point, the variability in peak-to-peak ratios can be significant. 
However, the variation is small in the same aggregate Tab. 3.4. The variability within 
each dataset comes from differences between lipid aggregates. For example, the ratio 
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1060/2908 in the first aggregate is on average 0.85, in the second aggregate it is 1.53, 
and it is 1 in the fourth aggregate. However, the variability among each lipid 
aggregate is very low as shown by the small standard deviation for all the ratios. 
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Figure 3.6 Variability of lipid aggregates, of M. tuberculosis lipid extracts, as seen in 
PCA score plot.  
The one month, three months and four months old cultures, are shown in red, blue 
and green respectively. The first three PCs are plotted. The red, blue and green dots 
represent the lipid extraction of M. tuberculosis from one month old, three months old 
and four months old cultures respectively. Each dot corresponds to one WMR 
spectrum. 
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Table 3.4 Peak-to-peak ratios of all lipid aggregates of 3 month old M.tuberculosis 
and associated single standard deviation. For each lipid aggregate interrogated the 
total intensity of the seven main peaks is also shown in this table. 
Aggregate 1 2 3 4 5 
Ratios Average Stdev Average Stdev Average Stdev Average Stdev Average Stdev 
1060/1131 1.30 0.02 1.04 0.01 1.03 0.01 1.16 0.02 0.99 0.02 
1060/1300 0.64 0.01 0.72 0.01 0.70 0.01 0.66 0.01 0.67 0.02 
1060/1440 0.62 0.01 1.09 0.02 1.06 0.03 0.78 0.02 1.04 0.04 
1060/1465 1.58 0.04 2.10 0.04 2.01 0.06 1.94 0.09 1.92 0.11 
1060/2876 1.23 0.03 1.83 0.03 1.79 0.04 1.44 0.03 1.75 0.07 
1060/2908 0.85 0.02 1.53 0.03 1.55 0.03 1.00 0.02 1.53 0.04 
Total peak intensity 15872 910 13633 258 12863 305 18205 361 14997 412 
The contribution of the major Raman peaks to the total intensity of those peaks was 
investigated and compared for the different conditions. The intensity of each peak and 
the total intensity of the seven main peaks were calculated for all the time points 
(Tab. 3.5) and plotted in Fig. 3.7. 
No significant differences were found in relative peak intensity between time points. 
The great variation between lipid aggregates led to vast standard deviation values that 
do not permit significant statistical differences in peak contributions between time 
points to be obtained. 
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Table 3.5 Contribution of each peak to the total intensity of the seven main peaks for 
all time points.  
time points  Raman peaks (cm-1) 1060 1131 1300 1440 1465 2876 2908 
1 month Percentage 14.37 13.55 21.57 18.97 7.62 10.10 13.80 
2 standard 
deviations (STD) 
0.77 0.84 0.57 0.90 0.75 0.72 0.69 
3 month Percentage 15.61 14.73 23.12 16.79 8.14 9.57 12.04 
2 standard 
deviations (STD) 
2.24 4.25 2.37 3.95 0.93 1.13 4.09 
4 month Percentage 15.76 14.54 23.57 16.62 6.26 9.29 13.96 
2 standard 
deviations (STD) 
1.65 1.86 2.55 2.40 0.87 1.81 1.71 
 
 
Figure 3.7 Contribution of each peak to the total intensity of the seven main peaks for 
the three time points.  
The x-axis shows the seven main peaks present on the Raman spectra of 1month 
(blue), three months (red) and four months (green). The y-axis represents the average 
contribution of each peak to the sum of the seven main peaks in percentage and this 
for all three data sets. The error bars correspond to two standard deviations above 
and under the mean. 
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For both one month and four months old cultures, M. tuberculosis cells were 
separated using a density-based method (D2O separation, see in Chapter 2 General 
methods section 2.3 for more details) to obtain a lipid rich (LR) fraction and a lipid 
poor (LP) fraction. The purity of the fractions was assessed by fluorescence 
microscopy. The total lipids are extracted from both LR and LP fractions. The WMR 
spectra of one month (LR and LP) and four months (LR and LP) are shown in Fig. 3.8 
and Fig. 3.9 respectively. Similarly, to the previous dried samples, LR and LP could 
not be discriminated due to important variation among each dataset (high variability 
between aggregates within the same sample). 
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Figure 3.8 Mean WMR spectra of M. tuberculosis lipid extract of LR (a) and LP (b) 
fraction of a one month old culture. 
The colour-shaded area represents the associated single standard deviation. The x-
coordinate in (Fig. 3.8 a, b) corresponds to the Raman shift (in wavenumber, cm-1) 
and the y-coordinate corresponds to the differential Raman intensity in arbitrary 
units. In a WMR spectrum, a Raman peak is located at the zero crossing point 
(denoted by the dash-dotted line) while the Raman peak intensity is represented by the 
peak-to-valley value around that point. The acquisition time for each single spectrum 
is 50 seconds in total (see Chapter 3 section 3.2.3 for more details). 
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Figure 3.9 Mean WMR spectra of M. tuberculosis lipid extract of LR (a) and LP (b) 
fraction of a four month old culture.  
The colour-shaded area represents the associated single standard deviation. The x-
coordinate in (Fig. 3.9 a, b) corresponds to the Raman shift (in wavenumber, cm-1) 
and the y-coordinate corresponds to the differential Raman intensity in arbitrary 
units. In a WMR spectrum, a Raman peak is located at the zero crossing point 
(denoted by the dash-dotted line) while the Raman peak intensity is represented by the 
peak-to-valley value around that point. The acquisition time for each spectrum is 50 
seconds in total (see Chapter 3 section 3.2.3 for more details). 
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Finding differences in the dried total lipid extract between the conditions using 
Raman spectroscopy is difficult. Investigating those samples by mass spectrometry 
could be an alternative. Mass spectrometry has been previously used to investigate M. 
tuberculosis lipid content (Sartain et al., 2011). 
 
 
3.3.3 Lipid quantification using WMR spectroscopy 
 
 
To obtain the relationship between lipid concentration and Raman peak intensity we 
used a solvent to dissolve a known lipid mass of a commercial lipid mix (Triglyceride 
mix, Sigma-Aldrich). The first solvent tested was chloroform, and no signal could be 
acquired as it evaporates too quickly even when trapped between quartz slides. 
DMSO was then tested as this solvent does not evaporate fast preserving the lipid 
concentration while measuring. It was observed that some lipids dissolved in DMSO, 
but the efficacy of the dissolution was not assessed. This means that the lipid 
concentration of the solution was not exactly known; however, the dilution factor was 
known. The lipid mix was diluted in DMSO at several concentrations in order to 
study the relation between lipid concentration and Raman peak intensity. Pure DMSO 
and all the lipid dilutions were interrogated by WMR spectroscopy for 150 seconds as 
total acquisition time. The results are shown in Fig. 3.10 a and an enlarged view is 
presented in Fig. 3.10 b. Pure DMSO does not display a peak at 1730 cm-1 compared 
to the solution containing the dissolved lipids. The Raman spectrum of pure DMSO 
shows a peak around 1440 cm-1 where one of the main lipid bands is also located. We 
observe that the lipid band is slightly shifted compared to the DMSO peak. A 
shoulder that decreases with lipid intensity can be noticed at 1450 cm-1 Fig. 3.10 a 
and b. 
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Figure 3.10 Lipid mix dissolved in DMSO at several concentrations.  
The mean WMR spectra of each condition is calculated over 10 spectra and 
represented by a coloured line. The x-axis show the Raman shift in wavenumbers (cm-
1) and the y-axis displays the Raman intensity in arbitrary units. The Fig. 3.10 a 
presents the WMR spectra of all conditions over a wide range, from 900 to 3100 cm-1. 
The Fig. 3.10 b is an enlarged view of the Fig. 3.10 a corresponding to the black 
window (1440 to 1800 cm-1).  
 
 
(a)  
(b)  
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From the WMR spectra, of the diluted lipids in DMSO, the Raman peak intensity at 
1730 cm-1 have been plotted against to the lipid concentration. The results are shown 
in Fig. 3.11. A linear relationship is found between the Raman intensity and the lipid 
concentration. The Raman peak intensity (in arbitrary unit) corresponds to 6132 times 
the lipid concentration value (in mg.µL-1). 
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Figure 3.11 Relation between Raman intensity and lipid concentration. 
The x-axis represents the lipid concentration in mg.µL-1, the y-axis the Raman peak 
intensity at 1730 cm-1. The dilution points are shown in blue with the corresponding 
standard deviation represented as error bars. The standard deviations were 
calculated from 10 values for each condition. A red line represents the relation 
between the Raman intensity and the lipid concentration. 
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3.4 Discussion 
 
M. tuberculosis and other mycobacteria species were previously studied and 
successfully discriminated by Raman spectroscopy (Buijtels et al., 2008, Stockel et 
al., 2016). These studies provided information about the standard Raman spectrum of 
M. tuberculosis. However, as far as we know, no study has been carried out on M. 
tuberculosis extracted lipids using Raman spectroscopy. The dried total lipid extract 
interrogated by Raman spectroscopy showed the exact position of the main Raman 
lipid peaks. The lipid peaks are presented in the Tab. 3.1 and Tab. 3.2 are located at: 
1063, 1131, 1300, 1449, 1465, 2875 and 2908 cm-1. All those bands can also be 
associated with lipids, based on Raman database (Movasaghi et al., 2007). 
It is important to note that WMR spectroscopy and standard Raman spectroscopy do 
not produce identical spectra (Fig. 3.3 and Fig. 3.4). Using WMR spectroscopy with 
PCA, the fluorescence background is subtracted in the WMR spectra (De Luca et al., 
2010, Mazilu et al., 2010). In the standard Raman spectrum, the peak at 1465 cm-1 
(Fig. 3.3) is visible but not clearly. The band 1449 and 1465 cm-1 are merged; the 
1465 cm-1 represents a shoulder on the side of the peak. This is therefore very difficult 
to estimate the intensity of this peak. By comparison the WMR spectrum shows two 
distinct peaks and both can easily be quantified (Fig. 3.4). Moreover, the ratio 
between peaks changes between standard Raman spectra and WMR spectra. For 
example, the ratio between the peak 3 and 4 is different in the standard Raman 
spectrum (Fig. 3.3) and the WMR spectrum (Fig. 3.4). The peak 4 is higher compared 
to the peak 3 in the standard Raman spectrum; in the WMR spectrum, the opposite is 
observed. WMR spectroscopy produces clearer spectra, which are easier to interpret 
compared to standard Raman spectroscopy. The advantages of WMR spectroscopy 
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over standard Raman spectroscopy have been previously investigated in several 
studies. WMR spectroscopy presents a much higher signal to noise ratio (PCA being 
the optimal algorithm to generate WMR spectra) compared to standard Raman 
spectroscopy (Mazilu et al., 2010), more easily interpreted spectra (De Luca et al., 
2010) and greater discrimination ability, finding higher sensitivity and specificity 
(Canetta et al., 2011). 
 
We observed high variability in peak-to-peak ratios from the same time point (on the 
same slide between lipid aggregates), as shown in Fig. 3.6 and Tab. 3.4. The 
heterogeneity, between lipid aggregates, could be linked to a difference in 
composition but also be representative of the orientation of the lipids presenting 
different vibrational output between aggregates. This has been previously observed 
(Czamara et al., 2015). The authors suggested that the variability in Raman spectra of 
solid lipids is due to differences the lipid chain orientation and differences in 
polarisation. They interrogated solid tripalmitin with Raman spectroscopy. From one 
field of view, they showed two spectra from different locations and their average 
spectrum. The ratio between peaks was very different. The ratio (2870 cm-1/1295 cm-
1) from the first location was 10; it was 40 from the second spot and 24 on average 
over the field of view (Czamara et al., 2015). The high variability among datasets of 
dried lipid extract led to the impossibility to discriminate between conditions. To 
avoid the impact of this important heterogeneity, lipid could be in the future studied in 
a liquid phase. The difficulty is to find a solvent that would dissolve all lipids from 
the sample and would not evaporate fast to preserve the sample concentration during 
the acquisition. 
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This study gave us information about M.tuberculosis lipid peaks, their exact position 
in the Raman spectrum and also where to expect high intensity peaks (around 1300 
cm-1 and 1450 cm-1). This method cannot tell us more about the specific nature of the 
lipid molecules that are present in the samples. Other methods could be applied, such 
as mass spectrometry to give accurate mass value and therefore identify specifically 
the molecules that are present in the sample (Sartain et al., 2011). We investigated the 
samples shown in this study using mass spectrometry but we have not finished the 
study and the data analysis. Further work in this direction are required. 
 
Raman spectroscopy is a quantitative methodology (Hanlon et al., 2000), we 
investigated the relationship between Raman intensity and lipid concentration to 
demonstrate the quantitative aspect of our Raman system. A linear relationship 
between the lipid concentration and the Raman peak intensity is observed (Fig. 3.11). 
This means that if a lipid peak is double the size in a first item compared to another 
there is twice as much lipid in the first item. The efficacy of DMSO to dissolve those 
lipids was not assessed; therefore, it is not possible to associate an intensity value to 
an exact lipid concentration. The Raman spectroscopy set-up makes it possible to 
quantify the lipid content but the difficulty is to convert the Raman intensity (in 
arbitrary unit) to a concentration (in mg.µL-1). It would be possible to associate the 
Raman intensity to a concentration if the same lipids were present in both the serial 
dilution and the sample and if the solvent can dissolve all those lipids. This would 
also be easier with a solvent that does not show Raman peaks at the same location 
than lipids. Further investigation in this direction could be done in future aiming at 
quantifying the exact lipid concentration (in mg.µL-1) of a single Mycobacterium 
tuberculosis cell using WMR spectroscopy. 
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Direct quantification of β-carotene in lipid bodies of algae has been performed using 
Raman spectroscopy (Pilat et al., 2012). Being able to associate Raman lipid peak 
intensity from a single bacterium to a lipid concentration could represent a future 
investigation. The use of mass spectrometry could permit investigation of the lipid 
content from different condition accurately; this method would provide a list of the 
lipid molecules present and their abundance. 
 
In summary, this initial study provides the exact lipid Raman peak positions and 
confirms the quantitative aspect of the approach. This is very important to investigate 
single bacteria. Moreover, it presents some of the advantages of using WMR 
spectroscopy. 
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Chapter 4 Remote sensing of mycobacteria 
cell states (LR and LP) in-vitro using Raman 
spectroscopy 
4.1 Introduction 
 
The results of recent tuberculosis clinical trials have demonstrated that a regimen 
which, rendered patients culture negative more rapidly could still be associated with a 
high relapse rate (Gillespie et al., 2014). This key result illustrates the importance of 
understanding mycobacterial cells that are dormant and could survive treatment in 
human tissue. In-vitro models show that “dormant” phenotype is associated with a 
lower metabolic rate, phenotypic resistance to antibiotics and accumulation of lipids 
in intracellular bodies (Baek et al., 2011, Daniel et al., 2004, Deb et al., 2009, Wayne 
and Hayes, 1996). In mycobacteria, lipid inclusions have been described both in-vitro 
and in sputum samples (Garton et al., 2002). An important Rpf-dependent population 
have been described in tuberculous sputum samples (Mukamolova et al., 2010). 
Direct study on tuberculous sputum samples showed the presence of lipid body-
positive cells and slowly replicating bacteria (Garton et al., 2008). Completing the 
link between lipid body positive cells and the clinical outcome, it has been shown 
recently that these cells are up to 40 times more tolerant to key components of the 
treatment regimen such as rifampicin (Hammond et al., 2015). Being able to identify 
both phenotypes (lipid rich and lipid poor) is a crucial research target to understand 
how to shorten TB treatment. Different methodologies have been applied to study the 
lipid rich and poor cells of mycobacteria species. Lipid storage was investigated using 
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staining methods and fluorescence microscopy. Using these techniques, it was shown 
that the abundance of lipid rich cells increases as the culture aged and also that the 
buoyant density of the cells decreases in an older culture (Deb et al., 2009). This 
means that the buoyant density of a LR cell differs from a LP cell. The lipid bodies 
have also been studied directly using electron microscopy revealing a monolayer 
surrounding the lipid bodies (Bleck et al., 2010). In this chapter we investigate the 
capacity of an all-optical, label-free and non-destructive method, Raman 
spectroscopy, to discriminate mycobacterial phenotypes (LR and LP) in cultures. 
Raman spectroscopy has been widely used for bacterial identification, in medically 
relevant organisms for example (Maquelin et al., 2002b). Raman spectroscopy has 
been successfully applied to discriminate between mycobacterial species including M. 
tuberculosis (Buijtels et al., 2008, Stockel et al., 2016). The ability of Raman 
spectroscopy to discriminate mycobacterial phenotypes (LR and LP) at a single cell 
level is investigated in this study. Two techniques are compared: standard Raman 
spectroscopy and WMR spectroscopy to validate the best Raman method for future 
TB infected tissue studies. 
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4.2 Methods 
4.2.1 Sample preparation for Raman spectroscopy 
 
The cells were heat inactivated at 80°C for 20 minutes. They were separated using 
D2O as described previously (see Chapter 2 General methods section 2.3). 
Similarly, 100 µL of both top and bottom fraction were harvested, the cells were spun 
down for three minutes at 20,000 x g, the supernatant was slowly removed and 
discarded. The cells were resuspended in 100 µL of PBS, and 20 µL was placed on a 
thin quartz slide left to air dry. Once the thin quartz slide was dry a thick quartz slide 
with a spacer was filled with 15 µL of PBS, and the thin slide was placed on the top 
of it upside down. In this way, the cells were captured inside the spacer and within 
PBS. The mount was then sealed using transparent nail polish. This sample slide was 
placed on a high NA microscope objective with the thin slide at the bottom and 
interrogated using Raman spectroscopy. In parallel, the fractions were stained with 
Nile red and observed under fluorescence microscopy to understand their purity (see 
Chapter 2 General methods section 2.5 and 2.6). 
 
4.2.2 Deuterium oxide separation using centrifugation  
 
The full protocol is presented in Appendices Section 2. A tube holder (Appendices 
Section 2, picture 1) was designed using the software Rhinoceros3D version 5.0 
(Robert McNeel & Associates, USA) and the item was printed using an Up! Plus 3D 
Printer (Tiertime, USA). This tube holder was printed with polylactic acid (PLA) and 
acrylonitrile butadiene styrene (ABS). A 50 mL Falcon tube was filled with paper 
tissue at the bottom (Appendices Section 2, picture 2). One mL of cell culture was 
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harvested and washed three times using PBS. For each washing step the cells were 
spun down at 20,000 x g for three minutes, the supernatant discarded and 1 mL of 
PBS was added. 
 
In order to get LR cells from liquid culture, the cellular pellet was resuspended in 755 
µL of MiliQ H2O, this volume was transferred into a 2 mL plastic Eppendorf tube, 
and 450 µL of D2O solution were added. This achieved a final density of 1.04 g.mL-1. 
The solution was mixed using a pipette. The tube was placed into a tube holder (3D-
printed) the holder was inserted into a 50 mL Falcon tube see Appendices Section 2, 
picture 2. The tube was centrifuged at 500 x g (1500 rpm on the J6-M1 centrifuge) 
for 15 minutes. Only the top fraction (the first 100 µL) was harvested. And placed in a 
1.5 mL plastic Eppendorf tube (Appendices Section 2, picture 3). 
In order to separate the LP cells from the culture, the cellular pellet was resuspended 
in 280 µL of MiliQ H2O this volume was placed in a 2 mL plastic Eppendorf tube, 
830 µL of D2O were added (1.08 g.mL-1 final density). The 2 mL plastic Eppendorf 
tube was placed in a tube holder (3D-printed) the holder was then inserted into a 50 
mL Falcon tube see Appendices Section 2, picture 2. The tube was centrifuged at 35 
x g (400 rpm on the J6-M1 centrifuge) for 15 minutes. The bottom fraction was 
harvested (100 µL). 100 µL was harvested from the bottom fraction and care was 
taken not to disturb the pellet, see Appendices Section 2, picture 4. 
The purity of the factions (LR and LP) was investigated using Nile red staining or 
WMR spectroscopy. If the purity was not high enough the centrifugation step was 
repeated. 1 mL of 1.04 g.mL-1 (for LR) or 1.08 g.mL-1 (for LP) solution was added to 
the 80 µL of remaining harvested cells and centrifuged again. The top (LR) or bottom 
(LP) fraction was then harvested and investigated. 
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4.3 Results 
 
All the experiments in this chapter were conducted using the Raman spectroscopy 
system 1 (see Chapter 2 General methods section 2.12). 
 
4.3.1 Conventional Raman spectroscopy 
 
Mycobacteria from stationary phase culture were harvested and separated using D2O 
separation. Both top (LR) and bottom (LP) fractions were interrogated using standard 
Raman spectroscopy. The experiment was performed with three mycobacteria 
species: M. smegmatis, BCG and M. tuberculosis. Conventional Raman spectra of 
single bacteria were taken, from more than 60 LR and LP cells in-vitro (randomly 
chosen from the slides). Fig. 4.1 a, c, e show the mean spectrum, of LR (red) and LP 
(green) averaged over all in-vitro conventional Raman spectra; the coloured areas are 
representing the associated single standard deviations. Major differences between the 
two cells subsets are found around 1300 cm-1 (lipid band A) and 1440-1450 cm-1 
(lipid band B) in Fig. 4.1 a, c, e. LR cells show higher Raman peak intensity in these 
two bands compared to LP cells. 
We applied a multivariate statistical analysis: Principal Component Analysis (PCA) 
(Ringner, 2008) to analyse all spectra from LR and LP data sets (for more detail see 
Chapter 1 Introduction section 1.5.6 and Chapter 2 General methods section 
2.10). All the principal components (PCs) obtained through the PCA are orthogonal to 
each other. PCs are listed in a decreasing order; where the PC1 accounts for more of 
the variation in spectra than PC2 and so on. The first 7 PCs are used to calculate the 
specificity and sensitivity with the leave-one-out cross validation (LOOCV) for each 
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data point (for more details see Chapter 1 Introduction section 1.5.7 and Chapter 2 
General methods section 2.11). The first 7 PCs correspond to more than 80% of the 
total variance in all spectra of each data set. In the 3D space corresponding to the first 
three PCs clear LR and LP clusters are observed as shown in Fig. 4.1 b, d, f. The two 
phenotypes (LR and LP) are distinguished with high specificity and sensitivity, shown 
in Tab. 4.1. These results show that the LR cells can be discriminated from LP cells 
using standard Raman spectroscopy. 
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Figure 4.1 LR and LP mycobacteria compared using standard Raman spectroscopy.  
Three mycobacteria were interrogated: M. smegmatis, BCG and M. tuberculosis. The 
Fig. 4.1 a, c, e shows LR (red curves), and LP (green curves) mean spectra calculated 
from over 60 spectra, of single cells, acquired using standard Raman spectroscopy. 
The coloured area corresponds to the single standard deviation associated with the 
mean spectra. In Fig. 4.1 a, c, e the x-axis represents the Raman shift (in 
wavenumber, cm-1) and the y-axis shows the Raman intensity in arbitrary units. Using 
principal component analysis, the spectra of both LR and LP were processed. The 
Fig. 4.1 b, d, f presents the PCA plots corresponding to the first three PCs. In this 3D 
space, each dot corresponds to a single bacterium. Clear LR and LP clusters can be 
observed. The time to acquire a Raman spectrum from a single bacterium was 30 
seconds for both the background and the signal. The window chosen for the study 
starts at 1000 cm-1 and ends at 1800 cm-1. This region presents several Raman peaks 
associated with lipids. The two main lipid peaks are the lipid band A (1300 cm-1) and 
the lipid band B (1440-1450 cm-1). 
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Table 4.1 Sensitivity and specificity of LR and LP M. tuberculosis, BCG and M. 
smegmatis cells (calculated from conventional Raman spectra). 
Species (lipid rich/lipid poor) Sensitivity Specificity 
M. smegmatis (n=1) 95.9 % 92.4 % 
BCG (n=1) 82.6 % 87.5 % 
M. tuberculosis (n=1) 82.1 % 79.5 % 
 
The calculation of sensitivity and specificity is explained in detail in Chapter 1 
Introduction section 1.5.7 and Chapter 2 General methods section 2.11. Both LR 
and LP phenotype have been discriminated using standard Raman spectroscopy with 
high sensitivity and specificity. However, WMR spectroscopy could potentially bring 
higher discriminative power by removing the auto-fluorescence background coming 
from the sample. 
 
4.3.2 WMR spectroscopy 
4.3.2.1 Optimisation of the acquisition time 
 
An experiment was designed to define the optimal acquisition time to study M. 
tuberculosis phenotypes using WMR spectroscopy. The time required to obtain one 
WMR spectrum corresponds to the acquisition time multiplied by the number of 
accumulations (gives the time needed for one spectrum) times five (as five distinct 
spectra are taken while the laser wavelength is modulated). These five spectra are 
used to construct the WMR spectra. For example, 1x5x5 seconds stands for one 
second acquisition, 5 times accumulated to create one spectrum, and 5 spectra like 
this one are acquired while the laser wavelength is changing to create one WMR 
spectrum. So in the case of 1x5x5, the total WMR spectrum acquisition time 
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corresponds to 25 seconds (5 spectra of 5 seconds each). The different acquisition 
times tested are presented in the Fig. 4.2. For each condition, WMR spectra of over 
30 single LR and LP cells were taken in-vitro. The red (LR) and the green (LP) curve 
in Fig. 4.2 a, b, c and d show the mean spectrum averaged over all in-vitro 
modulation Raman spectra, the associated standard deviations being represented by 
the coloured areas. The purity of the fractions, LR and LP, was assessed by 
fluorescence microscopy. 
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Figure 4.2 Optimisation of acquisition time for M.tuberculosis single cell using WMR 
spectroscopy.  
The Fig. 4.2 a, b, c, d shows LR (red curves) and LP (green curves) mean spectra 
calculated from 30 to 40 spectra, of single cells, acquired using WMR spectroscopy. 
The coloured area corresponds to the single standard deviation associated with the 
mean spectra. In Fig. 4.2 a, b, c, d the x-axis represents the Raman shift (in 
wavenumber, cm-1) and the y-axis shows the differential Raman intensity in arbitrary 
units. In a WMR spectrum, the Raman peaks correspond to the zero crossing point 
(the point where the curve cross the dash-dotted line); the Raman peak intensity is the 
peak-to-valley value around this zero crossing. The total acquisition time for one 
WMR spectrum is 25 seconds (Fig. 4.2 a), 50 seconds (Fig. 4.2 b), 100 seconds (Fig. 
4.2 c) and 150 seconds (Fig. 4.2 d) (see Chapter 2 General methods section 2.8 for 
more details). The window chosen for the study starts at 1000 cm-1 and end at 1800 
cm-1. This region presents several Raman peaks associated with lipids. The two main 
lipid peaks are the lipid band A (1300 cm-1) and the lipid band B (1440-1450 cm-1). 
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The first two acquisitions times tested (1x5x5 seconds and 2x5x5 seconds) display 
very low Raman intensity and a very high noise level that is visible in the Fig. 4.2. a 
and b. The standard deviation is very important in these two conditions. Moreover, 
the noise level reduces compared to the Raman intensity as the acquisition time 
increases. The information cannot be extracted from the spectra if the signal to noise 
level is too low, the differences have to come from the Raman peaks and not from 
noise. When total acquisition was increased to 100 seconds (4x5x5 seconds), a much 
better signal to noise ratio was observed compared to previously Fig. 4.2. c. However, 
the noise level and, therefore, the standard deviation remained high. For example, 
many little peaks due to noise could be found between 1500 and 1800 cm-1 Fig. 4.2. c. 
The next total acquisition time tested was 150 seconds (6x5x5 seconds), which 
showed a good signal to noise ratio and a low standard deviation Fig. 4.2. d. The 
acquisition time 6x5x5 seconds was chosen and used for all the future WMR 
spectroscopy measurements of single mycobacteria. The Fig. 4.2. d is also presented 
in Fig. 4.3. e. 
 
4.3.2.2 WMR spectroscopy on in-vitro LR and LP cells 
 
Mycobacteria from stationary phase culture were harvested and separated using D2O 
separation. Both top and bottom fractions were stained using Nile red and observed 
with fluorescence microscopy. A clear enrichment in LR cells was observed in the top 
fraction; similarly, the bottom fraction showed mainly LP cells. The LR and LP 
fractions used in Raman spectroscopy were over 90% pure based on direct 
microscopy counts assessed by eye. The experiment was performed with three 
mycobacteria species: M. smegmatis, BCG and M. tuberculosis. WMR spectra of 
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single bacteria were taken, from approximately 60 LR and LP cells in-vitro (randomly 
chosen from the slides). The differences between LR and LP WMR spectra are mostly 
the same than observed in the standard method. LR cells display higher Raman peak 
intensity in both lipid bands A and lipid band B compared to LP cells Fig. 4.3 a, c, e. 
We applied the PCA to analyse all spectra of each LR and LP subsets. The first 7 PCs 
represent over 70% of the total variance in all WMR spectra from each phenotype set. 
With only the first 3 PCs distinct cluster can be identified as shown in Fig. 4.3 b, d, f. 
LR and LP phenotypes are distinguished with high specificity and sensitivity as 
shown in Tab. 4.2. In order to calculate the sensitivity and specificity, the first 7 PCs 
are used in the LOOCV for each cell subsets. The sensitivity and specificity are 
higher when using WMR spectroscopy compared to conventional Raman 
spectroscopy. 
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Figure 4.3 WMR spectroscopy on LR and LP cells of M. smegmatis, BCG and M. 
tuberculosis.  
The Fig. 4.3 a, c, e shows LR (red curves) and LP (green curves) mean spectra 
calculated from approximately 60 spectra, of single cells, acquired using WMR 
spectroscopy. The coloured area corresponds to the single standard deviation 
associated with the mean spectra. In Fig. 4.3 a, c, e the x-axis represents the Raman 
shift (in wavenumber, cm-1) and the y-axis shows the differential Raman intensity in 
arbitrary units. In a WMR spectrum, the Raman peaks correspond to the zero 
crossing point (the point where the curve crosses the dash-doted line); the Raman 
peak intensity is the peak-to-valley value around this zero crossing. Using principal 
component analysis, the spectra of both LR and LP were processed. The Fig. 4.3 b, d, 
f presents the PCA plots corresponding to the first three PCs. In this 3D space, each 
dot corresponds to a single bacterium. Clear LR and LP clusters can be observed. 
The total acquisition time for one WMR spectrum was 150 seconds (see Chapter 2 
General methods section 2.8 for more details). The window chosen for the study 
starts at 1000 cm-1 and end at 1800 cm-1. This region presents several Raman peaks 
associated with lipids. The two main lipid peaks are the lipid band A (1300 cm-1) and 
the lipid band B (1440-1450 cm-1). 
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Table 4.2 Sensitivity and specificity of lipid poor and lipid rich M. tuberculosis, BCG 
and M. smegmatis cells (calculated from WMR spectra). 
Cell type (lipid rich/lipid poor) Sensitivity Specificity 
M. smegmatis (n=1) 96.8 % 93.8 % 
BCG (n=1) 96.8 % 100 % 
M. tuberculosis (n=1) 96.1 % 92.6 % 
 
 
4.3.3 D2O separation using centrifugation 
 
The D2O separation has an overnight step; to speed up this protocol and reduce the 
stress to the bacteria undergoing separation, a protocol of separation using 
centrifugation have been developed. The protocol is presented in the Appendix 
Section 2. This protocol uses two steps to obtain both LR and LP cell from one 
bacterial culture. Each step was optimised to get high purity of either LR (lower 
density solution, higher centrifugation speed and harvested the top) or LP (higher 
density solution, slower centrifugation speed and harvested the bottom above the 
pellet). Firstly, to obtain LR bacteria, cells were resuspended in a low density solution 
(1.04 g.mL-1) and centrifuged at 500 x g for 15 minutes. The top fraction, enriched in 
LR cells, was subsequently harvested. The second step, to separate LP bacteria, used a 
higher density solution (1.08 g.mL-1) and a lower centrifugation speed (35 g for 15 
minutes). The bottom of the tube, enriched in LP cells, was harvested. Bacteria 
remain less than 20 minutes in H2O/D2O solution, and both LR and LP bacteria can 
be obtained within one hour. 
Initial experiments were carried out using M. smegmatis to validate this protocol. First 
using Nile red staining to get the proportion, of LR and LP, for each set. One example 
of both LR and LP preparation are shown in Fig. 4.4 and Fig. 4.5 respectively. A 
clear enrichment was observed in both LR and LP fraction. LR fraction was found to 
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be 92% pure based on the count of 134 bacteria and LP fraction 90% pure based on 
the count of 351 bacteria. 
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Figure 4.4 Nile red stained M. smegmatis from the top fraction (LR) of the 
centrifuged D2O separation.  
Bacteria were centrifuged in H2O/D2O solution (density, 1.04 g.mL-1) at 500 g for 15 
minutes. The top fraction was harvested and Nile red stained (2.5 µg.mL-1) (see 
Chapter 2 General methods section 2.5 for more details). The fraction was observed 
under fluorescence microscopy (see Chapter 2 General methods section 2.6 for more 
details). The figure shows: the green emission in Fig. 4.4. a that corresponds to 
intracellular non-polar lipids, the red emission in Fig. 4.4.b that represents the polar 
lipid and the combined picture in Fig. 4.4. c. In this figure, the white arrow shows a 
LP cell, all the other bacteria in this picture are LR. The scale bar represents 5 µm. 
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LP LP 
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Figure 4.5 Nile red stained M. smegmatis from the bottom fraction (LP) of the 
centrifuged D2O separation. 
Bacteria were centrifuged in H2O/D2O solution (density, 1.08 g.mL-1) at 35 g for 15 
minutes. The bottom fraction was harvested and Nile red stained (2.5 µg.mL-1, see 
Chapter 2 General methods section 2.5 for more details). The fraction was observed 
under fluorescence microscopy (see Chapter 2 General methods section 2.6 for more 
details). The figure shows: the green emission in Fig. 4.5. a that corresponds to 
intracellular non-polar lipids, the red emission in Fig. 4.5. b that represents the polar 
lipid and the combined picture in Fig. 4.5. c. In this figure, the white arrow shows a 
LR cell, all the other bacteria in this picture are LP. The scale bar represents 5 µm. 
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The centrifugation D2O separation was tested on M. tuberculosis and the fractions 
interrogated by WMR spectroscopy. After processing the two sets (LR and LP) were 
successfully discriminated with both high sensitivity (0.88) and specificity (0.95) 
using the first 7 PCs (corresponding to 75.3% of the total variance). The average 
spectra of M. tuberculosis LR and LP cells are shown in Fig. 4.6. a and the 
corresponding PCA plot is presented in Fig. 4.6. b. Based on those initial experiments 
it seems that the centrifuged D2O separation could be an interesting way of getting 
enriched fraction in LR and LP cells. More repeats should be performed to strengthen 
these results. 
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Figure 4.6 WMR spectra of M. tuberculosis LR and LP fraction after centrifugation 
D2O separation and their corresponding PCA cluster.  
The Fig. 4.6 a shows LR (red curves) and LP (green curves) mean spectra calculated 
from approximately ~30 (LR) and ~60 (LP) spectra, of single cells, acquired using 
WMR spectroscopy. The coloured area corresponds to the single standard deviation 
associated with the mean spectra. In Fig. 4.6 a the x-axis represents the Raman shift 
(in wavenumber, cm-1) and the y-axis shows the differential Raman intensity in 
arbitrary units. In a WMR spectrum, the Raman peaks correspond to the zero 
crossing point (the point where the curve crosses the dash-doted line); the Raman 
peak intensity is the peak-to-valley value around this zero crossing. Using principal 
component analysis, the spectra of both LR and LP were processed. The Fig. 4.6 b 
presents the PCA plots corresponding to the first three PCs. In this 3D space, each 
dot corresponds to a single bacterium. Clear LR and LP clusters can be observed. 
The total acquisition time for one WMR spectrum was 150 seconds (see Chapter 2 
General methods section 2.8 for more details). The window chosen for the study 
starts at 1000 cm-1 and end at 1800 cm-1. This region presents several Raman peaks 
associated with lipids. The two main lipid peaks are the lipid band A (1300 cm-1) and 
the lipid band B (1440-1450 cm-1). 
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4.4 Discussion 
Raman spectroscopy provides global information, about all components of the cell, 
requires minimal sample preparation and can target a single bacteria (Wagner, 2009). 
This technology has already been used to study mycobacteria and discriminate species 
but not using the WMR spectroscopy technique (Buijtels et al., 2008, Stockel et al., 
2016). More importantly, Raman spectroscopy has never been used to discriminate 
mycobacterial phenotypes. Our findings using Raman spectroscopy indicate that 
discrimination between the two phenotypes (LR and LP) can be realised with both 
standard and WMR spectroscopy techniques (Fig. 4.1 and Fig. 4.3). These results also 
highlight the advantages of using WMR spectroscopy over standard Raman 
spectroscopy to investigate phenotypic differences among bacterial species. WMR 
spectroscopy brings both higher sensitivity and specificity (Tab. 4.1 and Tab 4.2). In 
this method, the Raman excitation corresponds to a scan of laser wavelength and 
when combined with multivariate statistical analysis it allows a complete fluorescence 
background removal (De Luca et al., 2010, Chen et al., 2015). However, this 
technique needs a longer acquisition time, more mathematical processing, a laser and 
a system that allows the modulation (Fig. 4.2). The acquisition time for one spectrum 
with standard Raman spectroscopy is around one minute, and it is around 2.5 minutes 
with WMR spectroscopy. 
The major differences allowing the discrimination between the two phenotypes were 
mainly the lipid band A and lipid band B. LR cells present higher lipid peak 
intensities on average compared to LP cells and there is important heterogeneity 
among each group. Raman intensity of LR and LP lipid peaks overlap, this shows a 
continuum of lipid concentration from low lipid content to a much higher. This study 
confirms that LR and LP cells are both present in all studied mycobacterial species. 
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The intracellular accumulation of non-polar lipid and specifically the storage of TAGs 
is common in the Actinomycetes group: in Rhodococcus, Nocardia, Mycobacterium 
and Streptomyces species. A Rhodococcus opacus strain is known to be able to store 
fatty acids up to 87% of the cell dry weight (Alvarez and Steinbüchel, 2002). The 
accumulation of those lipids is one of the factors associated with a dormancy 
phenotype in mycobacteria (Lipworth et al., 2016). Many other bacterial species are 
known to store intracellular energy reserves (Wang and Bakken, 1998, Alvarez and 
Steinbüchel, 2002). Moreover, the capacity of a strain to store intracellular energy 
compounds has a positive impact on its survival in a starvation period (Wang and 
Bakken, 1998). Many microorganisms can show no sign of life under adverse 
conditions, but they are not dead. When the conditions change, they can restore and 
return to normal activity. Up to 80% of the microorganisms in soil samples appear to 
be metabolically inactive and many of these can be resuscitated (Lennon and Jones, 
2011). Dormant mycobacteria present lipid accumulation, tolerance to antibiotics and 
display a low metabolic rate (Lipworth et al., 2016). Based on this definition all 
dormant cells are LR, but it is difficult to say if all LR cells are dormant. However, 
we know that LR cells present a much higher tolerance towards key antibiotics of the 
regimen used to treat TB, M.smegmatis LR cells were found up to 40 times more 
resistant to rifampicin compared to LP cells (Hammond et al., 2015). Therefore, study 
of the LR phenotype is of high medical relevance. Identifying both LR and LP 
phenotypes with our methodology could indicate whether the bacterium targeted is 
phenotypically resistant to antibiotics or not. This opens wide possibility to 
investigate the phenotypic antibiotic resistance of single M.tuberculosis cell directly 
in infected tissue and understand better the phenotypic antibiotic resistance ex-vivo. 
Studies targeting sputum samples have shown that the LR phenotype could be 
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predominant in-vivo (Garton et al., 2008). However, sputum may not reflect exactly 
what happens in the lungs. Determining the proportion of phenotypically antibiotic 
resistant bacilli at the site of infection to understand more about the pathology of TB 
and potentially understand more about the bacteriology of relapse is key. Sloan et al. 
2015 showed that few patients with unfavourable outcomes had bacteria with 
mutations associated with antibiotic resistance, supporting the notion that dormant 
organisms could be the main reason for relapse (Sloan et al., 2015). Moreover, they 
observed a higher percentage of lipid body positive cells in sputum, three to four 
weeks into treatment, in patients that had unfavourable outcome compared to other 
patients. 
 
Measuring single bacteria is a real challenge as the bacilli targeted are very small, less 
than a micron wide and few microns long (mycobacteria are rod shaped: 0.2-0.6 µm 
wide and 1-10 µm long) (McMurray, 1996). Regarding the measurement accuracy 
and the focusing a manual stage was used. Focusing 0.1 µm out of the cell could 
result in a loss of signal.  Standard and WMR spectroscopy succeeded to discriminate 
LR and LP cells with both a high sensitivity and specificity. The two phenotypes after 
separation were placed on two separate quartz slides and it is possible that their 
background signal (debris, unwashed molecules…) were not exactly identical and 
could have increased the discriminative power. However, most of the variation 
between the two sets come from the lipid band B. If only this region 1400 to 1500 cm-
1 is used for the analysis; both LR and LP can still be discriminated for all the data 
sets (Appendices section 4 Tab. 1 and 2). 
All bacteria separated using the overnight D2O separation were heat killed. Heat 
killing is known to produce no significant changes in the Raman spectra (Buijtels et 
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al., 2008). All the measurements have been taken from heat-killed bacteria. Even if 
this process can affect the Raman spectrum slightly both lipid rich and lipid poor cells 
were going through the same process as they were separated. Moreover, to be able to 
work on M. tuberculosis outside a category 3 laboratory an inactivation step is 
required. 
 
The presence of lipid bodies results in a difference of buoyant density between the 
two fractions (Deb et al., 2009). The buoyant density of M. tuberculosis cells is 
between 1.02 g.mL-1 and 1.13 g.mL-1 (den Hertog et al., 2009). Hammond et al. 
proposed a density-based technique, making possible to obtain both lipid rich and 
lipid poor fractions with a high purity (Hammond et al., 2015). The D2O separation 
was applied in this study. The results presented in this study confirm the enrichment 
of the top fraction in LR cells and the bottom fraction in LP cells as LR and LP 
datasets were discriminated with high specificity and sensitivity. Moreover, the 
Raman spectra of the LR single cells display much higher Raman intensity in the lipid 
peaks and similar Raman intensity in the other spectral region when compared to 
Raman spectra of LP single cells. 
In order to speed up the D2O separation that takes several hours, a protocol using a 
centrifugation step has been designed in this chapter (Appendices Section 2). Both 
LR and LP samples can be obtained from the culture within one hour. Moreover, the 
bacteria would remain for less than 20 minutes in the H2O/D2O solution, limiting the 
stress on live bacteria. The initial separations using this protocol have been analysed 
using Nile red staining or WMR spectroscopy (Fig. 4.4, Fig. 4.5 and Fig. 4.6). The 
data suggest that the protocol succeeded in enriching both top and bottom fraction in 
LR and LP cells respectively. More experiments are required to validate this protocol. 
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The LR and LP samples could be centrifuged again if the purity is not high enough 
from the first passage; a second centrifugation could increase the enrichment while 
the bacterial load would decrease. 
 
If we are to shorten TB treatment, understanding relapse mechanism is key and 
therefore the link between bacterial phenotype and relapse. Relapse could be due to 
LR cells that resist treatment. To investigate this hypothesis we need a label-free, non-
destructive technique such as WMR spectroscopy ensuring that the outcome will not 
be impacted by the methodology. The future experiment is to apply the method 
developed in this chapter to tissue samples infected by M.tuberculosis and test if we 
can obtain the phenotype of a single bacterium. 
 
In summary, we have shown that Raman spectroscopy could be used to discriminate 
LR cells (associated with dormancy) from LP cells (not associated with dormancy) in 
mycobacterial species. Spectral regions corresponding to lipids can be used to 
perform this discrimination: the lipid band A (1300 cm-1) and the lipid band B (1440 
to 1450 cm-1). We also demonstrated the interest of using WMR spectroscopy when 
studying bacterial phenotypes. This method provides higher sensitivity and specificity 
when discriminating LR and LP bacteria compared to standard Raman spectroscopy. 
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Chapter 5 Investigation of dormancy in TB 
infected tissue by Raman spectroscopy and 
fluorescence imaging   
5.1 Introduction 
 
Raman spectroscopy has been previously used to study medically relevant 
microorganisms (Maquelin et al., 2000, Maquelin et al., 2002a, Maquelin et al., 
2002b, Pahlow et al., 2015). This method is showing great promise for potential 
medical applications such as diagnostics (Choo-Smith et al., 2002, Tu and Chang, 
2012). There are yet few studies on Mycobacterium tuberculosis using Raman 
spectroscopy (Buijtels et al., 2008, Stockel et al., 2016). To date, most studies on 
mycobacteria using Raman spectroscopy were conducted using in-vitro samples 
(Pahlow et al., 2015). Several identification studies present results of bacteria in 
clinical samples such as urine blood and sputum but not on mycobacteria species 
(Rusciano et al., 2013, Cheng et al., 2013, Kloss et al., 2013, Kloss et al., 2015). 
However, studies interrogating single bacteria directly in tissue, such as lung 
infection, have not been reported. Studying bacteria with Raman spectroscopy in 
tissue is challenging as tissue itself produces Raman signal. It would be very 
informative to work directly on the actual causal agent of the disease in a real context. 
The organisms grown in an animal could present differences compared to the 
organisms grown in-vitro. Growth conditions can impact the Raman spectrum (Harz 
et al., 2005). Animal models are used to study TB pathology and test treatment 
regimens. Models have been used for decades to develop anti-tuberculosis drugs and 
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to evaluate the efficacy of drug combinations. Gumbo et al. in 2015 defined three 
questions that the model should be able to answer in a TB drug development context: 
“What combination(s) of drugs will be most effective? What dose(s) and schedule(s) 
of each drug should be administered? And What duration of treatment(s) will be 
efficacious?” (Gumbo et al., 2015). All TB animal models show advantages and 
disadvantages. There is no model that perfectly mimics Human TB. Guinea pigs are 
the chosen TB animal model for this study because the lesions which they develop 
during PTB are histologically similar to the disease seen in humans (Clark et al., 
2015). Moreover, there is some relationship between treatment shortening potential of 
certain drugs in this animal model and clinical outcome (Gumbo et al., 2015). 
Having the possibility to target a single bacterium directly at the site of infection and 
obtain information about its chemical and cellular content and use this to make an 
inference regarding its phenotype and its potential antibiotic tolerance could bring a 
greater biological understanding of the diseases and the bacteriology of relapse. 
Therefore, I investigated single bacteria cells in TB infected guinea pig lung tissue 
using Raman spectroscopy by designing a system and a methodology able to target 
single bacillus in tissue and assigning it to a lipid rich or lipid poor phenotype. 
Getting information about bacterial phenotype and population in the lung could help 
understanding the pathology better. 
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5.2 Methods 
5.2.1 Animal infection 
This method section was carried out in Public Health England (PHE) see Appendices 
section 3 for more details. Each guinea pig was infected, using M.tuberculosis 
H37Rv, for 4 weeks. The guinea pig showing the highest bacteria load was killed, and 
the lungs were taken and directly fixed in formalin. 
 
5.2.2 Paraffin sectioning of TB infected guinea pig lungs 
 
This method section was carried out in PHE. Tissues were fixed in 10% (v/v) neutral 
buffered formalin (10% NBF) for 24 hours. They were then cut into small pieces and 
processed overnight. The tissue sat in 10% (v/v) NBF until the cycle began and then 
they were dehydrated through a series of alcohols (70%, 90% and 100% (v/v) IMS 
(Industrial Methylated Spirits) for a total of 7 hours. The tissue was then cleared with 
xylene; the sections went through 3 changes of this chemical over 3.5 hrs. Then 
finally the sections went through 4 changes of paraffin wax for a total of 
approximately 5 hours, the samples sat in the wax until removed from the processor. 
They were then embedded in paraffin wax (ultraplast wax) in moulds and attached to 
the cassettes for microtomy. The wax blocks were then cut to produce 3-5 microns 
slices that were placed onto the quartz slides. 
 
5.2.3 Frozen section of TB infected guinea pig lungs 
 
This method section was carried out in PHE and at Amsbio, UK. Once the guinea pig 
was dead, the tissue was immediately taken and fixed in 10% neutral buffered 
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formalin. Optimal cutting temperature (OCT) solution (30% w/v sucrose in PBS) was 
used to embed and freeze the tissue before cutting. The tissue was then cryosliced by 
the external company (Amsbio, UK). The tissue sections were 5 µm thick.  
Amsbio, UK AMS Biotechnology (Europe) Limited / Registered office: 184 Park 
Drive, Milton Park, Abingdon OX14 4SE / Registered in England & Wales: Company 
number 2117791 / ISO 9001:2008 registered firm). 
 
 
5.2.4 Unstained tissue mount for Raman spectroscopy 
 
The frozen section on a thick quartz slide (SPI Supplies, 01016-AB) was directly 
mounted with a quartz coverslip (SPI Supplies, 01015T-AB) without any spacer and 
without PBS. The mount was sealed using transparent nail polish. This preparation 
was observed under WMR spectroscopy. 
The frozen section on a quartz coverslip (SPI Supplies, 01015T-AB) was directly 
mounted on a thick quartz slide (SPI Supplies, 01016-AB) without any spacer and 
without PBS. The mount was sealed using transparent nail polish. This preparation 
was ready for observation under WMR spectroscopy. 
 
5.2.5 Nile red stained bacteria, slide preparation 
 
From Nile red stock solution at 250 µg.mL-1 in DMSO (Sigma-Aldrich), 1 µL was 
added to 100 µL of bacterial suspension. The bacteria were then left for ten minutes at 
room temperature and in the dark (covered with aluminium foil). After the tubes were 
centrifuged for three minutes at 20,000 x g, the supernatant was discarded and the 
pellet resuspended in 100 µL of PBS. The bacteria were washed like this, with PBS, 
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twice. Finally, the pellet was resuspended in 20 µL of PBS, 10 µL were heat fixed 
either on a quartz coverslip for Raman spectroscopy or on a glass slide for 
microscopy. For Raman the fixed cells were mounted on top of a quartz slide, 
meaning that they end up trapped between the two quartz slides. The mount was then 
sealed with nail polish and observed under Raman spectroscopy (combined system, 
see Chapter 2 General methods section 2.13 for more details). For fluorescence 
microscopy, a drop of immersion oil was directly placed on the fixed cells for direct 
observation (see Chapter 2 General methods section 2.6 for more details). 
 
5.2.6 Nile red staining of TB infected guinea pig tissue lung tissue sections 
 
The infected guinea pig frozen lung was sliced to produce 5 µm thick sections that 
were attached to a quartz coverslip (SPI Supplies, 01015T-AB). The tissue was 
stained using Nile red at a final concentration of 25 µg.mL-1 (DMSO 10% v/v final 
concentration). A 2 µL drop of Nile red solution was pipetted on top of the frozen 
tissue section, and directly a thick quartz slide (SPI Supplies, 01016-AB) was placed 
on top it. This mount was sealed using transparent Nail polish. The sample was 
studied using the Raman system or fluorescence microscopy (see Chapter 2 General 
methods section 2.6 and 2.13 for more details). 
 
5.2.7 Charging quartz slides 
 
The quartz slides were first washed with distilled water followed by 70% (v/v) 
ethanol. The slides were covered by tissue to be protected from dust and left to air dry 
for several minutes. The coating agent used, to positively charge the quartz slides, 
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was 3-Aminopropyltriethoxysilane (Sigma, UK; A-3648; Silane). A 2% silane 
solution was prepared by adding 0.3 mL of coating agent to 15 mL of acetone. The 
quartz slides to charge were placed in the silane solution for approximately 30 
seconds. Quickly after taking the slides out of the silane solution, the slides were 
washed with distilled water for only a few seconds. Then the slides were covered 
(typically placed in a box) and left to air dry in an incubator at 37°C overnight. 
 
5.2.8 Frozen section of mice lymph nodes 
 
Fresh BCG infected mice lymph node tissue was taken out of the freezer (-80°C). On 
dry ice, a mould was filled at 50% with OCT (Thermo-scientific), the fresh piece of 
tissue placed on top of it, and then the mould was filled to the top with OCT covering 
the tissue. On the dry ice, the OCT frost and made a block. The block was then 
removed from the holder, adjusted on a chuck and covered with OCT, left to freeze on 
dry ice. Moving on a cryostat (-20°C) the chuck was inserted in the holder, and 10 
microns thick sections were serially cut. The tissue sections were attached to the 
positively charged glass or quartz slides. 
 
5.2.9 Nile red staining and immunostaining of BCG infected tissue 
 
Tissue sections attached to positively charged glass microscopy slides (Fisher 
Scientific, 10149870) were stained with Nile red. A 10 µL drop was added on top of 
the tissue sections at a final concentration of 25 µg.mL-1 (DMSO 10% v/v final 
concentration). The tissue sections were washed with MiliQ water, left to air dry at 
room temperature and protected from dust for several minutes. A glass coverslip was 
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placed on top of the tissue sections. The tissue was then observed under Leica 
fluorescent microscope (see Chapter 2 General methods section 2.6 for more 
details). After fluorescence microscopy, the same stained tissue section was 
investigated by immuno-staining. 
 
5.2.10 Raman spectroscopy on tissue attached to positively charged slides 
 
Quartz coverslip, quartz slides and glass microscopy slides were used for both 
immuno-staining and WMR spectroscopy. The tissue sections were attached to each 
slide types. The tissue sections on quartz coverslip (SPI Supplies, 01015T-AB), were 
mounted on top of a quartz slide (SPI Supplies, 01016-AB) and no spacer or PBS was 
used. The mount was then sealed at the corners only with transparent nail polish. The 
tissue sections on quartz slide (SPI Supplies, 01016-AB) were mounted with a quartz 
coverslip (SPI Supplies, 01015T-AB) and no spacer or PBS was used. The mount was 
sealed at the corners only with transparent nail polish. The tissue sections on glass 
microscopy slide (Fisher Scientific, 10149870) were mounted with a quartz coverslip 
(SPI Supplies, 01015T-AB) and no spacer or PBS was used. The mount was sealed at 
the corners only with transparent nail polish. Each of those preparations was then 
interrogated by WMR spectroscopy. 
 
5.2.11 Immunostaining procedure 
 
Once the tissue was investigated with either WMR spectroscopy or microscopy (for 
the Nile red stained slide) the mount was opened, and the slide with the tissue section 
placed at -20°C. All the incubation steps during the immuno-staining procedure were 
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realised inside a humid box (the box was humidified using a wet tissue). The 
immuno-staining was carried out as follows: in order to remove the OCT from the 
tissue sample, all the slides to study were immersed in PBST (PBS and tween 20 at 
0.1% v/v) for ten minutes under permanent agitation (35 oscillation per minute). 
Directly on the slide and around the tissue an hydrophobic wall was created using a A 
Dako pen (Dako, S2002). From a 30 % (v/v) H2O2 stock solution (Sigma, H1009) a 
3% (v/v) solution was generated using distilled water; 120 µL of this preparation was 
pipetted on top of the tissue, within the hydrophobic wall. The tissue was incubated 
ten minutes with the H2O2 solution. Again, the slides were immersed in PBST, for 
five minutes and with agitation (35 oscillation per minute). Dako serum-free protein 
block (Dako, X0909) was directly pipetted on top of the tissue sections, 
approximately two drops. The tissue was incubated with the Dako serum-free protein 
block (Dako, X0909) for ten minutes. During the incubation the primary antibody 
(Dako, A0452, CD3 antibody) solution was generated as follows: 1 in 400 dilution in 
Dako (S0809) solution. After the incubation with Dako serum-free protein block 
(Dako, X0909) the liquid was removed, and without any washing, the primary 
antibody was pipetted on top of the tissue sections. The incubation with the primary 
antibody was around 30 minutes. After the incubation, the slides were washed two 
times in PBST for five minutes each under continuous agitation (35 oscillation per 
minute). The secondary antibody (Dako, K4003; HRP conjugated) was used, two to 
three drops, on the tissues sections. The incubation time with the secondary antibody 
was also 30 minutes. Again, the tissue sections were immersed twice in PBST for five 
minutes each time and under permanent agitation (35 oscillation per minute). On 
tissue, 120 µL of tyramine-signal-amplification (TSA)-CY5 (PerkinElmer, NEL745 
B001KT) was pipetted, and the slides were incubated for 10 minutes. Following this 
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incubation step, the slides were immersed in PBST twice, five minutes each time and 
under permanent agitation (35 oscillation per minute). The tissue sections were 
counter stained using 120 µL of Hoechst dye solution (Thermo Fisher, H3570) diluted 
at 1:1000 with distilled water. The incubation with the counter stain was 10 minutes. 
The slides were immersed in PBST, five minutes each time and under permanent 
agitation (35 oscillation per minute). Directly after the second wash, the slides were 
immersed into 80% (v/v) ethanol for approximately one minute. The slides were air 
dried at room temperature, protected from light. Following this step, tissues sections 
were mounted with a coverslip or a slide and using 30 µL of mounting medium (Life 
technology, P36930). The slides were air dried for several hours and stored at 4°C. 
For the image acquisition the slides were investigated using a HistoRX microscope 
station (HistoRX, PM2000) with the AQUA software. The settings through the 
experiments were 30 ms acquisition time for CY5 (viewed using a CY5 filter cube) 
and 2 ms acquisition time for Hoechst (viewed using a DAPI filter cube). 
 
5.2.12 Raman spectroscopy acquisition time 
 
All spectra taken in this chapter were WMR spectra and the acquisition time was 150 
seconds (See Chapter 2 General methods section 2.8 for more details). 
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5.3 Results 
5.3.1 Tissue embedded in paraffin 
  
Our collaborators in PHE provided TB infected guinea pig lung tissue. Two Raman 
spectroscopy systems were used in this chapter to acquire the WMR spectra (see 
Chapter 2 General methods section 2.12 and 2.13 for more details). 
First, paraffin embedded TB infected lung tissue sections were used and studied using 
the first Raman spectroscopy system. Single bacteria were observed on the Raman 
spectroscopy system (Fig. 5.1). A single bacillus is clearly visible and located in lung 
alveoli. Bacteria were identified based on their shape and size (rod shape: 0.2-0.6 µm 
wide and 1-10 µm long) (McMurray, 1996). The corresponding spectrum was then 
compared to the in-vitro data previously acquired for comparison. The tissue structure 
was found intact and preserved after the fixation and sectioning process. 
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Figure 5.1 Paraffin embedded tissue section. 
The picture is showing a single bacillus in guinea pig lung alveoli. The picture was 
acquired in the Raman spectroscopy system one. The single bacillus is encircled. The 
scale bar is 5 µm. 
 
 
 
 
 
 
 
 
5μm 
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In this study, only single bacteria located in alveoli were targeted as the presence of 
surrounding tissue or material would have an impact on the spectrum. When the 
bacteria were interrogated, a very intense signal was observed even within a second, 
Fig. 5.2. The values of intensity observed were highly superior (more than 10 times) 
to the one expected according to previous single cell results or even compared to 
other biological features. When targeting other areas of the lung tissue section the 
same spectrum was observed and this intense signal was also displayed outside the 
tissue section (in the paraffin). The signal was mostly coming from the embedding 
agents, as the signal did not change even when taken outside of the tissue section. 
Paraffin was used to embed the tissue; the background signal was too strong to permit 
getting any data from the tissue or single bacteria. The spectrum displays very intense 
bands especially around 1000 cm-1 and 1440-1450 cm-1; the last one being the main 
band (Lipid band B) used to discriminate between LR and LP. 
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Figure 5.2 WMR spectrum of paraffin embedded tissue section.  
The blue line represents the WMR spectrum after processing. All spectra taken across 
the tissue section gave the same signal, targeting single bacillus, lung tissue, alveoli 
or even only the paraffin. The x-axis shows the Raman shift in cm-1, the y-axis 
represents the counts. The zero crossing that is represented by the red line shows the 
Raman peak position. The intensity of the peak corresponds to the peak-to-valley 
around the zero crossing point. The acquisition time was 150 seconds per spectra (see 
Chapter 2 General methods section 2.8 for more details). 
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Observing the problem that paraffin embedding caused for the use of Raman 
spectroscopy, the initial idea was to de-paraffin using dewaxing agents. But reading 
about the dewaxing protocols and its use with Raman spectroscopy it was found that 
after using dewaxing agents the section still presents wax residues. Even if the major 
part of the wax can be removed, it cannot be in totality. Raman spectroscopy could 
still after dewaxing pick-up signal coming from the paraffin residues (Faolain et al., 
2005). Moreover, the paraffin presents a high intensity peak around 1440 cm-1, which 
is one of the main regions of interest for the study of LR and LP in Mycobacterium 
tuberculosis. This precluded the use of Paraffin embedding for the study of single 
bacteria within tissue sections. Frozen sectioning was another technique available that 
had the advantage that fewer compounds are added during the sample preparation 
process. 
 
5.3.2 First experiment using frozen tissue sections 
 
The infected lung tissue section was attached to the thicker quartz slide, see Fig. 5.3, 
this made the working distance more important compared to the in-vitro work. In this 
case, the objective was further away from the target. This mount was the same as the 
one used for paraffin embedded tissue. The tissue was fixed on the most solid slide 
because the quartz coverslips are very thin and highly breakable. 
The frozen section of the guinea pig lung showed intact tissue with clear alveoli and 
structures and intact single bacteria as the shown in Fig. 5.4. 
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Figure 5.3 Description of the sample preparation.  
This figure shows the tissue sample between the two quartz slides and the objective of 
the Raman spectroscopy system. The mount is composed of a thick quartz slide onto 
which the tissue was attached and a quartz coverslip that is in direct contact with the 
oil immersion objective. The mount is sealed using transparent nail polish at the 
edges. 
 
 
 
 
Figure 5.4 Frozen section of TB infected guinea pig lung showing a single bacillus in 
alveoli. The picture shows how images were displayed on the Raman spectroscopy 
system. The scale bar is 5 m. 
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The background Raman signal in the alveoli was very low, and it was possible to 
target single bacterium and obtain a signal from a single cell. The signal coming from 
a single cell was stronger than the signal coming from the background only. Over a 
hundred single bacteria (112) were interrogated in the first experiment on frozen lung 
tissue section. The results are shown in Fig. 5.5. The intensity level was lower than 
for in-vitro spectra, between 5 to 6 times lower, the energy level could not be 
compared to the training sets of LR and LP in-vitro bacteria from the previous 
chapter. Moreover, the signal to noise ratio was high meaning that the noise intensity 
was high compared to the Raman peak intensity. 
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Figure 5.5 WMR spectra of M. tuberculosis from frozen guinea pig lung tissue 
sections.  
The blue line represents the average WMR spectrum calculated from the spectra of 
112 single bacilli. The colour shade corresponds to one standard deviation. The x-
axis shows the Raman shift (cm-1), the y-axis the intensity in arbitrary units. The 
figure displays the finger print region of the spectrum (between 1000 to 1800 cm-1). 
The zero crossing that is represented by the dash-dotted line shows the Raman peak 
position. The intensity of the peak corresponds to the peak-to-valley around the zero 
crossing point. The acquisition time was 150 seconds per spectra (see Chapter 2 
General methods section 2.8 for more details). 
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The main difference between this study and the in-vitro study, previously showed in 
Chapter 4, is where the sample is located in the mount. In the previous in-vitro work 
the bacteria were dried directly on the coverslip, very close to the objective. In this 
experiment, the tissue was fixed on the thick slide as shown in Fig. 5.3, which means 
that the working distance was different. This could have led to signal loss. The 
technique using frozen tissue sections, however, showed that the tissue could be 
interrogated by WMR spectroscopy. We observed a high conservation of the tissue 
structure, clearly visible single bacteria and a very low background signal. For the 
next experiment, frozen tissue sections were used and were attached to the coverslip 
to reduce the working distance with the objective. 
 
5.3.3 Second experiment using frozen tissue sections 
 
For the second experiment studying, TB infected guinea pig lung tissue the same 
methodology as previously was used, but the tissue was fixed to the coverslip as 
shown in the Fig. 5.6. Over a hundred single bacilli present in alveoli and clearly 
identified were interrogated. The Fig. 5.7 shows several examples of single bacilli in 
guinea pig lung alveoli. In total 107 single bacteria were interrogated by WMR 
spectroscopy. The average WMR spectrum and associated standard deviation are 
shown in Fig. 5.8 a. Very important variability could be observed in both lipid band 
A (1300 cm-1) and lipid band B (1440-1450 cm-1) in Fig. 5.8 a. Very little differences 
were observed between the quartz slide Raman spectrum, and the TB infected guinea 
pig lung alveoli background Raman spectrum Fig 5.8 b. Fig 5.8 b and c show that no 
signal from the tissue participates to the WMR spectrum of the single M. tuberculosis 
cells as the alveoli background is comparable to the quartz slide itself. In this study, 
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bacteria located in the tissue were not targeted as their Raman signal could be 
distinguished from the lung tissue signal itself. The majority of bacteria are probably 
located in consolidated tissue and not in alveoli. 
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Figure 5.6 Description of the sample preparation.  
This figure shows the tissue sample between the two quartz slides and the objective of 
the Raman spectroscopy system. The mount is composed of a coverslip onto which the 
tissue sections were attached and a quartz slide placed on top of it. The mount is 
sealed using transparent nail polish at the edges. The coverslip is directly in contact 
with the oil immersion objective of the Raman spectroscopy system. 
 
 
 
Figure 5.7 Frozen lung tissue section with single bacteria in alveoli.  
The picture displays four fields of view, taken in the Raman spectroscopy system, with 
a single M.tb bacillus present in lung alveoli (encircled). The scale bar is 5 µm. 
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Figure 5.8 WMR spectra of M. tuberculosis from frozen guinea pig lung tissue 
sections. 
Fig 5.8 a shows the average WMR spectrum calculated from the spectra of 107 single 
bacilli (blue line). Fig 5.8 b presents the average WMR spectrum of a quartz slide 
(red), and the TB infected guinea pig lung alveoli background (green). Fig 5.8 c 
combines the previous two figures (Fig 5.8 a and b). The colour shade represents one 
standard deviation. The x-axis shows the Raman shift (cm-1), the y-axis the intensity in 
arbitrary units. The figure displays the finger print region of the spectrum (between 
1000 to 1800 cm-1). The zero crossing that is represented by the dash-dotted line 
shows the Raman peak position. The intensity of the peak corresponds to the peak-to-
valley around the zero crossing point. The lipid band A is located at 1300 cm-1 and 
the lipid band B around 1440-1450 cm-1. The acquisition time was 150 seconds per 
spectra (see Chapter 2 General methods section 2.8 for more details). 
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It was difficult to compare the in-vitro and ex-vivo data sets directly; the lipid bands A 
and B were not affected equally by the fixation and freezing procedure (Buijtels et al., 
2008, Galli et al., 2014) (Fig. 5.9 a and b). We observed that the lipid band A 
intensity was lower in tissue spectra by comparison to the in-vitro spectra. However, 
there was little change in the lipid band B intensity. This lipid band was less impacted 
by the sample preparation process and could be compared to the in-vitro data sets. In 
order to understand the proportion of LR and LP cells in tissue, we designed a ratio 
using a lipid band presenting important variability (lipid band B) and a band that does 
not vary much between LR and LP, a reference band. The band selected is between 
1050 cm-1 and 1070 cm-1 (reference band), a region, which is conserved between LR 
and LP (Fig. 5.9 a), and this band is intense showing a good signal to noise ratio. The 
reference band also displayed little variability among the spectra taken from lung 
tissue sections. This band was the internal reference for the ratio. The peak-to-peak 
ratio calculated between the lipid band B and the reference band was named (R band 
B/Ref band). For each WMR spectrum of both M.tuberculosis in-vitro (LR and LP) (Fig. 
5.9 a) and M.tuberculosis in lung tissue (Fig. 5.9 b), the maximum peak intensity 
value of the two bands (lipid band B and the reference band) were used to calculate 
the ratio (R band B/Ref band). The results of R band B/Ref band are shown in Fig. 5.9 c; a higher 
ratio value corresponds to a higher relative quantity of lipids in the bacteria. The ratio 
values of in-vitro LR and LP overlap but their respective peaks of distribution are 
very distinct (Fig. 5.9 c). Looking at M.tuberculosis ex-vivo R band B/Ref band, we 
observed ratio values corresponding to both LP and LR. The wide distribution of the 
R band B/Ref band, calculated from WMR spectra of bacteria in lung tissue confirmed that 
both LR and LP cells were present in the infected lung tissue. Interestingly we also 
observed that ex-vivo ratio predominantly overlap with LR ratio (Fig. 5.9 c). 
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Figure 5.9 M. tuberculosis in guinea pig lung tissue, a phenotypic investigation. 
Fig. 5.9 a shows the average WMR spectra of both LR (red line) and LP (green) cells 
taken in-vitro over 60 single bacteria for each set. The shaded coloured zone 
represents the corresponding single standard deviation. The x-axis is the Raman shift 
(in wavenumber, cm-1) and the y-axis shows the differential Raman intensity in 
arbitrary units. Fig. 5.9 b presents the average WMR spectra of M. tuberculosis cells 
taken in the guinea pig lung tissue and calculated using 107 single bacterial WMR 
spectrum. The shaded coloured zone represents the corresponding single standard 
deviation. The lipid band A is located at 1300 cm-1 and the lipid band B around 1440-
1450 cm-1. For all single WMR spectrum the acquisition time is 150 seconds in total 
(see Chapter 2 General methods section 2.8 for more details). Both the Fig. 5.9 a 
and b show the finger print region of the spectrum (between 1000 to 1800 cm-1). Fig. 
5.9 c displays the peak-to-peak ratio (R band B/Ref band) calculated for all WMR spectrum 
of M. tuberculosis in-vitro LR, LP (Fig. 5.9 a) and ex-vivo (Fig. 5.9 b). In order to 
calculate this ratio the maximum peak value from the lipid band B is divided by the 
maximum peak intensity of the reference band (Ref band: 1050 cm-1 to 1070 cm-1). 
The in-vitro LR R band B/Ref band values are represented by the red bars, the LP by the 
green bars and the ex-vivo ratio by the blue bars. Corresponding coloured lines have 
been inserted to show the shape of distribution for each set. The x-axis shows the R 
band B/Ref band values; the y-axis corresponds to the percentage of the bacterial 
population at each R band B/Ref band value. For example, 5.5% of in-vitro LR cells show 
an R band B/Ref band of 1.5, where it is 34% of in-vitro LP cells and 6.5% of M. 
tuberculosis in tissue. 
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The lipid band A was lower in the WMR spectrum of M. tuberculosis cells taken in 
tissue than it was in WMR spectrum acquired in-vitro. The lipid band A in the ex-vivo 
WMR spectra was reduced to 61% of the lipid band A of the in-vitro WMR spectra. 
Applying a multiplication factor to the lipid band A of the ex-vivo WMR spectra we 
calculated ratios using the lipid band A and the same reference band used previously. 
This ratio was named R band A/Ref band. Similarly to the previous ratio, this one was 
applied to all WMR spectra both in-vitro (LR and LP) and ex-vivo. The results of this 
ratio (R band A/Ref band) are presented in Fig. 5.10. The ex-vivo R band A/Ref band values are 
widely distributed, and we can observe values that match both LR and LP R band A/Ref 
band values. The ex-vivo R band A/Ref band values are also skewed to LR phenotype 
similarly to what was observed previously in Fig. 5.9. 
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Figure 5.10 Peak-to-peak ratio (R Band A/Ref Band) calculated from M. tuberculosis in-
vitro (LR and LP) and ex-vivo WMR spectra.  
This ratio has been calculated by dividing the maximum value in lipid band A with the 
maximum value from the reference band (Ref Band: 1050 cm-1 to 1070 cm-1). The 
fixation and freezing process of the infected guinea pig lung tissue have impacted the 
lipid band A and reduced it to 61% of the lipid band A found in the in-vitro WMR 
spectra. In order to calculate the R Band A/Ref Band the lipid band A in the ex-vivo spectra 
have been adjusted to take the intensity reduction into account. The coloured bars 
represent the R Band A/Ref Band values of the in-vitro LR cells (in red), the in-vitro LP 
cells (in green) and the ex-vivo cells (in blue). Corresponding coloured lines have 
been inserted to show the shape of distribution for each set. The x-axis shows the R 
Band A/Ref Band values; the y-axis corresponds to the percentage of the bacterial 
population at each the R Band A/Ref Band value. 
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M. tuberculosis in tissue showed important variability in terms of lipid content as 
shown in Fig. 5.9 c. It is notable that ratios homologous to both LR and LP cells can 
be observed in tissue. As shown in Chapter 3 the relation between Raman peak and 
the lipid concentration is linear. Therefore if a lipid peak in a single bacterium is 
twice higher compared to another cell, it would suggest that the first bacterium 
contains twice the quantity of lipids. This result suggests that in tissue some bacteria 
can present twice as much lipid than others. Further experiments are required to 
associate the presence of intracellular lipid bodies in M. tuberculosis cells and the 
increase in Raman lipid peaks intensity. 
 
5.3.4 Nile red staining and fluorescence microscopy 
 
A one-week-old culture of M. smegmatis was stained using 2.5 µg.mL-1 of Nile red 
and observed using fluorescence microscopy. The results are visible in Fig. 5.11 and 
Fig. 5.12. LR and LP cells could clearly be identified and the lipid bodies observed 
and counted using Nile red staining. 
Bacteria present different sizes, a different number of lipid bodies and different lipid 
body sizes. In terms of lipid content, the bacterial population present a large spectrum 
between absence to presence of several large lipid bodies and all different scenarios 
could be found from zero to several lipid inclusions. In Fig. 5.12 LR and LP cells can 
be observed, LR cells present very different lipid content up to 5 distinct lipid 
inclusions in Fig. 5.12 b. The lipid content among mycobacteria is very 
heterogeneous. 
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Figure 5.11 M.smegmatis one-week-old (stationary phase) culture stained using Nile 
red and observed using fluorescence microscopy. 
The figure is showing four composite images (Fig. 5.11 a, b, c and d). Each image is 
composed of three sections, on the top left the green channel, on the top right the red 
channel and on the bottom left the combined image of the previous two pictures. In 
Fig. 5.11 a, a LR bacteria can be observed with one clear lipid body, in Fig. 5.11 b a 
LP bacteria can be observed with no clear lipid body visible. In Fig. 5.11 c and d 
both a LR and a LP cell can be observed, with an LR cell showing two lipid bodies in 
Fig. 5.11 c. The scale bar represents 5 µm. 
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Figure 5.12 M.smegmatis one-week-old culture stained using Nile red and observed 
using fluorescence microscopy. 
The figure is showing two composite images (Fig. 5.12 a and b). Each image is 
composed of three sections, on the top left the green channel, on the top right the red 
channel and on the bottom left the combined image of the previous two pictures. LR 
and LP cells can be observed in both Fig. 5.12 a and b. LR cells show various 
number and sizes of lipid bodies. The scale bar represents 5 µm. 
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5.3.5 System combining Raman spectroscopy and fluorescence imaging 
 
A new Raman spectroscopy system was developed to be able to study stained bacteria 
and then take their Raman spectrum. This system was able to generate blue and green 
light used to excite stained bacteria similarly to the Leica fluorescence microscope 
(see previous images). The green excitation light gave rise to red fluorescence 
emission predominantly from Nile red in a polar lipid environment; the blue 
excitation light gave rise to the green emission associated with Nile red in a non-polar 
lipid environment. The fluorescence part of the combined system was designed to 
mimic the Leica fluorescence microscope (light source and filter cubes). For the 
Raman spectroscopy part this system was built to be comparable to the Raman 
spectroscopy system one, the same laser is powering the system. For more details 
about the combined system refer to the Chapter 2 General methods section 13. 
 
5.3.5.1 In-vitro comparison between stained and unstained bacteria using 
WMR spectroscopy 
 
In order to investigate the impact of Nile red on the WMR spectra of single bacteria; 
M.smegmatis culture was stained using 2.5 µg.mL-1 Nile red, heat fixed on a quartz 
coverslip and interrogated using Raman spectroscopy. The results are shown in Fig. 5. 
13. Nile red staining gave stronger fluorescence background than unstained samples. 
The stain affected the standard Raman spectra, especially the fluorescence 
background but the WMR approach removed the influence coming from the dye 
(removed the auto-fluorescence background). Nile red staining does not impact the 
WMR spectra significantly. 
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Figure 5.13 Comparison of Nile red stained and unstained M. smegmatis single cell 
using WMR spectroscopy. 
The coloured lines correspond to the average spectrum of unstained (red) and stained 
(green), the average spectrum has been calculated using 40 single spectra for each 
set. The colour-shaded area surrounding the lines represents a single standard 
deviation. The x-axis displays the Raman shift in wavenumber (cm-1), the y-axis 
represents the differential Raman intensity in arbitrary units. The time required to 
obtain one single cell spectrum is 150 seconds (see Chapter 2 General methods 
section 2.8 for more details). Fig. 5.13 shows the finger print region of the spectrum 
(between 1000 to 1800 cm-1). 
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5.3.5.2 In-vitro experiment on Nile red stained mycobacteria 
 
An initial in-vitro experiment using Nile red stained M. smegmatis was performed. A 
100 µL of bacterial suspension was stained using 2.5 µg.mL-1 Nile red. The new 
system built was able to combine fluorescence imaging and Raman spectroscopy (see 
Chapter 2 General methods section 13 for more details). Prior to taking Raman 
signal the preparation was studied using white light, then green excitation light 
(TRITC, standard Nikon fluorescence cube) leading to red emission (Nile red in polar 
lipid environment) and finally blue excitation light (FITC, standard Nikon 
fluorescence cube) generating green emission (Nile red in a non-polar lipid 
environment). This system mimics the fluorescence microscope used previously (Fig. 
5.11 and Fig. 5.12). The Fig. 5.14 shows the white light output, single bacilli and 
groups of cells can be observed in this field of view. The circles show the single 
bacteria studied, 8 in total. 
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Figure 5.14 M. smegmatis Nile red stained observed under white light. 
Field of view showing several bacilli, the bacteria encircled are studied in this 
experiment. The exposure time to acquire this picture, using white light, in the 
combined fluorescence and Raman spectroscopy system is 2 ms. The scale bar 
represents 5 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 µm 
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Once the white light image was saved the green excitation light, showing the red 
emission, was switched on. The Fig. 5.15 a shows the corresponding picture. All 
bacteria can be clearly observed on this picture. The red emission corresponds to that 
of Nile red in a polar lipid environment. The image was processed in MATLAB® in 
order to remove uniformly the light background, see Fig. 5.15 b. Most bacteria are 
showing similar red light emission intensity level. The blue excitation light was then 
switched on showing the green emission, coming from Nile red in a non-polar lipid 
environment (lipid bodies). The results are presented in Fig. 5.16 a and the image 
processed in MATLAB® in Fig. 5.16 b. Important differences can be observed 
between bacteria in this image. A combined image, red and green light emission, is 
shown in Fig. 5.17 a and the Fig. 5.17 b displays the assignment of bacteria to LR or 
LP based on their fluorescence profile. 
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Figure 5.15 M. smegmatis Nile red stained observed under green excitation light 
showing red emissions. 
The image shows the same field of view as Fig. 5.14 but shows red fluorescence. The 
total acquisition time is 150 ms. The Fig. 5.15 a displays the original image showed 
by the camera on the system. The camera only shows black and white; the intense 
white corresponds to intense red light emission (Nile red in a polar lipid 
environment). The Fig. 5.15 b shows the same image but processed in MATLAB®; 
this permit to remove the background light. The red light emission corresponds to 
Nile red in a polar lipid environment. This system is mimicking the Leica fluorescence 
microscope. The scale bar represents 5 µm. 
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Figure 5.16 M. smegmatis Nile red stained observed under blue excitation light 
showing green emissions. 
The image shows the same field of view as Fig. 5.14 with fluorescence acquired with 
the blue light excitation. The total acquisition time is 600 ms. The Fig. 5.16 a displays 
the original image showed by the camera on the system. The camera only shows black 
and white; the intense white corresponds to intense green light emission (Nile red in a 
non-polar lipid environment). The Fig. 5.16 b shows the same image but processed in 
MATLAB®; this permit to remove the background light. The green light emission 
corresponds to Nile red in a non-polar lipid environment. This system is mimicking 
the Leica fluorescence microscope. The scale bar represents 5 µm. 
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Figure 5.17 Composite image of both green and red light emission and assignment to 
LR or LP. 
The Fig 5.17 a present the composite image of both the red and green fluorescence 
emission. Among the studied bacteria, some display only red fluorescence and others 
show both red and green fluorescence. Based on those results the bacteria are 
assigned to either LR (red circle) or LP (green circle) as shown in Fig 5.17 b. The 
scale bar represents 5 µm. 
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When the green fluorescence background was removed, some bacteria did not display 
any green fluorescence; compared to other cells that presented strong green intensity, 
much higher than the background level. Clear differences between LR and LP cells 
were observed based on the green light emission Fig. 5.16 (presence of non-polar 
lipids) and also when looking at the combined picture Fig. 5.17 a. Based on this, 
single bacteria were assigned to either LR or LP Fig. 5.17 b. There is, especially 
among LR cell, high variability in green emission light intensity. This suggests that 
LR cells do not all carry a similar quantity of lipids. 
Each single bacterium (shown in Fig. 5.17 b) was interrogated with Raman 
spectroscopy; the results are shown in Fig. 5.18. Only 8 spectra were taken on this 
initial experiment using conventional Raman spectroscopy (see Chapter 2 General 
methods section 2.8 for more details). An important background signal was coming 
from the slide, and Nile red, removing this fluorescence entirely was difficult, and 
some was still visible in the reference spectra. Higher lipid peaks intensities were 
observed in the original spectra for each assigned LR cells compared to the assigned 
LP bacteria. After processing and normalisation, the two groups were not 
discriminated. 
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Figure 5.18 Standard Raman spectroscopy average spectra of LR and LP cells. 
The cells (8 in total) have been pre assigned to either LR or LP based on their 
fluorescence output (Fig. 5.17 b.). The red line represents the average standard 
Raman spectrum of LR cells, and the green corresponds to LP cells. The shaded 
coloured area shows one standard deviation. The x-axis shows the Raman shift (in 
wavenumber, cm-1) and the y-axis displays the differential Raman intensity in 
arbitrary units. The acquisition time for both the background and the bacteria is 30 
seconds, so around a minute per spectrum in total (see Chapter 2 General methods 
section 2.8 for more details). The Fig. 5.18 shows the finger print region of the 
spectrum (between 1000 to 1800 cm-1). 
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This short study showed interesting preliminary results and suggested that the system 
could perform both Raman spectroscopy and fluorescence analysis. Moreover, it was 
demonstrated that LR and LP cells could be described using the fluorescence and 
targeted by Raman spectroscopy. These initial results had to be confirmed more 
widely. WMR spectroscopy was used because of the high fluorescence background 
observed (Fig. 5.18). 
An in-vitro experiment using Nile red stained and heat killed M. tuberculosis (4 
month old culture) was carried out. A 100 µL volume of bacterial suspension was 
stained using 2.5 µg.mL-1 Nile red (final concentration). Prior to taking Raman signal 
the preparation was studied using the white light, then the green excitation light 
(TRITC, standard Nikon fluorescence cube) and finally the blue excitation light 
(FITC, standard Nikon fluorescence cube). The first image (Fig. 5.19) shows the 
white light output, single bacilli and groups of cells (clumps) can be observed in the 
field of view. Then the green excitation light corresponding to the red fluorescence 
emission is shown in Fig. 5.20 b. All bacteria can be clearly observed on this image. 
Most of the bacteria showed similar red fluorescence emission intensity level. The 
blue excitation light resulting in green fluorescence emission, arises from Nile red in a 
predominantly non-polar lipid environment is shown in Fig. 5.20 a. Important 
differences can be observed between bacteria on this image. The combined image of 
both Red and green emission is shown in Fig. 5.20 c, Fig. 5.20 d presents a zoomed 
view of the combined image with an LR cell next to an LP cell. The assignments to 
LR or LP, based on the fluorescence results, are presented in Fig. 5.21. 
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Figure 5.19 Nile red stained M. tuberculosis observed under white light. 
This field of view is showing many bacilli, single cells and aggregated cells. The 
exposure time to acquire this picture, using white light, in the combined fluorescence-
Raman spectroscopy system is 2 ms. The scale bar represents 10 µm. 
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Figure 5.20 M. tuberculosis Nile red stained observed under both green and blue 
excitation light. 
The green fluorescence emission (blue excitation light) output is shown in Fig. 5. 20 
a; The red fluorescence emission (green excitation light) output is shown in Fig. 5. 20 
b. The Fig. 5. 20 c shows the combined image of red and green light emission. Fig. 5. 
20 d is a zoomed area corresponding to the white rectangle in the combined picture; 
it shows a clear LR cell, with an intracellular lipid body and a LP cell next to it. The 
total acquisition time is 150ms for the red light emission and 600ms for the green 
light emission. The scale bar represents 5 µm. The Fig. 5.20 shows the MATLAB® 
processed picture, with the background light removed. 
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 Figure 5.21 Assignment to LR or LP based on fluorescence information. 
Among the studied single bacteria, some display only red and other show both red 
and green. Based on those results the bacteria are assigned to either LR or LP as 
shown in this figure. The scale bar represents 10 µm. 
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In each field of view, some bacteria were presenting much higher intensity green 
fluorescence emission compared to the other cells. Two groups were created a LR and 
a LP as shown in Fig. 5.21. WMR spectroscopy was used on each single bacterium 
previously assigned by fluorescence. In total 200 spectra (100 LR and 100 LP) across 
20 fields of view were acquired coming from four different slides and over six 
working days. The WMR spectroscopy results and associated PCA analysis are 
presented in Fig. 5.22. The in-vitro cell pre-assigned to LR or LP based on their 
fluorescence were discriminated by WMR spectroscopy with both high sensitivity 
(84.0%) and specificity (80.2%) (n=4) (Fig. 5.22 a and b). Most of the variability 
among the WMR spectra is located in the lipid band A and the lipid band B. 
Moreover, the LR cluster in Fig. 5.22 b is much more dispersed than the LP cluster. 
By using this combined fluorescence and Raman spectroscopy system, we 
demonstrated that the presence of green fluorescence emission of Nile red and 
therefore intracellular lipid bodies (LR cell) correlates with higher Raman intensity 
lipid bands (A and B) (Fig. 5.22 a). 
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Figure 5.22 Nile red stained in-vitro grown M. tuberculosis studied by fluorescence 
and WMR spectroscopy. 
Stained cells have been assigned to either LR or LP based on their fluorescence as 
seen in the previous figures. Then each single bacterium is interrogated by WMR 
spectroscopy. The Fig. 5.22 a shows the average WMR spectrum of LR (red line) and 
LP (green line) cells pre-assigned by fluorescence. The average spectrum is 
calculated over a 100 single bacterium for both LR and LP phenotypes. The shaded 
coloured zone represents the corresponding single standard deviation. The x-axis is 
the Raman shift (in wavenumber, cm-1) and the y-axis shows the differential Raman 
intensity in arbitrary units. The Fig. 5.22 b displays the corresponding PCA plot 
showing how the two data sets are clustering. The plot is showing the first three PCs, 
and each dot corresponds to a single bacterium. The lipid band A is located at 1300 
cm-1 and the lipid band B around 1440-1450 cm-1. The time required to obtain one 
single cell spectrum is 150 seconds (see Chapter 2 General methods section 2.8 for 
more details). The figure shows the finger print region of the spectrum (between 1010 
to 1800 cm-1). 
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5.3.6 TB infected guinea pig lung tissue stained with Nile red and interrogated 
by the combined system (WMR spectroscopy and fluorescence imaging)  
 
The frozen TB infected guinea pig lung tissue sections were stained with Nile red 
using a final concentration of 25 µg.mL-1. M. tuberculosis cells in the alveoli of 
infected lung tissue sections were interrogated by both fluorescence and WMR 
spectroscopy. A total of 93 single bacilli were studied, 56 assigned to LR and 37 to 
LP based on their fluorescence emission. An example of single LR and LP cell 
located in alveoli of infected lung tissue section are shown in Fig. 5.23. Once 
assigned to LR or LP the bacteria were interrogated using WMR spectroscopy; the 
average spectra for both phenotypes are shown in Fig. 5.24 a. The corresponding 
PCA plot, Fig. 5.24 b, displays two distinct clusters with LR cells showing a wider 
distribution as found previously in the in-vitro results (Fig. 5.22 b). Similarly to the 
in-vitro results the presence of green light emission correlates with higher intensity in 
lipid bands A and B. The two phenotypes were successfully discriminated with high 
sensitivity (92.6%) and specificity (84.6%) (n=3) (Fig. 5.24 a and b). The in-vitro and 
ex-vivo spectra are plotted together in Fig. 5.24 c with the corresponding PCA plot, 
shown in Fig. 5.24 d. The in-vitro and ex-vivo spectra of LR cells cluster together, 
and the same is observed for the LP cells (Fig. 5.24 d). The LR phenotype is 
predominant in the TB infected lung with 60% of the cells interrogated being LR. 
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Figure 5.23 Guinea pig TB infected lung tissue section stained with Nile red. 
The tissue sections are investigated using the combined fluorescence and Raman 
spectroscopy system. The first column (Fig. 5.23 a and e) shows the red fluorescence 
emission (Nile red in a polar lipid environment), the second column (Fig. 5.23 b and 
f) displays the green fluorescence emission (Nile red in a non-polar lipid 
environment). The third column (Fig. 5.23 c and g) corresponds to the combined 
image of the red and green fluorescence emission, and the last column (Fig. 5.23 d 
and h) represents the bright field image. The Fig. 5.23 a, b, c and d present an 
example of LR cell, encircled in blue, showing clear green fluorescence emission 
coming from intracellular non-polar lipids (Fig. 5.23 b). The Fig. 5.23 e, f, g and h 
present an example of LP cell, encircled in yellow, which does not shows any green 
fluorescence emission (Fig. 5.23 f). The fluorescence background is coming from the 
Nile red stained tissue. The scale bar represents 2 µm. 
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Figure 5.24 M. tuberculosis from guinea pig lung tissue investigated by WMR 
spectroscopy. 
Prior to WMR spectroscopy measurements the single bacteria have been assigned to 
LR or LP based on their fluorescence emission. The Fig. 5.24 a shows the average 
WMR spectrum of LR (red line) and LP (green line) cells pre-assigned by 
fluorescence. The shaded coloured zone represents the corresponding single standard 
deviation. The Fig. 5.24 b displays the corresponding PCA plot showing how the two 
data sets are clustering. The plot is showing the first three PCs, and each dot 
corresponds to a single bacterium. The Fig. 5.24 c and d show both in-vitro (Fig. 
5.22) and ex-vivo (Fig. 5.24 a and b) data combined. The Fig. 5.24 c shows the 
average spectrum of in-vitro LR (red line), in-vitro LP (green line), ex-vivo LR (blue 
line) and ex-vivo LP (yellow line). The Fig. 5.24 c display the corresponding PCA 
plot showing the first three PCs. The x-axis is the Raman shift (in wavenumber, cm-1) 
and the y-axis shows the differential Raman intensity in arbitrary units. The lipid 
band A is located at 1300 cm-1 and the lipid band B around 1440-1450 cm-1. The time 
required to obtain one single cell spectrum is 150 seconds (see Chapter 2 General 
methods section 2.8 for more details). The figure shows the finger print region of the 
spectrum (between 1010 to 1800 cm-1). 
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5.3.7 Study of Raman shift windows  
 
All M. tuberculosis in-vitro and ex-vivo data sets have been analysed using different 
Raman shift windows: 700~1800 cm-1, 1000~1800 cm-1, 1000~1500 cm-1, 1250~1500 
cm-1 and 1400~1500 cm-1. This was done in order to observe if the sensitivity and 
specificity would decrease when using a smaller portion of the Raman spectrum for 
analysis. All Raman shift windows showed similar sensitivity and specificity results in 
all M.tuberculosis data sets (in-vivo and ex-vivo); the highest standard deviation, in 
sensitivity or specificity, found was less than 0.045 (Appendices Section 4 Tab. 1 to 
4). The two phenotypes can still be discriminated in all data sets, with high sensitivity 
and specificity, when targeting only the region 1250~1500 cm-1 (lipid band A and B) 
or 1400~1500 cm-1 (lipid band B) (Appendices Section 4 Tab. 1 to 4). This confirms 
that the major difference between the two phenotypes are located in lipid bands A and 
lipid band B. 
 
5.3.8 Immunostaining  
 
In order to compare the impact of Nile red staining and WMR spectroscopy, on tissue 
samples, immuno-staining was performed on tissue sections after these two methods. 
The quartz slides and coverslips were positively charged using a silane solution. The 
slide surface was interrogated using WMR spectroscopy to observe if any extra peaks 
could be observed compared to uncharged slides. This process did not impact the 
Raman spectrum, as no signal from silane was observed; both charged and uncharged 
quartz slides showed identical background, see in Fig. 5.25. 
 
 203 
 
 
 
 
  
 
Figure 5.25 Raman spectrum of the surface of uncharged and charged quartz 
coverslips. 
The blue line represents the Raman spectrum of uncharged (Fig. 5.25 a) and charged 
(Fig. 5.25 b) quartz coverslip. The x-axis shows the Raman shift in cm-1, the y-axis 
represents the counts. The acquisition time was 1 seconds per spectrum. Both charged 
and uncharged slides display identical signals no peak from 
aminopropyltriethoxysilane can be observed. 
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Frozen sections of mice lymph node infected with BCG were attached to positively 
charged glass slides or quartz slides (both coverslip and slide). Tissue sections 
attached to a glass slide, quartz slide and quartz coverslip were investigated using 
WMR spectroscopy. The Fig. 5.26 shows WMR spectra of mice lymph node tissue 
acquired from glass slide (Fig. 5.26 a and b), quartz slide (Fig. 5.26 c and d) and 
quartz coverslip (Fig. 5.26 e and f). The Fig. 5.26 presents the unprocessed (Fig. 5.26 
a, c and e) and the processed (Fig. 5.26 b, d and f) spectra. The unprocessed 
spectrum shows five spectra (five different coloured lines, in Fig. 5.26 a, c and e) 
acquired while the laser wavelength was tuned. This is why the Raman peak positions 
changes slightly for each of the five Raman spectra. In the unprocessed spectrum, 
there is still both Raman peaks and fluorescence. After processing all fluorescence is 
removed and only the Raman peaks, which did shift according to the laser 
wavelength, are kept. The Raman peaks coming from the tissue are clearly visible, in 
unprocessed spectra, when the tissue is attached to quartz slide (Fig. 5.26 c) or quartz 
coverslip (Fig. 5.26 e) but the peaks are hidden in the background signal coming from 
the glass in (Fig. 5.26 a). The Raman peaks, from tissue attached on glass, appear 
after data processing. This shows how the background signal from glass has been 
removed using WMR spectroscopy. The WMR spectrum of tissue can be observed in 
all preparations after data processing (Fig. 5.26 b, d and f). However, the processed 
spectrum acquired from tissue on the quartz coverslip shows much higher signal 
intensity and low noise level. The best WMR spectrum of tissue was acquired when 
the tissue section was attached to quartz coverslip. 
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Figure 5.26 WMR spectra of BCG infected lymph node tissue sections, a comparison 
between preparations. 
The mounts were made of a glass slide, quartz slide or quartz coverslip. Both 
unprocessed (Fig. 5.26 a, c and e) and processed (Fig. 5.26 b, d and f) WMR spectra 
of tissue attached to a glass slide (Fig. 5.26 a and b), quartz slide (Fig. 5.26 c and d) 
or attached to quartz coverslip (Fig. 5.26 e and f) are presented. For all the figures 
the x-axis shows the Raman shift in cm-1, the y-axis represents the counts. In the 
unprocessed data (Fig. 5.26 a, c and e) each coloured line corresponds to one of the 
five Raman spectra taken during the modulation. In the processed data (Fig. 5.26 b, d 
and f) the blue line represents the WMR spectrum after processing. The zero crossing 
that is represented by the red line shows the Raman peak position. The intensity of the 
peak corresponds to the peak-to-valley around the zero crossing point. The 
acquisition time was 150 seconds per spectra (see Chapter 2 General methods 
section 2.8 for more details). 
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The frozen mice lymph nodes infected with BCG were stained with Nile red and 
studied with fluorescence microscopy. 
All the tissue preparations were studied by immuno-staining and compared: 
• The positive control corresponding to tissue attached to a positively charged 
glass slide (usually used in this method), 
• Tissue attached to positively charged quartz slides both coverslip and slides. 
• Nile red stained tissue attached to positively charged glass slides. 
• Negative control (no primary antibody) with tissue attached to positively 
charged glass slide (usually used in this method). 
 
The immuno-staining was targeting T-cell using an anti-CD3 primary antibody. A 
secondary anti-primary antibody was then used. The secondary antibody was HRP 
conjugated. Finally, tyramine-signal-amplification (TSA)-CY5 was added leading to 
an enzymatic reaction involving Tyramine and HRP. The two molecules form a 
covalent bond; the CY5 attached to the TSA can now produce fluorescence. The 
tissue was counter stained with Hoechst dye that stained the nucleus of all cells 
present in the tissue. The positive control was compared to a negative control. The 
negative control followed the same protocol as the positive protocol but no primary 
antibody was added, to verify that there was no unspecific staining. Negative control 
did not show any specific staining on the cells meaning that the staining observed in 
the positive control slide was specific to T-cells (Fig. 5.27). 
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Figure 5.27 Comparison between positive and negative control of immuno stained 
tissue sections. 
Frozen sections of BCG infected mice lymph node were used in this experiment. The 
sections were 10 µm thick. The tissue was stained using a CY5 dye that conjugates to 
a secondary antibody, which is attached to a primary antibody targeting specifically 
T-cells. The tissue was also stained using a counter stain called Hoechst, staining cell 
nuclei. The difference between the positive control and the negative control is that no 
primary antibody was used in the negative control. This test was realised to 
demonstrate that the CY5 fluorescence was specific. The positive control is shown in 
the first column Fig. 5.27 a, c and e and the negative control in the second Fig. 5.27 
b, d and f. The first row, Fig. 5.27 a and b, is a grey scale picture showing CY5 
fluorescence (T-cells). The second row, Fig. 5.27 c and d, presents Hoechst staining 
(cells nuclei) in grey scale. The last row corresponds to the overlay of the previous 
two rows; where the CY5 fluorescence is shown in red and the Hoechst counter 
staining in blue. The scale bars represent 30 µm. 
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Then we compared the tissue attached to a positively charged glass slide that was 
interrogated by WMR spectroscopy previously and the tissue attached to a positively 
charged glass slide that was stained by Nile red previously. The results are shown in 
Fig. 5.28. If the tissue sections were stained with Nile red first and then immuno 
stained the CY5 and Hoechst staining were found very poor in quality. The CY5 
staining was not specific Fig. 5.28 b and f and the counter stain was not making 
possible an accurate localisation of cells nuclei. This made it impossible to observe T-
cells specifically. In comparison the tissue previously studied by WMR spectroscopy 
was not damaged at all, good quality Hoechst staining was observed, showing the 
nuclei of cells, specific CY5 stain was clearly visible, rendering possible the specific 
localisation of T-cells. The comparison between the two slides (Nile red stained and 
WMR spectroscopy) in Fig. 5.28 shows clearly that Nile red staining did impact and 
damage the tissue investigated whereas Raman spectroscopy did not. 
The tissue attached to quartz (slide and coverslip) previously interrogated by WMR 
spectroscopy was immunostained. The results were compared to the one previously 
obtained when the tissue was attached to a glass slide (Fig. 5.28 a c and e). Similar 
immunostaining results were found with the charged quartz slides compared with the 
glass slide. High quality Hoechst counter stain is observed and specific CY5 staining. 
T-cells can be specifically identified Fig. 5.29. Immunostaining can be performed on 
tissue sections that have been previously interrogated by Raman spectroscopy, as this 
method does not damage the sample. Moreover, immunostaining performed well on 
any of the positively charged slides tested, glass and quartz. 
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Figure 5.28 Impact of WMR spectroscopy and Nile red staining on the output of 
immuno-staining. 
The Fig. 5.28 shows a comparison of immuno-stained tissue sections that were 
previously interrogated by WMR spectroscopy (Fig. 5.28 a, c and e) or Nile red 
staining (Fig. 5.28 b, d and f). Frozen sections of BCG infected mice lymph node 
were used in this experiment. The sections were 10 µm thick. The tissue was stained 
using a CY5 dye that conjugates to a secondary antibody, which is attached to a 
primary antibody targeting specifically T-cells. The tissue was also stained using a 
counter stain called Hoechst, staining cell nuclei. The tissue interrogated first by 
WMR spectroscopy is shown in the first column (Fig. 5.28 a, c and e) and the tissue 
investigated first by Nile red staining is presented in the second column (Fig. 5.28 b, 
d and f). The first row, Fig. 5.28 a and b, is a grey scale picture showing CY5 
fluorescence (T-cells). The second row, Fig. 5.28 c and d, presents Hoechst staining 
(cells nuclei) in grey scale. The last row corresponds to the overlay of the previous 
two rows; where the CY5 fluorescence is shown in red and the Hoechst counter 
staining in blue. The scale bars represent 100 µm. Each figure shows a zoomed area. 
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Figure 5.29 Immuno-staining on tissue attached to quartz slides. 
The tissue sections were previously interrogated by WMR spectroscopy. Frozen 
sections of BCG infected mice lymph node were used in this experiment. The sections 
were 10 µm thick. The tissue was stained using a CY5 dye that conjugates to a 
secondary antibody, which is attached to a primary antibody targeting specifically T-
cells. The tissue was also stained using a counter stain called Hoechst, staining cell 
nuclei. The Fig. 5.29 shows the immuno-staining results from tissue attached to 
quartz slide (Fig. 5.29 a) and the results from tissue attached to quartz coverslip (Fig. 
5.29 b). The Fig. 5.29 a and b corresponds to an overlay picture showing both CY5 
fluorescence in red and the Hoechst counter staining in blue. The scale bars represent 
20 µm. 
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5.4 Discussion 
 
Recent clinical trials failed to shorten TB treatment to four months due to high relapse 
rate. The pathology of relapse remains largely unknown (Gillespie et al., 2014, 
Phillips et al., 2016). Relapse can be observed in patients that have been found 
sputum culture negative early in treatment (Phillips et al., 2016). Relapse is a crucial 
area of research to shorten TB treatment. The study of M.tuberculosis phenotypes has 
been mainly focussed on sputum. However, sputum might not fully represent the 
bacteria present in the lung and more importantly the one responsible for relapse 
(Mukamolova et al., 2010). This chapter proposes a method to investigate 
mycobacterial phenotype directly at the site of infection using lung tissue section of 
TB infected guinea pig. To our knowledge, this work represents the first study using 
Raman spectroscopy to investigate M. tuberculosis phenotypes in-situ. Guinea pigs 
are used in TB research as an animal model (Gumbo et al., 2015). This animal model 
has been chosen for this study because guinea pigs develop similar lesions to humans 
in PTB (Clark et al., 2015). 
The first infected guinea pig tissue sections tested were paraffin embedded. When 
observed on the Raman spectroscopy system the lung structure was preserved 
meaning that the process did not damage the tissue. Moreover, single bacteria could 
be observed within alveoli (Fig. 5.1). Spectra of single bacillus were taken using 
WMR spectroscopy method and a very strong and complex spectrum signal was then 
noted (Fig. 5.2).  This signal was very different from the in-vitro M. tuberculosis 
spectrum from single cells (see Chapter 4 Fig. 4.3), and the level of intensity was a 
lot higher, over 20 times more intense. This spectrum was obtained from locations all 
over the slide and corresponds to the paraffin used to embed the tissue. The dewaxing 
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procedure does not remove 100 percent of the paraffin and Raman spectroscopy can 
still pick up signals from the paraffin after dewaxing (Faolain et al., 2005). Paraffin 
presents an intense band around 1450 cm-1 meaning it would participate in the main 
lipid band (lipid band B) used as a major discriminating factor between LR and LP 
cells. This would make the result not interpretable, and bacteria could not be assigned 
to any phenotype. Frozen sections are also commonly used; the main advantage of the 
frozen section is that fewer chemicals are used in the process compared to the paraffin 
embedding method. The first experiment using frozen tissue sections showed low 
intensity spectra as the tissue sample was located far away from the objective. The 
tissue was attached further away compared to previous experiment resulting in a loss 
of signal (Fig. 5.3, Fig. 5.4 and Fig. 5.5). The optimal protocol and slide preparation 
for the study of single bacteria in a frozen tissue section by WMR spectroscopy are 
shown in Fig. 5.6, Fig. 5.7 and Fig. 5.8. The spectra of single M. tuberculosis ex-vivo, 
in Guinea pig lung tissue sections, are comparable to the in-vitro results regarding 
peak intensity and position. However, a direct comparison is difficult as differences 
are observed between in-vitro and ex-vivo spectra. For example, the lipid band A, 
around 1300 cm-1, displays a lower intensity in the spectra of M. tuberculosis cells 
from tissue due to the fixation and freezing procedure (Buijtels et al., 2008, Galli et 
al., 2014) (Fig. 5.9 a and b). The lipid band A and B are not impacted similarly by the 
procedure; when comparing LR, LP and tissue spectra using a ratio (R band B/Ref band), 
we found that both phenotypes were present in tissue and that the population is 
skewed towards LR cells (Fig. 5.9 c). Similar results were found when using the lipid 
band A for the ratio (Fig. 5.10). 
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We observed that Nile red staining does not impact the Raman spectrum as no 
significant spectral differences could be found between M. smegmatis stained and 
unstained data sets (Fig. 5.13). 
An initial experiment using both fluorescence and Raman spectroscopy showed that 
the fluorescence system could identify LR and LP cells (Fig. 5.14 to Fig. 5.17). The 
single cells were interrogated using standard Raman spectroscopy, and high 
background intensity was observed (Fig. 5.18). 
Using WMR spectroscopy and fluorescence combined we achieved the discrimination 
between M. tuberculosis LR and LP cells with high sensitivity and specificity in in-
vitro grown cells and in guinea pig infected lung tissue sections (Fig. 5.22, Fig. 5.23 
and Fig. 5.24). A good background subtraction was observed in the WMR spectra 
compared to the standard Raman spectra (Fig. 5.18 and Fig. 5.22). 
Raman spectroscopy has been used to differentiate bacterial species and genus 
(Maquelin et al., 2002b, Buijtels et al., 2008). However, our study by genera M. 
tuberculosis phenotypes in-vitro and ex-vivo makes a major step forward. We are 
confident of this data as they come from multiple preparations interrogated over 
several days and combined at the end; removing, differences that could come from 
fluctuation in the laser power or different background signal from the preparation. 
Moreover, in all those in-vitro and ex-vivo experiments (Fig. 5.19 to Fig. 5.24), both 
LR and LP cells were present on each slide (mixed population) compared to the 
previous experiments (Chapter 4) where LR and LP cells were located on separated 
preparation. Moreover, during the D2O separation most of the cells are lost in the 
bottom of the cuvette (mainly clumps). Some of the population variability might be 
lost during the separation process. These last two points show some of the potential 
limitations of the initial experiments we designed in the Chapter 4. However, the 
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spectral differences between LR and LP cells observed after the separation are very 
comparable to the result observed after the combined and unbiased experiments 
shown in Fig. 5.19 to Fig. 5.22. 
LR spectra from in-vitro and ex-vivo cells are very comparable in peak intensity and 
cluster together in the PCA plot; the same is observed for the LP cells that show very 
comparable intensity between in-vitro and ex-vivo spectra and cluster together in the 
PCA plot (Fig. 5.24 c and d). LR cells from both in-vitro and ex-vivo experiments 
show wider cluster in the PCA plot compared to LP cells (Fig. 5.22 b and Fig. 5.24 
b), suggesting more heterogeneity in the LR group. This could be explained by the 
fact that LR cells can present one to several intracellular lipid bodies and each lipid 
inclusion can vary in size (Fig. 5.11 and Fig. 5.12). So there would be a continuum 
between LR cells that would have one small lipid bodies to LR cells that would have 
several large inclusions and all cases in between can be observed. 
Being able to differentiate LR and LP cells is of high relevance as LR cells are 
associated with low metabolism (Garton et al., 2008) and phenotypic tolerance to 
antibiotics (Gomez and McKinney, 2004, Deb et al., 2009). LR cells can be up to 40 
times more resistant to key components of the TB treatment regimen such as 
rifampicin (Hammond et al., 2015). In this study, we showed that around 60% of the 
cells interrogated in tissue were LR and therefore may represent an antibiotic tolerant 
sub-population. This very important observation would suggest performing drug 
sensitivity testing (DST) on a population that presents a significant proportion of LR 
cells. Moreover, the bacteria responsible for relapse are thought to be dormant and LR 
(Phillips et al., 2016). The tool developed in this study could be used to investigate 
the bacteria directly at the site of infection and start unravelling the phenomenon of 
relapse. The existence of LR cells in patient’s sputum at a certain time in treatment is 
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correlated with a higher risk of poor outcome (Sloan et al., 2015). Our results show 
that LR cells are present in infected lung tissue and suggest that LR cells could 
predominate (Fig. 5.24 a and b). The data were acquired from single bacilli in the 
alveoli and not in solid tissue. We do not know if the population observed in the 
alveoli is similar or different to the population present in the solid tissue. 
The use of the combined methodology confirmed the results obtained from the 
previous experiments and that LR cells show a Raman spectrum with increased 
intensity mainly visible in the lipid bands A and B. WMR spectroscopy can be used 
on its own without any stain, similarly to what is shown in Fig 5.8. The lipid content 
can then be investigated by direct measurement of the intensity of the lipid band B or 
by using a ratio. 
The Raman signal window used in this Chapter and Chapter 4 is comprises between 
1000 and 1800 cm-1. This is where are located most of the Raman peaks related to the 
bacteria. Changing the size of this window only slightly impact the results. Sensitivity 
and specificity for the different window sizes tested vary a little; the maximum 
standard deviation observed was 0.044 (see in Appendices section 4 Tab. 1 to 4 for 
more details). This shows that a similar discrimination of LR and LP cells could be 
achieved by using a reduced window (1400-1500 cm-1). This corresponds mainly to 
the lipid band B. The fact that a reduced window could be used means that the system 
could use a specific wavelength selector (grating) for the range 1400-1500 cm-1; this 
would increase the resolution and therefore allow a shorter acquisition time. Imaging 
tissue in-vivo using video-rate with a tuneable laser (either coherent anti-Stokes 
Raman scattering or stimulated Raman scattering) could be a potential approach for 
future experiments (Evans et al., 2005, Saar et al., 2010).   
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In order to understand better the pathology of the disease, it would be very useful if 
information in addition to the phenotype could be extracted from the tissue sample. 
The use of a non-destructive, label-free method such as WMR spectroscopy should 
permit to re-use the tissue sample for other techniques. Immunohistochemistry (IHC) 
staining to investigate immune cells surrounding the bacteria could be of high interest. 
To be able to perform both methods on the same tissue sample, the tissue has to be 
attached on quartz for Raman spectroscopy for optimal result and to a positively 
charged surface for IHC. We developed and validated a protocol to charge quartz 
slides and coverslips, which do not impact the Raman spectrum (Fig. 5.25). Optimal 
Raman spectroscopy results were obtained with tissue attached to quartz coverslips 
(Fig 5.26). WMR spectroscopy was found to be non-destructive and can be used 
before IHC (Fig 5.27 and Fig 5.28). We also demonstrated that Nile red staining and 
IHC could not be combined as Nile red staining is a destructive method. Tissue 
samples investigated by Nile red staining cannot be used subsequently for further 
investigation by IHC. However, tissue samples investigated by WMR spectroscopy 
can be used subsequently for further investigation by IHC. (Fig 5.28). 
Immunostaining can be conducted on tissue sections attached to glass slides or quartz 
slides showing equivalent results (Fig 5.29). This protocol could be used for any 
study that would aim at using both Raman spectroscopy and IHC. 
 
In future experiments, WMR spectroscopy could be directly applied to tissue 
structures such as granuloma and in human tissue sections using the methodology 
validated in this Chapter. Following WMR spectroscopy IHC could be applied. Using 
this combined approach would first provide information about the bacteria, their 
phenotype and phenotypic resistance to antibiotics, and then information about the 
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surrounding immune cells. This approach could be conducted in human lung tissue 
section coming from different cohorts such as relapse, reinfection… 
 
In summary, in this Chapter, we first validated a protocol to interrogate single bacteria 
in tissue section using WMR spectroscopy. We combined Raman spectroscopy and 
Nile red staining and discriminated both LR and LP cells in-vitro and ex-vivo. This 
experiment validated that LR cells present higher intensity bands mainly in lipid band 
A and B. We showed that both LR and LP cells are present in tissue and that the LR 
phenotype could predominate and also that in-vitro and ex-vivo spectra were 
comparable, even if some differences exist mainly due to the tissue section 
preparation process. In both in-vitro and ex-vivo samples, WMR spectroscopy can be 
used on its own to investigate the lipid content using the lipid band B intensity. The 
higher the intensity of the Raman peak is the more lipids are present in the single 
bacterium. 
Finally, we developed a protocol to perform both WMR spectroscopy and IHC on the 
same tissue section; Nile red cannot be used for staining prior to IHC. 
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Chapter 6 Mycobacterial growth dynamics: 
lipid body formation and loss 
6.1 Introduction 
 
Bacteria can enter dormancy that is a reversible state by definition (Lipworth et al., 
2016). Dormancy is triggered when microorganisms are facing adverse environmental 
conditions (Lennon and Jones, 2011). As shown previously in Chapter 1 section 1.4 
many in-vitro models of dormancy exist in TB research. Dormancy in mycobacteria is 
associated with the accumulation of intracellular lipid bodies and also higher 
phenotypic antibiotic resistance (Lipworth et al., 2016). This suggests that LP bacteria 
can become LR and vice-versa. 
Mycobacteria entering stationary phase accumulate lipid bodies (Garton et al., 2002, 
Shleeva et al., 2002, Bowness et al., 2015). It was also demonstrated that LP bacteria 
could rapidly, within 15 minutes, display lipid bodies when grown in medium 
supplemented with fatty acids (Garton et al., 2002). Mycobacteria store lipids when 
facing adverse conditions as a dormancy phenomenon. Most bacteria in the 
environment can be found in a dormant state. However, as the environmental 
conditions start to improve the organisms can quit this dormant state and reactivate 
and start dividing (Lennon and Jones, 2011). Can LR bacteria convert to LP when 
facing favourable growth conditions and if yes, how quickly LR bacterium can 
become LP? 
Investigating this conversion phenomenon is central in the field as LR cells are 
phenotypically resistant to antibiotics and LP cells are sensitive (Hammond et al., 
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2015). Moreover, bacteria that survive treatment and are involved in relapse are 
thought to be dormant (Phillips et al., 2016, Hammond et al., 2015). 
The conversion from LR to LP could be observed when growth conditions improve 
for bacteria. For example, in relapse or when a granuloma ruptures, in those cases the 
dormant, phenotypic antibiotic resistant cells, could reactivate and start replicating. 
Reduction of intracellular TAG level and increases of TAG lipase activity are 
observed in mycobacterial cells exiting dormancy. The assimilation of TAGs, and 
therefore the presence of TAG lipase activity, is necessary for mycobacterial regrowth 
and to exit dormancy (Low et al., 2009). 
 
In-silico models can be used to simplify very complex systems that are hard to study 
using in-vitro or in-vivo models. They can be used to combine knowledge from 
previous experiments, test hypotheses and make predictions. Those models are not 
expensive and use controlled parameters. However, in-silico models are limited by the 
knowledge given by in-vitro or in-vivo experiments. Mathematical models can be 
used to model TB infection, granuloma, relapse, ask questions through virtual 
experiments or to help to find new drug or regimens and test them in virtual clinical 
trials (Linderman and Kirschner, 2015). Many in-silico models have been designed to 
study TB infection and granulomatous structures (Segovia-Juarez et al., 2004, 
Gammack et al., 2005, Marino et al., 2011, Fallahi-Sichani et al., 2011).  
Those models present many parameters about immune cells but not many about 
bacteria. The general structure and formation of granulomas have been proposed, 
however, the exact role that M. tuberculosis plays in this process is not well known. 
Recent studies have demonstrated the central role of the pathogen in the formation of 
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granulomatous structures and confirmed that is not only host-mediated (Guirado and 
Schlesinger, 2013, Davis and Ramakrishnan, 2009, Ehlers and Schaible, 2013). 
Knowing more about the conversion rate from LR to LP would help to build more 
robust mathematical models of granuloma and relapse; it would also help to perform 
virtual experiments and virtual clinical trials. The aim of this chapter is to investigate 
the change in phenotypic proportions in culture over time and to try to understand if 
bacteria convert from LR to LP when re-cultured in nutrient rich medium. If this is 
the case, an additional aim would be to calculate this conversion rate. The findings of 
this study could be added to in-silico models. 
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6.2 Methods 
6.2.1 Conversion rate 
 
Eppendorf tubes (one per time point) were filled with 200 μL of a seven day old M. 
smegmatis culture (≈1.107 bacteria per ml). The bacteria were spun down for 3 
minutes at 20,000 x g and the cell pellet washed with 200 μL of PBS. Bacteria were 
then spun down for 3 minutes at 20,000 x g and t=0 (first time point) was resuspended 
in 200 μL of PBS; all the other bacterial pellets were resuspended in 500 μL of fresh 
medium (7H9 broth with glycerol and tween 80) and incubated for a specific time at 
37°C. After incubation bacteria were spun down for 3 minutes at 20,000 x g and 
resuspended in 200 μL of PBS. All time points were either investigated using Nile red 
(see Chapter 2 General methods section 2.5) and observed by fluorescence 
microscopy (see fluorescence microscopy in Chapter 2 General methods section 
2.6) or interrogated using WMR spectroscopy (see Chapter 2 General methods 
section 2.8). From the 200 μL of bacterial suspension in PBS a fraction was used for 
either fluorescence microscopy (100 μL) or WMR spectroscopy (20 μL) and 20 μL 
was stored at -20°C for q-PCR analysis. 
 
6.2.2 Slide preparation for WMR spectroscopy  
 
For each time point (conversion rate experiment), from the 200 µL of bacterial 
suspension in PBS 20 µL were taken and diluted with 20 µL of PBS. Then, 10 µL 
were heat fixed on a quartz coverslip (01015T-AB, SPI Supplies, PA, USA). A thick 
quartz slide (01016-AB, SPI Supplies, PA, USA) with a spacer was used to trap the 
fixed bacteria between the two slides. The montage was then sealed using transparent 
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nail polish. The quartz coverslip was placed on the high NA microscope oil 
immersion objective of the Raman spectroscopy system and interrogated using WMR 
spectroscopy (see Chapter 2 General methods section 2.8 for more details). 
 
6.2.3  DNA quantification of the 16S rRNA gene by q-PCR  
 
The tubes for q-PCR analysis were stored at -20°C, 80 µL of PBS were added to each 
tube. The tubes were then spun down for 3 minutes at 20,000 x g, the PBS was 
discarded and the bacterial pellet resuspended in 1X TE buffer. The tubes were well 
vortexed to re-suspend the cell pellet. The cell suspension was incubated at 95°C for 
20 minutes under constant shaking at 1000 rpm (heat block with a shaking option), to 
lyse the bacteria. Only 2 µL of this suspension was used per q-PCR reaction. A pre-
mix was prepared including 0.2 µL of sense primer (M. tuberculosis 16S 151F; 
CTGGGAAACTGGGTCTAA), 0.2 µL of antisense primer (M. tuberculosis 16S 
256R; CACCAACAAGCTGATAGG) (200 nM final each), 5 µL of EvaGreen (BIO-
RAD, UK), 2.6 µL of Milli-Q water. The pre-mix was added into 2 µL of DNA 
suspension to make a final volume of 10 µL per one PCR reaction. PCR cycles were 
performed using a Rotor-Gene machine (Rotor-Gene Q, QIAGEN). The temperature 
profiles consisted of 95°C for 2 minutes, 40 cycles of 95°C for 15 seconds, 60°C for 
60 seconds and green fluorescence measurement and finally melting analysis (from 
60°C to 99°C). 
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6.3 Results 
6.3.1 LR and LP proportion over time 
 
Stationary phase cultures of M. smegmatis (seven days old) were stained using Nile 
red and found to be predominantly LR  (77.6% LR; STD ±	1.6%	;	n=3). Stationary 
phase cultures (one week to two weeks old 100 µL in 10 mL) were re-cultured in 
fresh, nutrient rich, medium (at 37°C) and Nile red stained after 24 hours. The 
cultures after 24 hours in fresh medium were found predominantly LP (24% LR; STD ±	4.1%	LR;	n=3).	The	counts	are	presented	in	Tab.	6.1	and	Fig. 6.1. Fluorescent	images	 from	both	conditions,	 stationary	phase	culture	and	24	hour	subculture,	are	shown	in	Fig. 6.2. 
The changes in LR proportion are very important and occur in the first 24 hours after 
subculture. Is it due to conversion? If yes, how quickly those bacteria convert from 
LR to LP in nutrient rich conditions? 
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Table 6.1 LR and LP counts from seven day old cultures and 24 hour old cultures 
(started from stationary phase culture). Three distinct experiments (biological 
replicates) for each condition (n=3). 
Time 
points  
LR counts LP counts Total % LR Average 
%LR ± 
STD 
7days 1 218 57 275 79.3 77.6 ±	1.6 7days 2 270 84 355 76.1 
7days 3 609 178 787 77.4 
24 hours 1 206 688 894 23 24 ±	4.1 24 hours 2 235 582 817 28.8 
24 hours 3 103 393 496 20.8 
 
 
Figure 6.1 LR percentages in M. smegmatis stationary phase cultures (seven days 
old) and 24 hour cultures (subcultured in fresh medium using ≥ 7 days old culture). 
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Figure 6.2 Do LR cells convert to LP cells in fresh, nutrient rich, medium?  
Fig. 6.2 a shows an image of Nile red stained M. smegmatis cells 24 hours after 
subculture in fresh medium. The culture was from a stationary phase culture ≥	7 days 
old. Fig. 6.2 b presents a picture of Nile red stained M. smegmatis stationary phase 
culture (7 days old). Fig. 6.2 c displays a growth curve showing the two time points: 
24 hours predominantly LP and 7 days which is mostly LR. In Fig. 6.2 a and b the 
scale bars represent 5µm. 
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6.3.2 Conversion rate experiment 
 
In order to investigate the conversion from a predominantly LR population to a 
mostly LP population during the lag phase, a one week old M. smegmatis culture was 
placed into a fresh 7H9 medium for various durations. The bacteria were then 
observed under fluorescence microscopy after Nile red staining. In this initial 
experiment (representing the experimental set up that will be repeated in the future), 
eight time points were studied to understand the conversion: t=0 h, t=1 h, t=2 h, t=3 h, 
t=4 h, t=5 h, t=6 h and t=24 hours. Both LR and LP bacteria were counted by 
microscopic observation in all time points. The information regarding the number of 
bacteria counted and the proportion of LR and LP cells for each time point are shown 
in the Tab. 6.2. 
Table 6.2 LR and LP count, using fluorescence microscopy, for each time point of the 
initial conversion rate experiment (n=1). 
time points LR count  LP count total count %of LR 
t=0 h (7 days old) 218 57 275 79.27 
t=1 h 210 56 266 78.95 
t=2 h 293 268 561 52.23 
t=3 h 329 234 563 58.44 
t=4 h 125 293 418 29.90 
t=5 h 203 482 685 29.64 
t=6 h 134 408 542 24.72 
t=24 h 206 688 894 23.04 
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The results are presented in Fig. 6.3. This shows the first conversion rate experiment. 
The one-week-old M. smegmatis culture was predominantly showing LR cells, over 
75%, and after five hours in a fresh medium, the percentage of LR cells among the 
population dropped down to approximately 25%. Both LR and LP cells were 
observed at each time points in all fields of view. The rapid and very important 
changes in LR cell proportions could not be explained by the growth of LP cells. All 
the tubes initially received an equal inoculum volume from the one-week old culture 
(200 µL), and no increase in bacteria per mL is observed between 0 hours and 6 
hours, as measured by q-PCR see Fig. 6.4. 
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Figure 6.3 Conversion of LR bacteria to LP when placed in fresh medium (n=1).  
The x-axis represents the time points in hours and the y-axis shows the percentage of 
LR bacteria in the population. 
 
 
Figure 6.4 DNA quantification of M. smegmatis 16S rRNA gene, converted to cells 
per mL, in all time points by q-PCR (n=1). 
The x-axis shows the time points in hours and the y-axis displays the bacterial 
concentration in cells per mL-1. The 16S rRNA gene exists in two copies in 
M.smegmatis genome. 
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The conversion from LR to LP in M. smegmatis has been further investigated using 
WMR spectroscopy. The conversion rate experiment was reproduced, but the changes 
in lipid content were followed by WMR spectroscopy instead of Nile red staining and 
fluorescence microscopy. 
 
The one-week old bacteria were harvested and inoculated into fresh medium for 0, 2, 
4 and 6 hours at 37°C. No significant changes in the number of cells were observed 
within the first 24 hours in this experiment, similarly to the previous experiment 
(quantification realised with q-PCR). The samples were interrogated by WMR 
spectroscopy, and 40 spectra of single bacteria were taken for each data point. WMR 
spectroscopy is a quantitative method that provides intensity values related to the lipid 
content of bacteria. Reduction in the main lipid bands can be related to a reduction in 
lipids. The WMR spectroscopy results from the conversion rate experiment are 
presented in Fig. 6.5 a. A decease in lipid band A and B intensity can be observed 
over time. This suggests that there is a reduction of lipid content in cells within the 
first two hours after being placed in a nutrient rich environment. 
The Fig. 6.5 b shows the average WMR spectra of the times point t=0 h and t=4 h 
without the standard deviation to have a clear view of where the changes in intensity 
occur between the two time points. The Fig. 6.5 c displays the average WMR 
spectrum of  total lipid extract from M. tuberculosis.  
When comparing the Fig. 6.5 b and c it is apparent that the changes in Raman peak 
intensity that happen over time occur in bands that are also present in the spectrum of 
the total lipid extract. 
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Figure 6.5 LR to LP conversion investigated by WMR spectroscopy (n=1). 
Fig. 6.5 a shows the results of the conversion rate experiment, the coloured lines 
represent the average WMR spectrum (40 spectra of single bacterium) of the different 
time points t=0 h (red), t=2 h (green), t=4h (blue) and t=6 h (pink). The 
corresponding shaded coloured area displays the standard deviation. The x-axis 
represents the Raman shift (in wavenumber, cm-1) and the y-axis shows the 
differential Raman intensity in arbitrary units. In a WMR spectrum, the Raman peaks 
correspond to the zero crossing point (the point where the curve cross the dash-dotted 
line); the Raman peak intensity is the peak-to-valley value around this zero crossing. 
The time point t=0 h corresponds to a one week old culture then t=2 h, t=4 h and t=6 
h are coming from the same one week old culture that was subcultured for 2,4 and 6 
hours into fresh medium at 37°C. Fig. 6.5 b displays the time points t=0 h and t=4 h 
without the standard deviation. Fig. 6.5 c shows the average WMR spectrum of total 
lipid extract (M. tuberculosis; 1 month old). 
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In order to understand the reduction in lipid content over time in mycobacteria, when 
placed in nutrient rich conditions, we focused on the most intense lipid band of the 
fingerprint region: the lipid band B (1440-1450 cm-1). The average lipid band B 
intensity for the different data points is shown in Tab. 6.3. A reduction in intensity 
can be observed from 525 at t=0 h to 352.8 at t=6 h; the standard deviation is also 
reducing over time suggesting that the bacteria interrogated at t=0 h were showing 
high variability in lipid content. 
The results found previously (Tab. 6.1) suggest that over 75% of the bacteria are LR 
in a seven day old culture. In theory, LP bacteria are showing less intense lipid bands. 
The intensity values were classified in decreasing order, and the first 75% were found 
to be superior to 400 arbitrary Units. Applying this theoretical threshold between LR 
and LP to the other time points, it was found that at t=2 h, t=4 h and t=6 h; 55%, 
47.5% and 22.5% of the bacteria were LR respectively (Tab. 6.3; n=1). The WMR 
spectra of the lipid band B, for all the time points, are shown in Fig. 6.6 a. All the 
lipid band B intensity values are plotted in Fig 6.6 b with the theoretical threshold at 
400 arbitrary units. 
Table 6.3 Lipid band B intensity during the conversion rate experiment (n=1). 
Time points Average intensity 
(Raman lipid band 
B) 
Standard deviation % of bacteria with a 
lipid band B 
intensity ≥ to 400 
(arb. units) 
t=0 (7 days old) 525 163.7 77.7 
t=2h 416 109.4 55 
t=4h 398 85.8 47.5 
t=6h 352.8 82.7 22.5 
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Figure 6.6 Lipid band B intensity reduction during the conversion rate experiment 
(n=1). 
The Fig. 6.6 a shows the results of the conversion rate experiment, the coloured lines 
represent the average WMR spectrum (40 spectra of single bacterium) of the different 
time points t=0 h (red), t=2 h (green), t=4 h (blue) and t=6 h (pink). The 
corresponding shaded coloured area displays the standard deviation. The x-axis 
represents the Raman shift (in wavenumber, cm-1) and the y-axis shows the 
differential Raman intensity in arbitrary units. In a WMR spectrum, the Raman peaks 
correspond to the zero crossing point (the point where the curve cross the dash-dotted 
line); the Raman peak intensity is the peak-to-valley value around this zero crossing. 
The time point t=0 corresponds to a one week old culture then t=2 h, t=4 h and t=6 h 
are the same one week old culture that was subcultured for 2,4 and 6 hours in fresh 
medium at 37°C. The Fig. 6.6 b displays all the lipid band B intensity values of t=0 h 
(w), t=2 h (n), t=4 h (∆) and t=6 h (×). Each symbol represents a single bacterium. 
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The reduction of the lipid band B over time was further investigated. The Fig. 6.7 a 
presents a boxplot of the lipid band B intensities of the different time points. The Tab. 
6.4 displays the result of a Tukey-test to compare the all the means pairwise. The time 
point t=0 h is found significantly different to the other time points. t=2 h, t=4 h and 
t=6 h are not significantly different to each other. All the statistical tests and 
corresponding figures were realised using the software R (R version 3.0.2 (2013-09-
25) -- "Frisbee Sailing"; Copyright (C) 2013 The R Foundation for Statistical 
Computing). The full script, with the code and results, is presented in Appendices 
section 5. 
 
Table 6.4 Tukey multiple comparisons of means (95% confidence level). (*)	 Infers	that	the	means	of	the	time	points	compared	are	significantly	different	(n=1).	 
Time points compared (pairwise) p-value 
2-0 1.08E-04	(*) 
4-0 4.50E-06	(*) 
6-0 0                (*) 
4-2 9.13E-01 
6-2 9.97E-02 
6-4 3.53E-01 
 
The Fig. 6.7 b presents all lipid band B intensity data, of all the time points, plotted 
with a regression line. The intercept (its starting point on the y-axis) of this regression 
line is 509.4 Lipid band B intensity in arbitrary units and the regression pace is -28.06 
Lipid band B intensity in arbitrary units per hour. 
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Figure 6.7 Statistical analysis of the reduction of the lipid band B intensity over time 
(n=1).  
Fig 6.7 a presents boxplots of the intensity values, of the lipid band B, for the t=0 h, 
t=2 h, t=4 h, t=6 h. Fig 6.7 b is a plot of the intensity values, of the lipid band B, for 
the t=0 h, t=2 h, t=4 h, t=6 h with the regression line that corresponds to the 
following equation: !"#$"%&#' = −28.06 × ℎ!"#$ + 509.4. 
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6.4 Discussion 
 
Recent clinical trials, testing new regimens for four months therapy, did not succeed 
to show superiority compared to the current six month long regimen. Relapse due to 
bacteria that survive the antibiotic challenge is thought to be the main reason why the 
duration of treatment cannot be reduced (Gillespie et al., 2014, Phillips et al., 2016). 
Those bacteria are thought to be dormant (phenotypically antibiotic resistant and lipid 
rich cells) (Phillips et al., 2016, Hammond et al., 2015, Lipworth et al., 2016). 
Investigating dormancy, phenotypic antibiotic resistance and lipid storage is central to 
the design of future TB treatments (Lipworth et al., 2016). 
A clinical trial is a long and very expensive process, and there are multiple drug 
regimens that could be tested. The use of mathematical model virtual experiments and 
virtual clinical trials could be a used to inform during the decision process and help to 
reduce the list of potential regimens before a new clinical trials are launch (Linderman 
and Kirschner, 2015).  
In-silico models are inexpensive, and the parameters used are all controlled and 
known. These models miss any influence from unknown parameters (Guirado and 
Schlesinger, 2013). Moreover, to build accurate mathematical models more 
parameters need to be generated through experimentation to minimise the number of 
estimated values.  
The capacity to convert between phenotypes (LR and LP) seems to be crucial as 
through this phenomenon bacteria can survive adverse conditions and reactivate later 
when conditions are favourable. It has been shown that bacteria grown in the presence 
of fatty acids can become LR (display intracellular lipid bodies) in only several 
minutes (Garton et al., 2002). 
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In this Chapter, we investigated the conversion of LR cells to LP cells. It was 
observed in this study that M. smegmatis stationary phase cultures (seven days old) 
were predominantly LR (77.6% LR; STD ±	 1.6%	 ;	 n=3). Seven day old or older 
cultures were subcultured in fresh, nutrient rich, medium. After 24 hours in those 
favourable growth conditions, the bacterial populations were found predominantly LP	
(24% LR; STD ±	4.1%	LR;	n=3; Tab. 6.1, Fig. 6.1 and Fig. 6.2). This shows very 
important changes in phenotypic distribution in the first 24 hours of culture. Is this 
change is due to conversion from LR to LP and if so how quickly does it occur? 
Could this change in phenotypic distribution linked to replication of LP cells? 
The first observation is that at these two time points both LR and LP cells are 
observed. Showing that not all cells become LR in nutrient poor conditions (stationary 
phase culture) and that not all cells are LP or convert rapidly to LP in a nutrient rich 
medium. 
To try to answer those questions we designed a conversion rate experiment to 
investigate this window: the first 24 hours of culture. A seven day old culture was 
used to start this experiment, an equal volume of culture was re-cultured in fresh, 
nutrient rich, medium for 0, 1, 2, 3, 4, 5, 6 and 24 hours (t=0 hours is the seven days 
old culture). The proportion of LR and LP cells was followed by Nile red staining and 
fluorescence microscopy. The culture at t=0 h was highly LR  (around 79%), and after 
5, 6 hours in a nutrient rich medium the population was found predominantly LP with 
around 25% of LR cells. The proportion of LR cells was similar in t=24 h (around 
25% LR), suggesting that most of the change in LR/LP proportion occurred within the 
first 6 hours (Fig. 6.3 and Tab. 6.2). For all the conditions, M. smegmatis 16S rRNA 
gene copy number was measured by q-PCR and then converted to cells per mL, to 
observe a potential change over time due to cell division. The number of cells during 
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the first 6 hours seems unchanged, suggesting that no or very little cell division 
occurred during this lag phase period (Fig. 6.4). This observation suggests that the 
very important change in LR/LP proportion in the first 6 hours cannot be explained by 
replication of LP cells but can only come from the conversion of LR bacteria to LP 
bacteria. The hypothesis is that facing favourable growth conditions LR bacteria start 
to use their stored lipid before starting to actively replicate.  
To investigate this conversion further and also to accurately calculate a conversion 
rate the experiment was repeated using WMR spectroscopy. This method can provide 
absolute quantification using the main lipid peak intensity values. A seven day old 
culture was used to start this experiment, an equal volume of culture was re-cultured 
in fresh, nutrient rich, medium for 0, 2, 4 and 6 hours (t=0 hours is the seven day old 
culture). Around 40 spectra of single cells were acquired for each time points. The 
main lipid peaks intensities reduce over time meaning that on average the bacteria 
interrogated were presenting less and less lipids (Fig. 6.5 a and Tab 6.3). The average 
WMR spectra of the time points t=0 h and t=4 h are directly compared in Fig. 6.5 b, 
showing that reduction in intensity over time is visible in peaks related to lipids. 
Those Raman peaks were also observed in the WMR spectrum of total lipid extract of 
M. tuberculosis Fig. 6.5 c (see Chapter 3 for more details). The areas, of the WMR 
spectra of the two time points, not related to lipids remain very similar. The main lipid 
peak, the lipid band B, was then used to extract intensity values from all the WMR 
spectra (Fig. 6.6). The average lipid band B intensity at t=0 h is 525  ±163.7 arb.units 
and at t=6 h it is 352.8±	 82.7	 arb.units (Tab. 6.3). The intensity values of all the 
WMR spectra of the different time points are plotted in Fig. 6.6 b and Fig. 6.7. The 
time points were compared pairwise using the Tukey test (Tab. 6.4) t=0 h is found 
significantly different from the other time points. This suggests that an already 
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important change in lipid content occurred within the first two hours of incubation. 
The other three time points were not found significantly different even if t=2 h and 
t=6 h present a p-value between 0.05 and 0.1.  
In order to calculate the conversion rate the intensity values were all plotted and a 
regression line was then calculated (Fig. 6.7 b) following the equation: !"#$"%&#' =−28.06 × ℎ!"#$ + 509.4. 
 
The conversion rate experiment using WMR spectroscopy needs to be repeated to 
obtain a more robust conversion rate. Another approach to calculate the conversion 
rate from LR to LP would be to use a methodology that permits the interrogation of 
living bacteria overtime. Trapping cells in a chamber using acoustic force combined 
with WMR spectroscopy could be an approach to investigate. This would allow 
following the spectra of a group of bacteria over time facing different conditions for 
example being re-cultured in fresh, nutrient rich, medium. 
 
Understanding better the change in phenotypic proportions of cells in mycobacterial 
population would be of high relevance as LR cells are phenotypically resistant to 
antibiotics and an issue in TB treatment. In patients, a higher percentage of lipid body 
positive cells, at three and four weeks of treatment, is linked to an unfavourable 
outcome (Sloan et al., 2015). Knowing the percentage of LR cells in patients’ sputum 
represents therefore an interesting topic to investigate. Automated image analysis 
could represent a solution; initial tests were done using the data sets presented in Fig. 
6.1 and Tab. 6.1 and comparable results were found compared to counting by eye 
with an average time to count each picture of only several seconds. An example is 
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shown in Appendices section 6. Automated image analysis could provide more 
objective, reliable and robust results than eye count. 
 
In summary, this study showed that important change in LR/LP proportion occurs 
when a predominantly LR culture is re-cultured in a nutrient rich medium. The LR 
cells convert to LP cells very quickly within the first 6 hours of culture. This Chapter 
proposes an experiment and a methodology to calculate the conversion rate of LR 
cells to LP cells. This chapter also discusses further techniques that could help 
studying the proportion of LR and LP bacteria in various contexts. 
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Chapter 7 General discussion and future work 
7.1 General discussion 
 
The objective of the clinical trials was to shorten the duration of treatment from six 
months to four months. The regimens tested were not found superior to the current 
treatment and this mainly because of high relapse rates. The bacterial clearance was 
rapid in those clinical trials (Gillespie et al., 2014, Jindani et al., 2014, Merle et al., 
2014). This would suggest that a population of bacteria survive the treatment and is 
able, in the future, to induce relapse. Those bacteria are thought to be dormant and LR 
(Phillips et al., 2016, Hammond et al., 2015). Therefore, investigating dormancy and 
antibiotic resistance is central to propose new TB treatment regimens (Lipworth et al., 
2016). The presence of intracellular lipid bodies is associated with dormancy. 
Mycobacteria can be found in two phenotypes: LR (with intracellular lipid bodies) or 
LP (without intracellular lipid bodies). LR cells present a higher phenotypic resistance 
to antibiotics (Hammond et al., 2015). 
The bacteriology of relapse is still mostly unknown and studying dormancy could 
bring a better understanding of this phenomenon. The major goal of this thesis is to 
investigate the capacity of Raman spectroscopy, a label free and non-destructive 
methodology, to study and discriminate dormant (LR) cells and active (LP) cells in 
in-vitro and ex-vivo samples. 
 
In Chapter 3, I interrogated total lipid extracts of M. tuberculosis with Raman 
spectroscopy to show the location of the main lipid peaks. Those Raman peaks were 
confirmed to be associated with lipids when compared to a Raman database 
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(Movasaghi et al., 2007). This finding was central for the following experiments as it 
gave us a good understanding of the position of M.tuberculosis lipids Raman peaks 
and where to expect high intensity bands. Recently, a study using Raman 
spectroscopy to interrogate M. tuberculosis cells showed the association with lipids of 
some of the Raman peaks (Stockel et al., 2016). However, our study presents the 
exact position of all the Raman peaks of M. tuberculosis lipids. This is the first study 
realised on total lipid extracts of M. tuberculosis using Raman spectroscopy providing 
new and key information central to our project. 
  
In chapter 4, I demonstrated that it is possible to distinguish LR from LP cells, using 
Raman spectroscopy, for the first time. Until this work, only different mycobacterial 
species had been discriminated using Raman spectroscopy (Buijtels et al., 2008, 
Stockel et al., 2016). Being able to discriminate the two phenotypes (LR/LP) within 
the same mycobacterial species is very interesting as one of these phenotypes is 
associated with phenotypic antibiotic resistance and relapse. This represents a major 
advance, as it is the first time that mycobacterial cell states have been distinguished 
using Raman spectroscopy. 
 
The work conducted in the Chapter 3 and 4 confirmed some of the advantages of 
using WMR spectroscopy over standard Raman spectroscopy that were previously 
showed: higher signal to noise ratio (Mazilu et al., 2010), easier to interpret the 
spectra (De Luca et al., 2010), better discriminative power (Canetta et al., 2011). 
WMR spectroscopy was then used for all the subsequent experiments in this thesis. 
This work demonstrates the advantages of using WMR spectroscopy to discriminate 
bacterial species or phenotypes. 
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I have identified two lipid peaks that permit the discrimination of LR and LP cells. 
This is the first study showing a marker to identify LR and LP cells in Mycobacterium 
species using Raman spectroscopy. This means that the window to study the 
phenotypes can be reduced to target specifically those two peaks. Reducing the 
window using a grating over a short range could permit high resolution spectral 
information to be obtained in a short acquisition time. Also, this is important for the 
use of other techniques of spectroscopy such as wide field video-rate acquisition 
using non-linear vibrational spectroscopy. This method uses a tuneable laser to 
perform either anti-Stokes Raman scattering or stimulated Raman scattering (Evans et 
al., 2005, Saar et al., 2010). 
 
Applying this method to investigate TB infected tissue samples represents the 
following step. Previous studies interrogated sputum samples with fluorescence 
microscopy and showed that LR cells could be predominant in-vivo (Garton et al., 
2008). Patient sputum samples showed a population that was mainly Rpf dependent 
and showing a degree of phenotypic antibiotic resistance (Mukamolova et al., 2010). 
However, the results observed in sputum samples may not entirely reflect the 
population present in the lungs.  Therefore, to investigate and try to understand better 
the proportion of phenotypically antibiotic resistant cells, dormancy and the 
bacteriology of relapse it is central to interrogate M. tuberculosis directly in infected 
tissue. 
 
In Chapter 5, I was able to take the results of chapter 4 and translate them into an 
effective method for distinguishing the lipid status of bacteria in tissue. This chapter 
presents an innovative method that for the first time discriminated M. tuberculosis LR 
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and LP cells, directly at the site of the disease, in TB infected guinea pig lung tissue 
sections. I demonstrated, for the first time that LR cells could represent the 
predominant phenotype in TB infected tissue. Around 60% of the bacteria 
interrogated were identified as LR in the TB infected guinea pig lung tissue section. It 
has been shown that LR cells display a degree of phenotypic resistance toward 
antibiotics (Hammond et al., 2015). The high proportion of LR cells in tissue suggests 
that DST should be performed on a sample that shows a high proportion of LR cells. 
 
A significant number of patients relapse after a “successful” treatment and this could 
be due to dormant, LR cells that survive the treatment (Phillips et al., 2016). The 
work of this thesis provides a tool that allows us to examine the phenotype (lipid 
content) of the bacteria directly at the site of the infection and obtain information 
regarding their phenotypic resistance. This could permit us to research the samples of 
patients with active disease and start to unravel the reasons for relapse.  
 
Raman spectroscopy is label-free and non-destructive meaning that the tissue 
interrogated can be reused for additional analyses. For example, we can investigate 
the immune status around each individual cell giving us the opportunity to understand 
the relationship between Lipid status and immune response using IHC.  
 
Clinical trials are very expensive and take a very long time to be conducted, and there 
are multiple drug regimens that could be tested. Using mathematical models, virtual 
experiments and also virtual clinical trials could help defining the regimen before 
starting a clinical trial (Linderman and Kirschner, 2015). Those in-silico models are 
not expensive, and the parameters they use are fully controlled. Their main drawback 
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is that they need good parameters coming from experiments. Moreover, an in-silico 
model cannot inform about the influence of unknown factors or parameters (Guirado 
and Schlesinger, 2013). There is, therefore, a great need for parameters defined 
experimentally to reduce the number of estimated values in in-silico models. 
Conversion between phenotypes (LR and LP) seems to be a central phenomenon to 
investigate as LR cells are showing higher phenotypic resistance to antibiotics. It has 
already been shown that in the presence of fatty acids a bacteria can become LR in 
just a few minutes (Garton et al., 2002). In Chapter 6, I showed that in M. smegmatis 
stationary phase cultures LR cells are predominant. Stationary phase cultures of 
Mycobacteria are known to be associated with the development of intracellular lipid 
bodies (Garton et al., 2002). Stationary phase cultures placed in favourable growth 
condition for 24 hours become predominantly LP.	The proportion of LR/LP evolves 
rapidly when a predominantly LR culture is placed in a nutrient rich medium. I 
demonstrated that LR cells could convert quickly to LP cells within the first hours of 
culture. The results presented in Chapter 6 also suggest that comparing stationary 
phase cultures (≈ 80% LR) and re-cultured cells 24 hours old (≈ 25% LR) or 
exponentially growing cultures could have been used as initial experiments to 
understand differences between Raman spectra of LR and LP cells. This would have 
been easier to perform and the whole bacterial population could have been 
interrogated. 
 
To summarise this thesis, we demonstrated, for the first time, the ability of Raman 
spectroscopy to discriminate LR and LP cells (phenotype level) in both in-vitro 
samples and in TB infected tissue sections. The initial experiments (in-vitro n=1) to 
discriminate LR and LP cells shown in Chapter 4 were confirmed and validated by 
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the combined approach of fluorescence imaging and WMR spectroscopy (in-vitro 
n=4; ex-vivo n=3), used in Chapter 5. This final experiment demonstrated, in an 
unbiased way, that the Raman lipid peak intensity increase observed in LR cells was 
due to the presence of intracellular lipids located in a non-polar environment (both in-
vitro and in tissue). From this experiment, WMR spectroscopy can now be applied to 
samples on its own with the knowledge that the intensity of the lipid bands will reflect 
the lipid content of the single cells interrogated. This thesis also demonstrates that it is 
possible to combine WMR spectroscopy with another method, as this technology is 
label-free and non-destructive. In this thesis, we also began to study the conversion of 
LR cells to LP cells. 
 
7.2 Future work 
 
With the tools that I have created in this research, it now becomes possible to 
interrogate a single bacterium in TB infected lung tissue and infer the phenotypic 
antibiotic resistance of the cell based on its lipid content. This method can be used 
with another method, as it is label-free and non-destructive, to answer a large number 
of research questions and can interrogate both in-vitro or tissue samples. For example, 
IHC could be used. We developed a protocol that permits attachment of frozen tissue 
sections to positively charged quartz coverslips. Raman spectroscopy would first 
identify the phenotype, and therefore inference about the phenotypic antibiotic 
resistance of the bacteria could be made. Then IHC could inform on the surrounding 
immune cells. This approach could be conducted on human lung tissue sections and 
different conditions or cohorts could be compared regarding their proportion of LR 
cells and the immune cells present next to the bacteria. Such studies will bring a better 
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understanding of the bacteriology of relapse that remains largely unknown. This 
knowledge could then be used to feed in-silico models. This will contribute to the 
basic science that will underpin the design and evaluation of new and better 
treatments for tuberculosis. 
In addition, the method and the protocols developed in this thesis can also be applied 
to other research areas that would be interested in multiple measurements in a tissue 
sample (Raman spectrum and IHC). This work provides a tool, to study bacterial 
phenotypes in various samples, to other researchers opening possibilities in numerous 
topics. 
 
In this thesis, some of the experiments need to be confirmed or repeated. This is the 
case for the protocol developed to do a D2O separation using centrifugation steps. The 
initial experiments showed promising results. This protocol could permit the 
separation of LR and LP cells quickly and minimise potential stress on living cells. 
The experiments proposed to calculate a conversion rate from LR to LP need to be 
repeated as well. Other methods could also be tested to answer this question such as 
combining acoustic trapping and Raman spectroscopy to interrogate living cells. Once 
calculated the conversion rate could then be added to in-silico models. 
 
Understanding the proportion of LR cells is critical, as LR bacteria could be 
responsible for relapse (Phillips et al., 2016), they are phenotypically resistant to 
antibiotics (Hammond et al., 2015) and a higher percentage of LR cells, at three and 
four weeks of treatment, is associated with an unfavourable outcome (Sloan et al., 
2015). In the future, I would like to investigate the automated analysis of Nile red 
stained images. This could have potential application in diagnostics and also answer 
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research questions. An example of automated analysis of an image showing both LR 
and LP cells (Nile red stained) is shown in Appendices section 6. 
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Appendices 
 
Section 1 
 
Appendices table 1.1 Peak-to-peak ratios calculated using Raman spectra of M. 
tuberculosis lipid extraction at different culture age and corresponding standard 
deviation. 
  1month 3 month 4 month 
Ratios Average Standard 
deviation 
Average Standard 
deviation 
Average Standard 
deviation 
1060/1131 1.06 0.02 1.07 0.10 1.08 0.03 
1060/1300 0.67 0.02 0.67 0.03 0.67 0.01 
1060/1440 0.76 0.04 0.95 0.16 0.96 0.12 
1060/1465 1.89 0.13 1.92 0.15 2.53 0.25 
1060/2876 1.43 0.09 1.64 0.20 1.72 0.26 
1060/2908 1.04 0.04 1.34 0.28 1.14 0.13 
              
1131/1060 0.94 0.02 0.94 0.08 0.92 0.02 
1131/1300 0.63 0.02 0.63 0.07 0.62 0.01 
1131/1440 0.72 0.04 0.90 0.21 0.88 0.12 
1131/1465 1.78 0.12 1.81 0.24 2.34 0.25 
1131/2876 1.34 0.09 1.56 0.30 1.59 0.26 
1131/2908 0.98 0.04 1.28 0.35 1.05 0.13 
              
1300/1060 1.50 0.04 1.48 0.06 1.50 0.03 
1300/1131 1.59 0.04 1.60 0.18 1.62 0.04 
1300/1440 1.14 0.04 1.40 0.21 1.43 0.18 
1300/1465 2.84 0.15 2.85 0.18 3.78 0.38 
1300/2876 2.14 0.09 2.43 0.25 2.57 0.39 
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1300/2908 1.56 0.05 1.99 0.38 1.70 0.19 
              
1440/1060 1.32 0.06 1.09 0.22 1.06 0.13 
1440/1131 1.40 0.07 1.19 0.36 1.15 0.15 
1440/1300 0.88 0.03 0.73 0.13 0.71 0.09 
1440/1465 2.49 0.12 2.07 0.31 2.66 0.21 
1440/2876 1.88 0.05 1.75 0.11 1.79 0.09 
1440/2908 1.38 0.05 1.41 0.08 1.19 0.04 
              
1465/1060 0.53 0.04 0.52 0.04 0.40 0.04 
1465/1131 0.56 0.04 0.56 0.09 0.43 0.05 
1465/1300 0.35 0.02 0.35 0.02 0.27 0.03 
1465/1440 0.40 0.02 0.49 0.07 0.38 0.03 
1465/2876 0.75 0.03 0.85 0.08 0.68 0.06 
1465/2908 0.55 0.03 0.70 0.13 0.45 0.04 
              
2876/1060 0.70 0.04 0.62 0.09 0.59 0.09 
2876/1131 0.75 0.05 0.67 0.16 0.65 0.10 
2876/1300 0.47 0.02 0.42 0.05 0.40 0.06 
2876/1440 0.53 0.02 0.57 0.03 0.56 0.03 
2876/1465 1.33 0.06 1.18 0.11 1.49 0.13 
2876/2908 0.73 0.04 0.81 0.09 0.67 0.04 
              
2908/1060 0.96 0.03 0.78 0.20 0.89 0.10 
2908/1131 1.02 0.04 0.86 0.30 0.97 0.12 
2908/1300 0.64 0.02 0.53 0.12 0.60 0.07 
2908/1440 0.73 0.02 0.71 0.04 0.84 0.03 
2908/1465 1.82 0.11 1.49 0.31 2.24 0.19 
2908/2876 1.37 0.07 1.25 0.14 1.51 0.09 
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Section 2 
 
 
D2O Centrifugation protocol for LR/LP separation 
 
The protocol explains how to get lipid rich (LR) and lipid poor (LP) cell from the 
same culture in two steps. The first step uses a lower density solution (1.04 g.mL-1) 
and a higher centrifugation speed and harvest the top fraction (to obtain LR cells). 
The second step uses a higher density solution (1.08 g.mL-1) and a lower 
centrifugation speed and harvest the bottom fraction (to obtain LP cells).  
 
In order to generate the different density solutions the following formula was used: 
 Vy = Vi (pi− p)(p− py) 
 
Where: 
Vy is the volume of D2O in mL. 
Vi is the volume of water in mL. 
Pi is the density water in g.mL-1 (1 g.mL-1). 
Py is the density of D2O in g.mL-1 (1.107 g.mL-1). 
P is the final density (1.04 g.mL-1). 
 
To do the separation you need a tube holder (Appendices picture 2.1) and a 50 mL 
falcon tube filled with tissue at the bottom (Appendices picture 2.2). A circular 2 mL 
eppendorf tube holder was designed. To draw the holder the software rihnocad was 
used and the item was printed in plastic using a 3D printer (PP3DPUP! printer). The 
diameter of the central hole is 10.9 mm, the holder diameter is 25.9 mm and the tube 
height is 50.3 mm. 
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Appendices picture 2.1: tube holder 3D printed 
 
 
Appendices Picture 2.2: 50 mL falcon tube 
.                
 
• Harvest one mL of cell culture that you grew in tween80 (0.05% final 
concentration) to avoid clumps. 
• Wash the cells three times using PBS (spin down cells at 20,000 x g for three 
minutes, remove supernatant add PBS). Discard the supernatant. 
  
To obtain LR cells from culture: 
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• Resuspend the cellular pellet in 755 µL of MiliQ H2O, transfer this volume in 
a two mL eppendorf tube and add 450 µL of D2O solution. This achieves a 
final density of 1.04 g.mL-1. 
• Mix the solution using your pipette to homogenise the solution.  
• Place this tube in the tube holder (3D-printed, see Appendices picture 1), 
now insert the holder in a 50 mL falcon tube (see Appendices picture 2).  
• Centrifuge the falcon tube at 500 x g (1500 rpm on the J6-M1 centrifuge) for 
15 minutes. 
• Harvest the top fraction (the first 100 µL) and place it in a 1.5 mL eppendorf 
tube (see Appendices picture 3, the red cross shows where to harvest the top 
fraction). 
 
Appendices picture 3: harvest top fraction for LR cells (red cross). 
 
• You can stain the cells with Nile red or interrogate them with WMR 
spectroscopy or another methods understand the purity of the separation. If the 
purity is not high enough the centrifugation step can be repeated. Add one mL 
of 1.04 g.mL-1 solution to your 80 to 100 µL of harvested cells that remain 
after the control and centrifuge again. Harvest the top fraction and perform 
your purity control again. 
 
To obtain LP cells from the culture 
 
• Resuspend the cellular pellet in 280 µL of MiliQ H2O place this volume in a 
two mL eppendorf tube, add 830 µL of D2O (1.08 g.mL-1 final density). 
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• Place the two mL eppendorf tube the tube holder (3D-printed, see Appendices 
picture 1) insert the holder in a 50 mL falcon tube (Appendices picture 2). 
• Centrifuge the tube at 35 x g (400 rpm on the J6-M1 centrifuge) for 15 
minutes. 
• Harvest the bottom fraction (100 µL. When harvesting the bottom fraction be 
careful to not take volume close to the pellet (see Appendices picture 4, red 
cross). 
 
 
Appendices picture 4: harvest bottom fraction for LP cells (red cross) 
 
 
• You can stain the cells with Nile red or interrogate them with WMR 
spectroscopy or another methods understand the purity of the separation. If the 
purity is not high enough the centrifugation step can be repeated. Add one mL 
of 1.08 g.mL-1 solution to your 80 to 100 µL of harvested cells that remain 
after the control and centrifuge again. Harvest the top fraction and perform 
your purity control again. 
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Section 3 
 
Animal infection 
 
Work was conducted according to UK Home Office legislation for animal 
experimentation and was approved by the local ethical committee. Specific pathogen-
free Dunkin Hartley guinea pigs were infected with M. tuberculosis H37Rv (NCTC 
cat. no. 7416) using a nose-only aerosol challenge exposure as described previously 
(Lever et al., 2000) and (Clark et al., 2011). All work with M. tuberculosis was 
conducted within an appropriate ACDP containment level 3 laboratory. 
M. tuberculosis challenge inoculum at a titre of approximately 5.106  CFU.mL-1 was 
prepared in a saline suspension. The inoculum was placed into the reservoir of the 3-
jet Collison nebuliser and the Collison nebuliser was connected to the fully contained 
Henderson apparatus, the AeroMP control unit, laptop and air compressor pump. The 
3-jet Collison nebuliser generates aerosol particles of M. tuberculosis with a mean 
diameter of 2 µm (diameter range of 0.5–7.0 µm). 
The inoculum was aerosolised for 10 minutes, without animals present in the system, 
using the following parameter settings applied to the AeroMP software; relative 
humidity, RH (65 ± 1%), temperature (21 ± 1°C) and air flow rates (45 and 7.5 L mL-
1) 1 for circulating aerosol and Collison nebulizer, respectively), maintained at the 
same level throughout. 
Following pre-aerosolisation of the M. tuberculosis suspension, the snout of each 
restrained guinea pig was presented to the nose only exposure system (sow) of the 
Henderson apparatus. The guinea pigs were exposed to aerosol particles using the 
same parameters as described in above for a total duration of 5 minutes (previously 
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shown to result in the delivery of approximately 50 surface lesions in the lungs of 
each animal). 
Following aerosol challenge, animals were housed in appropriate ACDP level 3 
facilities. 
The relationship between the titre of inoculum in the aerosol nebulizer and the 
resulting CFU delivered to the lungs of each animal is specific for each nebuliser and 
apparatus type set-up. The parameters must be defined for each and the titre of 
inoculum adjusted as appropriate to obtain the required level of infection. 
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Section 4 
 
Raman shift window 
 
Raman spectra analysis of M. tuberculosis LR and LP single cells comparing 
different Raman shift window 
   
Appendices Table. 4.1 Sensitivity and specificity calculated using different Raman 
shift windows from standard Raman spectra for M. tuberculosis in-vitro (data shown 
in Chapter 4, Fig 4.1). Standard deviations are 0.034 and 0.022 for sensitivity and 
specificity respectively. 
 
Raman shift window Variance  
from first 7 PCs 
Sensitivity Specificity 
700~1800 cm-1 81.2% 0.76 0.81 
1000~1800 cm-1 80.8% 0.82 0.80 
1000~1500 cm-1 86.3% 0.83 0.84 
1250~1500 cm-1 91.3% 0.83 0.82 
1400~1500 cm-1 95.4% 0.77 0.78 
 
Appendices Table. 4.2 Sensitivity and specificity calculated using different Raman 
shift windows from WMR spectra for M. tuberculosis in-vitro (data shown in Chapter 
4, Fig 4.3). Standard deviations are 0.014 and 0.017 for sensitivity and specificity 
respectively. 
 
Raman shift window Variance  
from first 7 PCs 
Sensitivity Specificity 
700~1800 cm-1 75.8% 0.96 0.91 
1000~1800 cm-1 78.1% 0.96 0.93 
1000~1500 cm-1 83.8% 0.98 0.93 
1250~1500 cm-1 89.8% 0.96 0.91 
1400~1500 cm-1 94.5% 0.94 0.89 
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Appendices Table. 4.3 Sensitivity and specificity calculated using different Raman 
shift windows from WMR spectra for stained M. tuberculosis in-vitro (data shown in 
Chapter 5 Fig. 5.22). Standard deviations are 0.018 and 0.028 for sensitivity and 
specificity respectively. 
 
Raman shift window Variance  
from first 7 PCs 
Sensitivity Specificity 
700~1800 cm-1 80.5% 0.86 0.82 
1000~1800 cm-1 79.2% 0.84 0.80 
1000~1500 cm-1 83.5% 0.86 0.79 
1250~1500 cm-1 88.9% 0.86 0.85 
1400~1500 cm-1 93.7% 0.89 0.85 
 
 
Appendices Table. 4.4 Sensitivity and specificity calculated using different Raman 
shift windows from WMR spectra for stained M. tuberculosis in tissue (data shown in 
Chapter 5 Fig. 5.24 a). Standard deviations are 0.022 and 0.044 for sensitivity and 
specificity respectively. 
 
Raman shift window Variance  
from first 7 PCs 
Sensitivity Specificity 
700~1800 cm-1 78.9% 0.90 0.74 
1000~1800 cm-1 73.9% 0.93 0.85 
1000~1500 cm-1 79.4% 0.91 0.84 
1250~1500 cm-1 85.2% 0.87 0.79 
1400~1500 cm-1 92.9% 0.91 0.80 
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Section 5 
 
Statistic on R software code and results. 
R version 3.0.2 (2013-09-25) -- "Frisbee Sailing" 
Copyright (C) 2013 The R Foundation for Statistical Computing 
Platform: x86_64-apple-darwin10.8.0 (64-bit) 
 
R is free software and comes with ABSOLUTELY NO WARRANTY. 
You are welcome to redistribute it under certain conditions. 
Type 'license()' or 'licence()' for distribution details. 
 
  Natural language support but running in an English locale 
 
R is a collaborative project with many contributors. 
Type 'contributors()' for more information and 
'citation()' on how to cite R or R packages in publications. 
 
Type 'demo()' for some demos, 'help()' for on-line help, or 
'help.start()' for an HTML browser interface to help. 
Type 'q()' to quit R. 
 
[R.app GUI 1.62 (6558) x86_64-apple-darwin10.8.0] 
 
[Workspace restored from /Users/vincentbaron/.RData] 
[History restored from /Users/vincentbaron/.Rapp.history] 
 
> data1=read.csv("/Users/vincentbaron/Desktop/DATA.csv",h=T) 
> boxplot(data1) 
> data1 
   seven.days two.hours four.hours six.hours 
1      970.17    513.69     364.69    356.71 
2      299.65    302.79     617.02    279.45 
3      641.18    637.63     249.14    368.01 
4      358.54    316.89     408.22    377.00 
5      473.79    496.62     466.72    342.29 
6      551.41    430.42     256.65    248.47 
7      577.16    301.60     485.11    330.30 
8      720.05    544.12     332.26    312.28 
9      504.72    344.64     261.53    309.38 
10     636.64    296.94     277.29    350.76 
11     495.40    320.97     389.73    330.66 
12     496.56    539.94     369.98    302.84 
13     873.75    410.37     429.79    422.56 
14     750.53    291.58     360.44    245.29 
15     421.23    452.53     469.75    502.98 
16     560.41    450.32     415.85    284.04 
17     604.47    316.38     300.79    339.75 
18     848.47    370.91     459.92    432.81 
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19     524.73    597.23     460.98    398.29 
20     441.26    282.89     464.13    256.38 
21     464.86    460.06     388.87    333.30 
22     743.28    360.88     414.64    436.74 
23     494.19    342.63     481.58    480.39 
24     383.09    307.33     415.43    255.14 
25     449.37    301.81     421.75    328.15 
26     733.04    254.33     333.37    349.95 
27     340.90    712.29     371.08    320.80 
28     594.67    411.07     371.35    434.40 
29     729.99    541.54     385.64    448.89 
30     300.74    384.50     461.81    336.29 
31     521.14    592.18     288.93    299.32 
32     455.22    384.37     445.29    261.32 
33     546.76    400.22     536.25    344.59 
34     456.84    413.62     296.57    259.11 
35     467.07    407.52     280.25    403.57 
36     527.26    441.41     483.62    674.90 
37     591.98    431.20     362.48    308.66 
38     375.46    454.89     575.24    321.38 
39     362.84    299.25     385.76    366.48 
40     283.41    521.37     380.59    358.95 
41     538.90        NA         NA        NA 
42     559.48        NA         NA        NA 
43     337.87        NA         NA        NA 
44     379.42        NA         NA        NA 
45     400.99        NA         NA        NA 
46     456.29        NA         NA        NA 
47     379.74        NA         NA        NA 
48     493.59        NA         NA        NA 
49     344.74        NA         NA        NA 
50     530.34        NA         NA        NA 
51     752.94        NA         NA        NA 
52     603.07        NA         NA        NA 
53    1046.47        NA         NA        NA 
54     415.38        NA         NA        NA 
55     412.81        NA         NA        NA 
56     318.13        NA         NA        NA 
57     586.19        NA         NA        NA 
58     541.70        NA         NA        NA 
59     405.52        NA         NA        NA 
60     540.55        NA         NA        NA 
61     342.57        NA         NA        NA 
62     400.21        NA         NA        NA 
63     713.84        NA         NA        NA 
> data2=read.csv("/Users/vincentbaron/Desktop/DATA 2.csv",h=F) 
> data2 
    V1        V2 
1    0  970.1682 
2    0  299.6470 
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3    0  641.1773 
4    0  358.5442 
5    0  473.7915 
6    0  551.4122 
7    0  577.1578 
8    0  720.0458 
9    0  504.7231 
10   0  636.6415 
11   0  495.4011 
12   0  496.5598 
13   0  873.7460 
14   0  750.5329 
15   0  421.2295 
16   0  560.4083 
17   0  604.4728 
18   0  848.4685 
19   0  524.7292 
20   0  441.2644 
21   0  464.8579 
22   0  743.2847 
23   0  494.1931 
24   0  383.0908 
25   0  449.3667 
26   0  733.0370 
27   0  340.9044 
28   0  594.6690 
29   0  729.9924 
30   0  300.7409 
31   0  521.1425 
32   0  455.2197 
33   0  546.7627 
34   0  456.8444 
35   0  467.0652 
36   0  527.2586 
37   0  591.9849 
38   0  375.4633 
39   0  362.8421 
40   0  283.4057 
41   0  538.8952 
42   0  559.4833 
43   0  337.8735 
44   0  379.4246 
45   0  400.9935 
46   0  456.2902 
47   0  379.7440 
48   0  493.5934 
49   0  344.7438 
50   0  530.3447 
51   0  752.9377 
52   0  603.0688 
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53   0 1046.4660 
54   0  415.3847 
55   0  412.8078 
56   0  318.1340 
57   0  586.1890 
58   0  541.7040 
59   0  405.5208 
60   0  540.5470 
61   0  342.5734 
62   0  400.2095 
63   0  713.8420 
64   2  513.6892 
65   2  302.7948 
66   2  637.6294 
67   2  316.8908 
68   2  496.6226 
69   2  430.4220 
70   2  301.5972 
71   2  544.1151 
72   2  344.6396 
73   2  296.9396 
74   2  320.9727 
75   2  539.9435 
76   2  410.3705 
77   2  291.5828 
78   2  452.5343 
79   2  450.3168 
80   2  316.3850 
81   2  370.9077 
82   2  597.2334 
83   2  282.8925 
84   2  460.0623 
85   2  360.8839 
86   2  342.6260 
87   2  307.3252 
88   2  301.8118 
89   2  254.3292 
90   2  712.2870 
91   2  411.0734 
92   2  541.5449 
93   2  384.4975 
94   2  592.1793 
95   2  384.3702 
96   2  400.2192 
97   2  413.6172 
98   2  407.5156 
99   2  441.4074 
100  2  431.1964 
101  2  454.8902 
102  2  299.2491 
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103  2  521.3659 
104  4  364.6897 
105  4  617.0166 
106  4  249.1387 
107  4  408.2167 
108  4  466.7179 
109  4  256.6457 
110  4  485.1123 
111  4  332.2597 
112  4  261.5285 
113  4  277.2903 
114  4  389.7332 
115  4  369.9808 
116  4  429.7885 
117  4  360.4385 
118  4  469.7470 
119  4  415.8490 
120  4  300.7862 
121  4  459.9188 
122  4  460.9774 
123  4  464.1319 
124  4  388.8653 
125  4  414.6444 
126  4  481.5850 
127  4  415.4312 
128  4  421.7547 
129  4  333.3707 
130  4  371.0782 
131  4  371.3544 
132  4  385.6427 
133  4  461.8073 
134  4  288.9343 
135  4  445.2886 
136  4  536.2483 
137  4  296.5717 
138  4  280.2547 
139  4  483.6174 
140  4  362.4844 
141  4  575.2411 
142  4  385.7603 
143  4  380.5888 
144  6  356.7140 
145  6  279.4522 
146  6  368.0119 
147  6  376.9983 
148  6  342.2893 
149  6  248.4699 
150  6  330.3042 
151  6  312.2771 
152  6  309.3832 
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153  6  350.7597 
154  6  330.6567 
155  6  302.8434 
156  6  422.5643 
157  6  245.2862 
158  6  502.9833 
159  6  284.0350 
160  6  339.7541 
161  6  432.8110 
162  6  398.2851 
163  6  256.3766 
164  6  333.2959 
165  6  436.7379 
166  6  480.3897 
167  6  255.1420 
168  6  328.1468 
169  6  349.9503 
170  6  320.8040 
171  6  434.4030 
172  6  448.8908 
173  6  336.2874 
174  6  299.3153 
175  6  261.3158 
176  6  344.5874 
177  6  259.1063 
178  6  403.5717 
179  6  674.9034 
180  6  308.6613 
181  6  321.3772 
182  6  366.4823 
183  6  358.9483 
> h=data2[[2]] 
> a1=aov(h~as.factor(data2[[1]])) 
> summary(a1) 
                       Df  Sum Sq Mean Sq F value   Pr(>F)     
as.factor(data2[[1]])   3  849141  283047   18.89 1.09e-10 *** 
Residuals             179 2682314   14985                      
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
> l1=lm(h~data2[[1]]) 
> summary(l1) 
 
Call: 
lm(formula = h ~ data2[[1]]) 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-225.99  -85.23  -11.48   63.32  537.07  
 
Coefficients: 
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            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  509.394     13.790  36.938  < 2e-16 *** 
data2[[1]]   -28.067      3.942  -7.121 2.44e-11 *** 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 123.5 on 181 degrees of freedom 
Multiple R-squared:  0.2188, Adjusted R-squared:  0.2145  
F-statistic:  50.7 on 1 and 181 DF,  p-value: 2.444e-11 
 
> TukeyHSD(x=a1) 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = h ~ as.factor(data2[[1]])) 
 
$`as.factor(data2[[1]])` 
          diff       lwr        upr     p adj 
2-0 -108.94525 -173.1259  -44.76460 0.0001077 
4-0 -126.95626 -191.1369  -62.77561 0.0000045 
6-0 -172.15423 -236.3349 -107.97358 0.0000000 
4-2  -18.01101  -88.9967   52.97468 0.9126135 
6-2  -63.20898 -134.1947    7.77671 0.0997463 
6-4  -45.19797 -116.1837   25.78772 0.3527737 
 
> plot (h~jitter(data2[[1]],+0.5)) 
> abline(509.394,-28.067) 
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Section 6 
Image analysis using Definiens software 
 
 
This section presents the image analysis of a picture showing a seven days old M. 
smegmatis culture stained with Nile red (see Appendices figure 6.1).  
 
 
 
Appendices figure 6.1 Combined red and green pictures of Nile red stained M. 
smegmatis cells. The red represents the polar lipids and the green the non-polar 
lipids. The scale bar represents 5 µm. 
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Items showing a detectable intensity value (in the red channel) over a certain area, set 
at 6 µm2, were defined as bacteria (see Appendices Fig. 6.2).  
 
 
 
Appendices figure 6.2 Items defined as bacteria before filters based on the red 
channel picture. The scale bar represents 5 µm. 
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Some of the items selected are too small or too big and correspond to debris, clumps 
and aggregates of several cells. First we applied a filter to remove any items smaller 
or equal to 1 µm2, see Appendices Fig. 6.3. 
 
 
 
 
Appendices Fig. 6.3. The items smaller than 1 µm2 are unselected using this filter. 
They are now not in blue compared to the Appendices Fig. 6.2. The scale bar 
represents 5 µm. 
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We applied a second filter to remove every item bigger than 7 µm2. The idea is to try 
to remove the clump, aggregates or group of bacteria, see Appendices Fig. 6.4. 
  
 
 
Appendices Fig. 6.4. The items bigger than 7 µm2 are unselected using this filter. 
They are now not in blue compared to the Appendices Fig. 6.2. The scale bar 
represents 5 µm. 
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We applied a last filter to remove items that do not display a “bacillus shape”. The 
more an item is square the more likely this item will be removed by this filter, see 
Appendices Fig. 6.5. 
 
 
 
Appendices Fig. 6.5. Using this filter the items are unselected based on their shape (if 
they are square). They are now not in blue compared to the Appendices Fig. 6.2. The 
scale bar represents 5 µm. 
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Using the green picture (non-polar lipids) the software detects the lipid bodies based 
on their intensity over a certain surface. To be selected the green intensity has to be 
intracellular (overlap with the red). The Appendices Fig. 6.6 shows the intracellular 
lipid bodies. 
 
 
 
Appendices Fig. 6.6 Detection of the intracellular lipid bodies using the green picture 
(non-polar lipids). The scale bar represents 5 µm. 
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The lipid bodies are then ranked based on their size: 
Small < 0.5 µm2 (Yellow) 
Medium 0.5-1µm2  (Orange) 
Large >1µm2 (Red) 
 
The Appendices Fig. 6.7 shows the intracellular lipid bodies and their size. 
 
 
Appendices Fig. 6.7 Lipid bodies and their sizes: small < 0.5 µm2 (Yellow), medium 
0.5-1 µm2  (Orange) or large >1 µm2 (Red). The scale bar represents 5 µm. 
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Section 7 
Impact of laser on single bacteria 
 
 
 
To obtain a strong Raman signal from a single cell, a power of 150 mW was applied 
onto the sample plane. We designed an experiment to assess the impact of the laser to 
the bacteria. This experiment was carried out, using a stationary phase culture of M. 
smegmatis, on 3 individual bacteria (N=3). We took 10 spectra in a row on the same 
bacteria. This represents 1500 seconds of exposure to the laser. No spectral 
differences were observed between the first spectrum and the last one (same result for 
the 3 bacteria). The results for one bacterium are shown in the Appendices Fig. 1 and 
Fig. 2. The focused laser power we used in this thesis did not induce any damage to 
the cell during the acquisition of spectra. 
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Appendices Fig. 7.1 This figures shows the WMR spectra of a M. smegmatis 
bacterium (showed in Appendices Fig. 7.2). This cell was from a stationary phase 
culture. Ten WMR spectra in row were acquired from this cell to assess the impact 
that the laser has on the bacterium. The Appendices Fig. 7.1 a shows the first WMR 
spectrum taken and the Appendices Fig. 7.1 b shows the last WMR spectrum taken. 
No spectral differences could be observed between the two spectra. Ten spectra 
represent 1500 seconds of exposure. The laser power on the bacteria was 150 mW. 
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Appendices Fig. 7.2 This figure shows one of the single bacterium targeted in the 
experiment to assess the impact that the laser has on bacterium (in the white circle). 
The corresponding WMR spectra are shown in the Appendices Fig. 7.1. 
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Tuberculosis remains a threat to global health and recent attempts to shorten therapy have not suc-
ceeded mainly due to cases of clinical relapse. This has focussed attention on the importance of
“dormancy” in tuberculosis. There are a number of different deﬁnitions of the term and a similar mul-
tiplicity of different in vitro and in vivo models. The danger with this is the implicit assumption of
equivalence between the terms and models, which will make even more difﬁcult to unravel this complex
conundrum. In this review we summarise the main models and deﬁnitions and their impact on sus-
ceptibility ofMycobacterium tuberculosis. We also suggest a potential nomenclature for debate. Dormancy
researchers agree that factors underpinning this phenomenon are complex and nuanced. If we are to
make progress we must agree the terms to be used and be consistent in using them.
© 2016 Elsevier Ltd. All rights reserved.
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1. Introduction
Improvement in tuberculosis treatment is seen widely as an
important goal of research to reduce preventable deaths. One of the
major barriers to progress is the prolonged duration of treatment,
which has put an emphasis on the unusual nature of tuberculosis
where the organism forms a life-long relationship with the host
persisting in a low metabolic state in the tissues. Recent phase III
clinical trials of shortened regimens have failed to show non-
inferiority mainly due to higher relapse rates in the experimental
arms despite more rapid clearance of bacteria [1e3]. This implies
that hidden populations of bacteria may be important in deﬁning
outcome as has been implied by recent publications [4,5]. Unrav-
elling the biology of the relationship between dormancy and
response to antibiotics is critical for the development of better
treatments for tuberculosis.
The diversity of terms used to describe the physiology of
Mycobacterium tuberculosis and other mycobacterial cells in tissues
creates a communication challenge. This has the effect that bacte-
riologists, immunologists, clinical trialists, clinicians and di-
agnosticians, are surrounded by a cloud of uncertain meaning. That
the same words have different meanings to scientists blocks
progress in this already difﬁcult area. To address this issue we have
reviewed and summarised the literature surrounding the term
dormancy and its companion terms persistence and latency, whilst
identifying some of the key biological questions that need to be
addressed (Table 3). We believe that it is only by creating a common
language to underpin the scientiﬁc conversation that efﬁcient
progress in scientiﬁc knowledge is possible and will allow a future
consensus to emerge and this is what we attempt to do in this
manuscript.
2. Dormant
It is important to distinguish the terms dormant and dormancy
from others that are often erroneously used as synonyms: latent/
latency and persistent and persistence (see below). A state of
dormancy has been hypothesised forM. tuberculosis cells in human
infection and it is a feature that has been recognised in awide range
of bacteria since 1944 [6]. At its simplest, the term dormant might
be deﬁned as “having normal physical functions suspended or
slowed down for a period of time; in or as if in a deep sleep”, but
how can this anthropomorphic concept be applied to bacteria in
humans? The working deﬁnition of mycobacterial dormancy is
complicated by the fact that it is usually described negatively:
inability to grow on solid medium, the presence of low metabolic
activity, alteration of gene regulation with the accumulation of tri-
acylglycerides in intracellular lipid bodies, loss of acid fastness,
tolerance to antibiotics, and the imputation that growth rate is
slow. To explore this state a number of dormancymodels have been
developed and these are described in more detail in Table 1 and in
the text below. The critical, implicit and as yet untested assumption
is that they all result in a similar phenotype and that these phe-
notypes are predictive of a state found in the human host. Although
there have been many descriptions of the histopathological
changes found in human and animal models of disease none of
these unequivocally identify mycobacterial cells in a dormant state
[7,8].
Experimental data are starting to reveal the physiological state
of organisms that might be candidates to be the elusive dormant
cell, for example some organisms in human and animal specimens
cannot be recovered on solid medium and can only be detected by
growth in liquid culture broth or by the addition of resuscitation
promotion factor (Rpf) [9e11]. Studies have shown that, after a
course of chemotherapy, liquid culture and the tissues of mice
contain un-culturable cells that transcribe messenger RNA [12].
Using a ﬂuorescent marked reporter strain the lungs of chronically
infected mice have been shown to harbour a subpopulation of
non-growing but metabolically active bacteria. Such bacterial cells
are notable in mice treated with the isoniazid, suggesting that
they may have a role in post-chemotherapeutic relapses [13].
Reports also indicate that, as mycobacteria become increasingly
difﬁcult to resuscitate, they have less capacity to cause infection in
mice [14].
The physiological conditions within a patient with tuberculosis
are starting to be understood and research has been directed to-
wards extending this knowledge and ﬁnding models that recreate
these conditions. The caseous granuloma is thought to be an
anaerobic environment providing circumstantial support for the
importance of some in vitro models described in more detail
below. A “dormancy” phenotype can be created in the laboratory
by applying different forms of stress: oxygen or nutrient deﬁ-
ciency, hyper-acidity, antibiotics and multiple combinations of
these. The published models include bacterial starvation [15],
successive shift-down or anaerobiosis (the Wayne model) [16],
external acidiﬁcation [17], antibiotic survival [12,18], multiple
stress [19e21] and these are reviewed in turn. For the moment we
will call all of these “dormancy” models, recognising that, at
present, we only have an atlas of phenomenology and there is a
need to identify the characteristics of each model
comprehensively.
Text box 1
Assumptions around dormancy
The critical, implicit and as yet untested assumption is that
all dormancy phenotypes are equivalent
the phenotypes are predictive of a state found in the human
host
bacteria in specimens and in tissue samples and animal
models of disease share some phenotypic characteristics
associated with dormancy
there is no unequivocal marker that identify mycobacterial
cells in a dormant state
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Table 1
Summary of mycobacterial dormancy models with a description of methods of selecting cellular sub-types, and the phenotypic and metabolic characteristics.
Principle of model and
organism
Morphology of cells Buoyant density Metabolism Microscopic observations Viability challenges Lipids in resultant cells
Gradual acidiﬁcation,
M. smegmatis [17,86]
Three types of cells
formed: ovoid,
transitional, rod shaped
e 60% ovoid after 30
days
Ovoid cells higher buoyant
density 1.8 M zone in 1.4e2.2 M
sucrose gradient
Post-stationary cultures
exhibit low but non
zero uptake of
radioactive DNA/RNA
precursors no
detectable respiration
Thickened, multi-layered cell
wall, electron dense cytoplasm
Ovoid forms more resistant to
antibiotics and heat
Not reported
Growth in modiﬁed potassium
free medium, M. smegmatis
[87]
Spherical cells,
condensation of
cytoplasm
Decreased total
metabolic activity and
total respiratory
activity
Increased number vacuoles,
decreased ribosomes. Cells with
“rareﬁed” cytoplasm non-viable
Total amount of lipid 2-fold
lower than metabolically active
cells.
Multiple-stress model on
M. tuberculosis [16,20]
Buoyant density decreased with
increasing time under multiple
stress
- Enzymes of
glyoxylate cycle are
upregulated.
Shutdown of ATP and
NAD energy
regeneration
systems.
- Overall slowdown of
transcription/
translation apparatus
Loss of acid fatness e 30% after
30 days of multiple stress
Resistance to RIF and INH e at
18 days c. 12% survive 5 mg/mL
RIF and c. 35% survive 0.8% mg/
mL INH
Increased lipid bodies (70% lipid
bodies positive at 18 days).
Accumulation of storage lipids
(WE and TG) in anaerobic but
not aerobic samples
Nutrient starvation
M. tuberculosis [54]
Signiﬁcantly decreased
respiration rate
No loss of viability after 6
weeks. Starved cultures
resistant to RIF and INH at 1 mg/
mL Sensitive to metronidazole
Down-regulation of genes
involved in lipid biosynthesis
(micro-array)
Low oxygen tension M. bovis
and M. tuberculosis [88]
Cell diameter of
anaerobically cultured
cells signiﬁcantly
thinner than aerobic:
M. bovis 255 vs 284 nm.
M. tb 278 vs 338 nm
- M. tuberculosis, M. bovis e
Markedly thickened (21.2 vs
16.1 nm) cell wall with
rupturing and pealing after 6
months in anaerobic or
micro-aerobic but not aerobic
conditions.
- No thickening inM. smegmatis
e less than 1% of cells intact
in 35 culture days.
Not reported
Long term anaerobic culture,
M. tuberculosis [88]
No difference in cell
length between
anaerobic and aerobic
cultures (1.14 vs
1.06 mm)
Thickened cell wall, dependent
on anaerobiosis and not cell
density. APP1 pigment
produced, only signiﬁcantly in
anaerobic cultures
No qualitative difference in cell
wall lipids
Plate based anaerobiosis
M. smegmatis [89]
Sensitivity to MTZ in
anaerobically grown cultures
Not reported
Oxygen depletion M. smegmatis
[90]
Percentage of bacilli
survival
M. smegmatis
CFU counting after 24 h
exposure to the drug
Low level DNA and RNA
synthesis
Anaerobic culture sensitive to
MTZ but not OF
Oxygen shift down
M. tuberculosis [16]
DNA synthesis
terminates with cell
division but some low
level RNA synthesis
continues. Slight fall in
ATP as cells enter
stationary phase
Non-replicating persistent cells
resistant to INH and CIP but not
to MTZ
Not reported
Nor reported
(continued on next page)
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3. Lipid body positive
Lipid bodies were ﬁrst described in a range of bacteria among
which was M. tuberculosis and other mycobacteria including
Mycobacterium leprae where it was classiﬁed as “fatty material
usually present but sometimes absent in common media [22,23].
These enigmatic bodies were little studied until the work of Gar-
ton and colleagues who showed that lipid bodies could be formed
rapidly from uptake of fatty acids or from simple carbon sources in
low-nitrogen conditions [24]. The lipid bodies contain poly-b-
hydroxyalkanoates, tri-acylglycerides and wax esters [24]. Such
lipid bodies are found more commonly as bacteria progress to
stationary phase as illustrated in Figure 1. Lipid bodies are found
more commonly in late stationary phase cultures of mycobacteria,
which are known to be more resistant to drugs and the concen-
tration of drug required to clear all bacteria (the MBC eminimum
bactericidal concentration) rises signiﬁcantly [25]. Older cells ex-
press lipid bodies [24,26,27] and it was assumed they are
responsible for the phenotypic resistance found.
Lipid body positive bacteria have been found to predominate in
human sputum and this was associated with transcriptional sig-
natures similar to those found in non-replicating mycobacteria [9]
The authors found that the lipid body count was highly correlated
with time to positivity in diagnostic liquid cultures, which they
concluded established a direct link between this cytological
feature and the size of a potential non-replicating population.
More recent work indicates that a range of growth-limiting
stresses trigger a common signal transduction pathway slowing
growth by redirecting carbon ﬂux towards storage [7]. These data
suggest that dormant bacteria survive chemotherapy both in vitro
and in mice, and are metabolically active, although at a low level.
Other studies show that there is a difference between number of
organisms cultivated on solid medium and detected by use of
MGIT [28]. In a study of sequential sputum samples from patients
receiving standard chemotherapy between day 21 and 28 the
change in the odds ratio of an unfavourable outcome for each
percentage rise in percentage lipid body positive and the acid fast
bacilli count was 1.21 (95% CI, .97e1.50; P ¼ .088). Thus it appears
that patients with a greater percentage of lipid body positive
mycobacterial cells detected in their sputum smear at later time
points are more likely to have an unfavourable outcome [29]. The
importance of lipid body positive bacteria has been emphasised by
an in vitro study that demonstrates lipid body positive cells can be
puriﬁed from all mycobacterial cultures tested and are pheno-
typically resistant to antibiotics irrespective of whether they are
derived from “old” or “young” cultures indicating that the pres-
ence of a lipid body is associated with phenotypic antibiotic
resistance [30].
3.1. Hypoxia
To create an in vitro hypoxic model Wayne and colleagues uses
a long term culture without agitation and oxygen excluded [16].
They demonstrated a fourfold increase in the isocitrate lyase ac-
tivity and ten-fold increase in glycine dehydrogenase. In a later
variant of the model where anaerobiosis was achieved sequen-
tially, relative resistance to isoniazid rifampicin and ciproﬂoxacin
was demonstrated [16] accompanied by a loss of glycine dehy-
drogenase activity. The Wayne model also includes an element of
starvation (see below) through nutrient depletion [16]. The
chaperonin alpha crystallin was found to be up-regulated in this
model [31]and knockout of its gene led to an increased rate of
growth in mice, suggesting that its function may be to slow
growth in dormancy [32]. Many genes, including alpha crystallin
alter their expression in response to hypoxia and are regulated byTa
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the DosR regulon. This two component regulator alters the
expression of a series of genes in response to hypoxia and nitric
oxide [33] and redox stress [34]. A total of 50 genes are up-
regulated including tri-acylglyceride synthase [19,21]. Comparing
cells in a Wayne model with SWATH mass spectrometry it was
shown that the DosR regulon induced proteins make up 20% of
hypoxic cells compared with 1% in exponentially growing cells. In
comparison there was little change in ribosomal proteins. Many
components of the electron transport chain and the energy
generating machinery changed in abundance. Differential regula-
tion of enzymes in the sub-networks of acetyl-CoA alanine/gluta-
mate, and trehalose metabolism were found. Competing
incorporation of acetyl-CoA either into TCA cycle or triacylglycerol
biosynthesis was found consistently. Lipid pathways were signiﬁ-
cantly upregulated when absolute protein concentration and Vmax
enzyme data were compared [35].
DosR is not an essential gene for survival in M. tuberculosis as
knockout strains have only amodest decrease inviability in a hypoxic
environment [36,37]. In a macaquemodel of infection, despite being
able to replicate initially, animals infectedwithDosRregulonmutants
failed to develop persistent infection or develop disease. This was
associatedwith the appearanceof a Th1 response andorganizationof
hypoxic lesions where M. tuberculosis expressed dosR [38]. Interest-
ingly, some Beijing lineage strains have been shown to express DosR
constitutively aswell as accumulating large quantities of lipid in lipid
bodies [19]. A recent study where the DosR regulon was induced to
wild type levels did not change M. tuberculosis replication kinetics
and the authors concluded that DosR expression alone is insufﬁcient
to explain latency [39]. A recent hypothesis published by Orme sug-
gests that the triggeringof theDosR is an adaptation to these inimical
conditions created by necrosis of tissue by host generated radicals.
The necrotic centre created is hypoxic, but the dead neutrophils and
other cells mean that the bacteria are not starved. His argument is
that the DosR response readies the organism for transmission: sur-
vival as an extracellular state [40].
The importance of a hypoxia is supported by the accumulating
evidence that anaerobic conditions are found in granulomas. A hyp-
oxia marker EF5 demonstrated granulomas with necrotic centres in
human tissue, which contrasts with mouse granulomatous lesions
where hypoxia does not appear to occur [41]. Signiﬁcantly it has been
shown that metronidazole has no effect on the outcome from the
Cornellmodelof tuberculosis treatment (seebelow)[42]whereas this
drug has been shown to be bactericidal with dormant mycobacteria
[43]. Theprobepimonidazole (PIMO),whichbinds tothiol-containing
peptides only at low partial pressures of oxygen, colocalised with
areas of caseous necrosis in guinea pigs, rabbits, and cynomologous
macaques [44, 45], but not with cellular granulomas in the standard
mouse model [46]. However, metronidazole lacked activity in a mu-
rine hypoxic granuloma model and in guinea pigs [47,48].
In human lung tissue endothelial cells have been detected with
an anti-CD31 immunohistochemistry probe in granulomas with
necrotic centres; thought to represent mature lesions. These cells
are not found in lesions without necrotic centres. This observation
may support the idea that hypoxia is associated with granuloma
maturity [41]. The importance of the nature of the animal model is
conﬁrmed by a study that compared the virulence of a strain of
Figure 1. Mycobacterial cells stained with Nile Red and viewed by ﬂuorescence microscopy at 100# (Leica DM5500) (excitation 480/40, 540/40. Emission 527/30, 645/75) showing
lipid poor cells (red) and lipid rich cells (red with central green lipid body). This is set alongside a hypothetical mycobacterial growth curve and the change in the phenotypic
susceptibility over time in a batch culture.
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M. tuberculosis with a dosRedosS deletion mutant (dosRedosS
[dosR-S]), comparing it to complemented strain and wild-type
H37Rv in rabbits, guinea pigs, and mice infected by the aerosol
route as well as using a mouse hollow-ﬁber system. In the mouse
and the guinea pig models, the dosR-S mutant exhibited a growth
defect but did not replicatemore than thewild type [49]. In another
guinea pig model, bedaquiline failed to eradicate bacteria in re-
sidual primary lesion necrosis with incomplete dystrophic calciﬁ-
cation that is hypoxic andmorphologically similar to that described
in human lung lesions. This suggests that this acellular rimmay be a
primary hypoxic location populated by bacilli phenotypically
resistant to this drug [50].
These results contrastwith thoseobtainedwhenmycobacteria are
exposed to a higher than atmospheric oxygen concentrations where
there is increased multiplication by H37Ra and BCG strains [51].
3.2. Starvation
Loebel ﬁrst demonstrated that starved cells had minimal evi-
dence of respiration [9,15,52]. Gengenbacher also used the Loebel
model and showed that depletion of oxygen killed starved bacilli
but death was prevented by nitrate indicating that survival and
respiration was possible in the presence of an alternative exoge-
nous electron acceptor. Nutrient-starved bacilli lacking isocitrate
lyase failed to reduce their intracellular ATP level and died, thus
establishing a link between ATP control and intermediary meta-
bolism. These data demonstrate a critical role for the glyoxylate
shunt in survival in a nutrient limited environment [53].
Betts et al. developed this model further and demonstrated
phenotypic resistance to rifampicin and isoniazid in starved cells
that contrasted with full activity against exponentially growing
cells. Importantly, metronidazole had no effect on starved bacteria
[54] as would be expected as its mode of action depends on
reducing conditions adding to the importance of recognising that
not all dormant phenotypes are identical. Using this combined
model they demonstrated differential up-regulation of proteins by
micro-array [54,55]. They found evidence for slow-down of the
transcription apparatus, energy metabolism, lipid biosynthesis and
cell division in addition to induction of the stringent response and
several other genes that may play a role in maintaining long-term
survival within the host. Energy metabolism genes (15%), 16% of
lipid metabolism genes 59% of the translation apparatus were
down-regulated. Of the 12 M. tuberculosis sigma factors (sigB, sigE,
sigF and sigD) four were up-regulated, but sigA expression did not
change signiﬁcantly. The majority of differentially expressed cell
process genes belonged to the transport/binding protein subclass
[54].
Another fermenter nutrient starvation model with controlled
oxygen concentration, monitored nutrient depletion found up-
regulation of genes in the glyoxylate shunt including isocitrate
lyase, along with components of the TCA cycle. SigB, sigE and sigH
were up-regulated and ATP synthase genes down-regulated. In
contrast to the results obtained by Betts et al., rpoA, B and rpoCwas
up-regulated. All genes associated with the mas gene cluster were
up-regulated throughout the period of stationary phase adaptation
(mas, fadD26, fadD28,mmpL7, and ppsAeE) and at day 75 there was
a sharp rise in expression of fadD26. The enzyme Relmtb, which is
required for survival of mycobacteria under long term in vitro
starvation conditions was up-regulated by day 18 and then
declined slowly [56].
Xie varied the PBS starvation model and added 16 different
agents to cultures suspended only in PBS and incubated these for 6
weeks. Of these 16, only four (chlorpromazine, isoniazid, rifampin,
triﬂuoperazine) were able to kill 99% of bacteria at concentrations
less than 160 mg/L [57]. There was one log difference in rifampicin
susceptibility between log phase and starved cells and this
increased to 2 orders for isoniazid.
3.2.1. Nitrogen limitation
Anuchin and colleagues developed a nitrogen limitation model
in which M. tuberculosis cells adopted an ovoid morphology that
were more resistant to heat, hygromycin and doxycycline stresses
compared to a 48 h culture [58]. In further studies, the authors
found intra-species morphological heterogeneity of dormancy.
They deﬁned cyst-like, coccoid and poorly differentiated cells that
all showed dormant-like properties and yet varied in their response
to exogenous stress. Cyst-like cells were shown to contain electron
transparent lipid bodies and were most resistant to heat stress and
displayed the greatest difference (two orders of magnitude) be-
tween viable count measured by colony forming units (cfu) and
most probably number methods (MPN).
3.2.2. Phosphate limitation
It has been hypothesised that M. tuberculosis encounter a
phosphate limited environment in the macrophage and that its
response mediated through pkk1 and RelA are important for
establishing tolerance to antibiotics [59,60].
3.3. Acidiﬁcation
M. tuberculosis is sensitive to low pH and survives in the phag-
olysosome by arresting acidiﬁcation [61]. Pyrazinamide, a drug only
active at low pH, can reduce treatment duration of tuberculosis
chemotherapy from nine to six months, and it was postulated that
this was due to its effect on cells in an acid environment [62]. When
the pH was reduced, ovoid cells with thickened cell wall, a low
metabolic activity and elevated resistance to antibiotics and heat-
ing developed and failed to form colonies on solid medium [17].
This phenomenon has been described in M. tuberculosis from
sputum samples [9]. Acidiﬁcation was also used as part of a mul-
tiple stress model in M. tuberculosis that included low oxygen (5%),
high CO2 (10%), low nutrient (10% Dubosmedium) [20,63]. The cells
stopped replicating, lost their acid-fastness, and had reduced sus-
ceptibility to isoniazid and rifampicin whilst accumulating tri-
acylglycerols and wax esters (WE) and up-regulating putative
neutral lipid biosynthetic genes [18,20,64].
3.4. Multiple stress
Since M. tuberculosis faces a range of stresses it is logical that a
more pathophysiological model would be one with multiple
stresses. Most models apply a single stress even though most
impart additional unmeasured stresses on the culture (e.g. accu-
mulation of metabolites, gradual acidiﬁcation, nutrient depletion).
Deb and colleagues created a ‘multiple stress’ model: low-nutrient
(10% Dubos medium), acidic (pH 5.0), high CO2 (10%) and low O2
(5%) [20]. In these conditions the cells accumulated non-polar lipids
as measured by TLC and [14C]oelic acid incorporation, were resis-
tant to isoniazid and rifampicin, lost acid fastness, increased Nile
Red ﬂuorescence and decreased in buoyant density. Genes involved
in the glyoxylate cycle (icl, gltA1), carbon storage (tgs), stress
response and hypoxia (hspX, Rv2031c, dosR) and anaerobic respi-
ration (frdA, narG/H/X, nirA) were up-regulated. Genes coding for
expression of ATP and NAD energy regeneration systems and the
transcription/translation apparatus were down-regulated. The au-
thors believe that this provides a model where cells display all of
the proposed hallmarks of dormancy.
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3.4.1. Stringent response
The stringent response, which utilizes hyperphosphorylated
guanine [(p)ppGpp] as a signalling molecule, controls gene
expression during starvation and is under the control of the RelA
and SpoT proteins in other species and by Rel(Mtb) in
M. tuberculosis. This response has been shown to be critical to
establish persistent infection in mouse and guinea pig models of
tuberculosis and is associated with shutdown of key metabolic
pathways [65,66]. There is a link to differential antibiotic response
as polyphosphate accumulation has been associated with tolerance
to isoniazid in M. tuberculosis [67].
3.5. Resuscitation dependency
Bacterial cells with phenotypic similarities with dormant bacilli
as measured by the presence of lipid bodies have been detected in
human sputum specimens [9,27] and can be the dominant cell type
making up to 99.9% of cells [12]. These cells may require the
addition of a bacterial cytokine, resuscitation promotion factor
(Rpf) to be detected by culture [9,68]. A study of smear-positive
sputum samples from the UK and The Gambia revealed that up to
86% of those staining positively with Zhiel-Neelsen were also
positive with Nile Red, a stain that preferentially binds lipid and
showed these organisms had lipid bodies. The transcriptome of
these cells is similar to slowly replicating or non-replicating
mycobacteria. Since the lipid body count was correlated with
time to positivity in diagnostic liquid cultures the authors
concluded that the presence of lipid bodies was linked to the size of
the non-replicating population [27]. It was notable that the char-
acteristic of Rpf dependence was retained in long-term storage at
4 $C. There was a more rapid decline in the cfu count of non-Rpf
dependent cells compared to the Rpf dependent count indicating
that these latter cells are relatively resistant to rifampicin. This
resuscitation index continued to increase among a small number of
subjects who were monitored over an extended period. Direct
treatment of sputum samples with rifampicin had less effect on Rpf
cells supporting the idea that these cells were tolerant of this
antibiotic at the low dose applied (1 mg/L) [9].
3.6. Antibiotic survival or persistence
The term “persistence” is often used to describe bacteria sur-
viving after a period of treatment. The ﬁrst description of rifampicin
tolerant cultures in which no bacteria could be cultured but
messenger RNA of speciﬁc M. tuberculosis genes could be detected
and radioactive uracil was incorporated, was performed by Hu and
colleagues [11]. These data suggest that dormant unculturable
bacterial cells are metabolically active [69]. Further work led to the
development of three separate models of antibiotic stress, namely
100 day microaerophilic cultures, pretreatment with rifampicin
and the pulsed introduction of air [69e71]. These 100 day cultures
contain 10e100 fold more unculturable cells which can be resus-
citated with Rpf than culturable bacteria [11].
Clinical relapse was noted in the relapse of patients infected
with resistant organisms in the ﬁrst streptomycin trial [72] and it
was McDermott who ﬁrst suggested that the inability of drugs to
kill all of the organisms was responsible for this phenomenon. It
was recognised early that the organisms were not eliminated by
treatment in the mouse model but could not be identiﬁed by any
method that required their multiplication although small numbers
of acid fast bacilli could be seen [73]. Following cortisol therapy or
spontaneously the infection relapsed and mycobacteria became
detectable again. It was in a subsequent paper that this group
showed the importance of pyrazinamide in killing these “persist-
ing” cells. A characteristic that the authors described as
“sterilisation” [74]. These experiments were fundamental in
developing what became known as the Cornell Model [75]. Further
work with this model demonstrates that after the completion of
chemotherapy, the tissues of the mice became “sterile”, no bacteria
could be cultured from the tissues even in liquid cultures, yet
messenger RNA of speciﬁc M. tuberculosis genes could be detected,
suggesting that the bacteria, although dormant, were metabolically
active [12]. The “sterile” phase of the Cornell model contains a high
proportion of Rpf-dependent M. tuberculosis cells which can be
killed by high but not low dose rifampicin [11]. A second “persis-
tence” model is described where a relatively resistant mouse strain
C57/BL6 is inoculated by the aerosol or parenteral route. The initial
infection is controlled but the organism persists without causing
overt disease [63].
Keren and colleagues have selected for antibiotic persister cells
by treating an exponentially growing culture with cycloserine and
performing an Afymetrix array. They found that 1408 genes were
down regulated and 282 up-regulated with growth and energy
related genes extensively down regulated. Of 65 Transcriptional
activators listed in the M. tuberculosis genome 10 were over-
expressed in persisters. One of these, Rv2866, is a relE homologue
and was recently shown to increase drug tolerance when over-
expressed in an Escherichia coli system. Key genes up-regulated
included sigF, dnaE2, acr2, lat and sigG. They created a four-
dimensional Venn diagram summarizing the differences and
commonalities of four models: persisters, starvation, enduring
hypoxic response (her), and non-replicating persistence. There are
ﬁve genes that are common to all models and 55 genes that are
common to persisters and at least 2 other models. Of special in-
terest are the ﬁve genes that are overexpressed in all models. These
genes are Rv0251c (acr2), encoding an alpha-crystallin, Rv1152, a
transcriptional regulator of the gntR family, Rv2497c (pdhA),
encoding a probable pyruvate dehydrogenase component, Rv2517c,
encoding a hypothetical protein, and Rv3290c (lat), encoding an L-
lysine-epsilon-aminotransferase [18,64].
3.6.1. Bioﬁlm dormancy models
Ackart and colleagues showed thatM. tuberculosis failed to form
bioﬁlms when cultured planktonically in the presence of Tween-80
and did not reach logarithmic phase growth and remained highly
susceptible to antimicrobial drugs. In contrastwhenTween is absent
bacilli formedcomplexmicrobial communities attached tountreated
well surfacesor to theextracellularmatrixderived from lysedhuman
leukocytes and tolerated drug treatment. This could be reversed by
treatment of microbial communities with DNase I or Tween [76].
4. Implications of dormancy
4.1. Susceptibility
The importance of dormancy in M. tuberculosis is the repeated
observation of phenotypic resistance to anti-tuberculosis agents
although the degree is not fully delineated due to the different
models of dormancy employed, the incomplete spectrum of agents
tested and the diversity of susceptibility methods employed. Cell
wall inhibitors are most affected but the action of the RNA poly-
merase inhibitor rifampicin and ﬂuoroquinolones acting on DNA
gyrase is also reduced [16]. This is not to say that testing suscep-
tibility of “dormant” cells is easy since, a priori, they may not grow
well on standard solid media making methodology problematic. In
Table 2 we summarise the effect of different models on the sus-
ceptibility to antibiotics with the methods that were used.
Through in vitro dormancy models a range of susceptibility test
are used (MIC, MBC and percentage of cell surviving after different
exposure time using CFU or resazurin reduction). This results in
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different drug dose for the same species through different models.
For example if we look at rifampicin in one species M. tuberculosis,
in the Wayne model 0.1 mg/mL correspond to 4.2% of bacilli sur-
viving after 192 h of drug exposure and for the in vitro granuloma
model a MIC was found between 0.47 and 0.94 mg/mL, illustrating
the difﬁculties in comparing susceptibility results from different
models even if they are generating “dormancy” cells types. To some
extent these observations have been clariﬁed by the report that
indicates that it is the presence of a lipid body irrespective of cell
age that is associated with a signiﬁcant increase in the minimal
bactericidal concentration of any mycobacterial species suggesting
that this is a phenomenon common to the genus [30].
5. Relationship to disease/pathology/treatment
A number of narratives have been created to link the concept of
dormancy with clinical disease and chemotherapy.
5.1. Special populations hypothesis
The ﬁrst “model” that attempted to this was the special pop-
ulations hypothesis [62] based on clinical trial results with in vitro
and mouse experiments. It has four cell “types”: continuously
growing cells, which isoniazid and rifampicin are said to act on,
those in acid conditions, the target of pyrazinamide, intermittently
metabolising cells against which rifampicin had its major activity
and non-growing cells that are resistant to antibiotics [62]. This
hypothesis has been inﬂuential in the design of clinical trials but
there is limited direct bacterial or pathological evidence to support
it.
5.2. Yin-yang hypothesis
Zhang and colleagues describe mixed growing and non-growing
subpopulations that exist in a continuum of metabolic states.
Table 2
Relative susceptibility of mycobacterial species to anti-tuberculosis agents in differing models of “dormancy”.
Model Methodologies Susceptibilities
How was susceptibility measured? Isoniazid Rifampicin Pyrazinamide Ciproﬂoxacin Metronidazole
Gradual acidiﬁcation
TB
MIC [92,94] 0.05 mg/mL 0.5 mg/mL 20 mg/mL
Growth in modiﬁed
potassium free medium
MIC [95]Plate counting methodology
lowest viable number e TB
1.0 mg/mL 5.0 mg/mL
Multiple-stress model
TB
Cell survival after %96 h exposure to
indicated levels of drug e CFU count
[20]
0.8 mg/mL 5.0 mg/mL 12 mg/mL
Nutrient starvation
TB
Cell survival after 168 h exposure to
indicated levels of drug e CFU count
[54]
10 mg/mL 10 mg/mL
Low oxygen tension
TB
MBC90Wayne cidal concentratione the
concentration of drug that reduced the
CFU of the initial inoculum by 90% after
5 days exposure [96]
4.0 mg/mL
Long term anaerobic culture
TB
7, 14, 21 day exposures to drugs e CFU/
MGIT (non-growth determined after
negative for 100 days) [97]
8 mg/mL 100 mg/mL 8 mg/mL
Plate based anaerobiosis M. tuberculosis number of viable cells
determined by CFU on 7 h11 [98]
M. smegmatis
Solid media plating for CFU counting.
25 mM viable cell
count is reduced by
50% compared to
the control [98].
Wild type viable counts
are reduced a 100 fold
at 100 mg/mL [89].
Oxygen depletion BCG
Solid media plating for CFU counting
[89,91].
BCG viable count are
reduced a 1000 fold at
100 mg/mL and 3 fold at
10 mg/mL. There is a
dose dependent effect
using MTZ.
Oxygen shift down
(Wayne model)
TB
M. tuberculosis cells survival.
Solid media plating for CFU counting.
0.4 mg/mL [16] 0.1 mg/mL [16] 1 mg/mL [16] 12 mg/mL in “non
replicating stage 2”
(Wayne & Hayes, 1996)
8 mg/mL (Wayne &
Sramek, 1994)
Oxygen depletion Percentage of bacilli survival
M. smegmatis
CFU counting after 24 h exposure to the
drug [90]
120 mg/mL
20 ± 10 percent
survival for persistent
culture (240 h old
sealed culture).
95 ± 9 percent survival
for active culture
(logarithmic aerobic
culture).
Culture in mHdeB* medium M. smegmatis percentage of resazurin (0
percent resazurin reduction) [99]
Mtb h37rv
MIC90 using resazurin microplate assay
(REMA) [99]
10 mM 1 mM
less than
0.19 mM
MBC90:
>100 mM
1 mM
Human granuloma
in vitro model [93]
M. tb
MIC deﬁned using Alamar blue
reduction [76]
MIC: 1.25e2.5 mg/
mL [76]
MIC: 0.47
e0.94 mg/mL
[76]
* Hartman'sede Bont medium.
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Among the growing sub-population (yang), are a small non- or
slow-growing population (yin). The evidence comes from batch
culture growth curves and the authors describe that as bacteria
enter stationary phase the yin increase and the yang decrease. This
model, they postulate, explains why, after twomonths of treatment
the persister cells revert to activity and can be killed by isoniazid
and rifampicin and why isoniazid is effective in the treatment of
latent disease [77]. This idea is supported by the observation that
both lipid rich and lipid poor cells are found in cultures of all ages.
5.3. The scout hypothesis
Shleeva and colleagues created a three stage model that
described the change in status from active growth, through a tran-
sition stage to “deep dormancy” [78] in which the cells were viable
but not culturable. The authors postulate that cells can reverse the
journey and become active again and contrast the results from the
Waynemodel where cells retain the ability to be cultured with their
own model where cells do not grow on solid medium without the
addition of Rpf or culture supernatant [16]. This apparent discrep-
ancy is resolved by the description of a “Wayne zone” that arises
because of the shorter time to achieve the state. They also describe a
“Cornell zone” in which cells enter a non-culturable state that pre-
cedes cell death. These cells require external intervention before
they can transition to theWayne zonewhere resuscitation can occur
if the correct conditions are encountered. Epstein built on this idea
to postulate a dormant state from which microbial cells awake at
random. The stochastic nature of this event could be precipitated by
a change in a master regulatory gene. These newly activated cells
become scouts that, if they survive in the environment go on to form
new colonies and through quorum sensing link to the larger bac-
terial population [79]. Disease recurrence would occur when scouts
encounter a favourable environment before the bacterial population
is eradicated by the immune system or chemotherapy. Although this
appears to be an anthropomorphic explanation of events, it remains
a stochastic process because “scouts” are continually produced and
reactivation only occurs when one survives to multiply and cause
relapse. How dormancy might be linked with clinical models of
latency is illustrated in Figure 2.
6. Disambiguation of dormancy
6.1. Latency
This term is an important concept in tuberculosis and the ma-
jority of those with primary infection are able to control the
infection and may not show any clinical illness and some authors
have suggested that latency and active disease are the extremes of a
spectrum [80]. Epidemiological studies suggest that there is a
5e10% chance that the controlled, or latent infection will become
patent to produce post primary disease. This is thought to be the
most frequent route to pulmonary tuberculosis [81]. Our ability to
study and manage the latent form of disease has been transformed
by enhanced diagnostic methods depending on tuberculosis spe-
ciﬁc T cell response assays or Interferon gamma response assays
(IGRAs) that are superior to tuberculosis skin tests [82].
The importance of latent infection in the natural history of tuber-
culosis has often led to a potentially false link with bacteriological
considerationsofdormancy. Theassumption is that themycobacterial
cells in latent infection are dormant. Yet, there is little experimental
evidence to support this hypothesis. Patientswith latent infection can
be treated successfully with isoniazid, a drug that inhibits cell wall
synthesis. The observations of Rpf dependent cells that show reduced
metabolic activity go some way to creating a bridge between the
concepts of dormancy and latency [9,27]. PCR has detectedM. tuber-
culosis in sections of adipose tissue samples from 39 subjects from
Mexico and France who had died from causes other than TB. M.
tuberculosisDNAcouldbedetected fat tissue surrounding thekidneys,
the stomach, the lymphnodes, the heart and the skin in 9/57Mexican
samples (6/19 individuals), and in 8/26 French samples (6/20 in-
dividuals) [83]. Other post mortem studies reported similar results
[84]. A subsequent study identiﬁed viable bacilli in extrapulmonary
sites, as evidenced by the detection of mycobacterial mRNA [85].
Further work is required using RNA based methods to conﬁrm that
activity level of bacterial cells in tissue. To avoidmisunderstanding the
authorsbelieve that thetermlatencyshouldonlybeused inrelation to
a clinical disease state and dormancy to the bacterial cell state.
7. A new nomenclature
Using the data set out in this review we propose that the term
dormancy should only apply to bacterial cells and speciﬁcally those
that are capable of regrowth: it should be a reversible phenome-
non. Bacteria in a viable non-culturable state, for example, would
have to be capable of resuscitation to qualify as “dormant” and to
distinguish them from “dead”.
Given the multiplicity and complexity of models described we
propose here that a dormancy model should be sub-deﬁned by
additional terms. Thus, the Loebel model would be described as
dormancy-starvation. Examples of how this approach could be
notated are found in Text box 2 and applying this could do much to
create clarity in this important area of mycobacterial research.
7.1. Future challenges and research
In this review we have described the range of models of
“dormancy”, yet, there are only a few reports of such cells from
patient samples [9,27]. Further study of patient material is needed
to understand the role of different dormancy phenotypes in human
disease. This would test the relationship between in vitro and ani-
mal models and clinical disease. Descriptions of the cell state of M.
tuberculosis in the tissues of patients with disease are handicapped
by the absence of comprehensive specimen collections and meth-
odologies to differentiate cells states reliably in situ. If we are to
Table 3
Summary of publications and their associated deﬁnitions of “dormancy”.
Authors and reference Deﬁnition
(Shleeva, Salina, & Kaprelyants, 2010) [100] The dormant state is understood here as a reversible state of a bacterial cell, when the level of metabolic activity
is decreased and the cell is able to survive for a long time without division
(Gengenbacher & Kaufmann, 2012) [53] Non-replicating bacilli maintaining full viability at a very low metabolic rate; organisms show minor
susceptibility or phenotypic drug resistance to antibiotics targeting functions required for growth.
(Voskuil, Visconti, & Schoolnik, 2004) [33] Without replication or signiﬁcant metabolism.
(Mariotti et al., 2013) [101] Dormancy is deﬁned as a stable but reversible non-replicating state of Mycobacterium tuberculosis.
(Kaprelyants, Gottschal, & Kell, 1993) [102] A reversible state of low metabolic activity, in which cells can persist for extended periods without division.
(Karakousis et al., 2004) [103] An altered physiologic state characterized by stationary-state colony-forming unit counts and decreased
metabolic activity and greater susceptibility to rifampin than isoniazid.
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understand the effect of these dormancy phenotypes on chemo-
therapy it is necessary to chart the number, occasion and cell state
of M. tuberculosis in patients with disease, and to understand the
rate that “dormant” cells transition to “active” states. The challenge
for the future is to integrate these disparate models and data into a
cohesive theory of pathology and its impact on the natural history
of tuberculosis and the therapy of the disease. Dormancy re-
searchers agree that the factors underpinning the phenomenon of
dormancy are important, complex and nuanced. If we are to make
progress we need to agree and use a consistent nomenclature. To
support this approach we have proposed a candidate terminology
for dormant TB, which should be updated regularly as new data
become available. If we do not, progress will continue to stumble
through mists of uncertain meaning.
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Label-free optical vibrational 
spectroscopy to detect the 
metabolic state of M. tuberculosis 
cells at the site of disease
Vincent O. Baron1, Mingzhou Chen  2, Simon O. Clark3, Ann Williams3, Robert J. H. 
Hammond1, Kishan Dholakia2 & Stephen H. Gillespie1
Tuberculosis relapse is a barrier to shorter treatment. It is thought that lipid rich cells, phenotypically 
resistant to antibiotics, may play a major role. Most studies investigating relapse use sputum 
samples although tissue bacteria may play an important role. We developed a non-destructive, label-
free technique combining wavelength modulated Raman (WMR) spectroscopy and fluorescence 
detection (Nile Red staining) to interrogate Mycobacterium tuberculosis cell state. This approach 
could differentiate single “dormant” (lipid rich, LR) and “non-dormant” (lipid poor, LP) cells with high 
sensitivity and specificity. We applied this to experimentally infected guinea pig lung sections and were 
able to distinguish both cell types showing that the LR phenotype dominates in infected tissue. Both 
in-vitro and ex-vivo spectra correlated well, showing for the first time that Mycobacterium tuberculosis, 
likely to be phenotypically resistant to antibiotics, are present in large numbers in tissue. This is an 
important step in understanding the pathology of relapse supporting the idea that they may be caused 
by M. tuberculosis cells with lipid inclusions.
Tuberculosis is now established as the most important cause of death due to infectious disease, yet treatment has 
not improved in fifty years. Relapse after successful treatment is the major barrier to shorter therapy for tubercu-
losis as has been confirmed by recent tuberculosis clinical trials where more bactericidal regimens have failed due 
to higher relapse rate1–3. Despite its importance, we know very little about the bacteriology of relapse even though 
this outcome is possible with patients who clear their sputum rapidly4. We need improved and non-destructive 
methods to study mycobacteria at the site of the disease.
It is often speculated that relapse is linked to bacteria that survive treatment. Several studies demonstrate the 
accumulation of lipids in intracellular bodies that are associated with a lower metabolic rate5–8. It has been shown 
recently that these lipid body positive cells are up to 40 times more resistant to key components of the treatment 
regimen such as isoniazid9.
An attractive approach to investigate the lipid content of Mycobacterium tuberculosis would be to use an 
all-optical label-free method to examine bacterial cells in tissue in a way that would, for example, allow additional 
immunology studies. Optical interrogation can lead to inelastic scattering of light and distinct vibrational bands 
in subsequent spectra that can be used to distinguish the molecular content of the bacteria under investigation. In 
particular, Raman spectroscopy has been used previously as a means of identifying bacterial taxonomy at a single 
cell level in a range of species including mycobacteria10, 11. These studies, however, have only previously been 
performed on isolated cultured cells12 and isolated cells from sputum13.
This letter reports, for the first time, the metabolic cell state of mycobacteria by exploring the lipid content of 
individual cells in tissue using wavelength modulated Raman (WMR) spectroscopy. WMR analysis uses a scan 
of the laser wavelengths, rather than a single wavelength, for Raman excitation combined with subsequent multi-
variate statistical analysis that removes all background fluorescence14, 15. WMR spectroscopy shows an increase in 
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signal-to-noise ratio compared to other methods including standard Raman spectroscopy16. Using this approach, 
we were able to detect LR M. tuberculosis cells in infected tissue with very high sensitivity and specificity. This is a 
major step towards understanding the pathogenesis of tuberculosis at the infection site and provides a paradigm 
for its application to a broad range of infectious diseases.
Results
Single cell discrimination between lipid rich and lipid poor bacteria. We separated mixed cultures 
of M. smegmatis, M. bovis (Bacillus Calmette-Guérin, BCG) and M. tuberculosis into lipid rich (LR) and lipid 
poor (LP) fractions with greater than 90% purity using our previously published method9, and performed WMR 
spectroscopy on the separated cells.
We recorded Raman spectra from ~60 individual lipid rich (LR) and lipid poor (LP) mycobacteria cells (M. 
smegmatis, BCG and M. tuberculosis) in-vitro. The spectra from the mycobacterial species are illustrated in the 
Supplementary Section 1. In wavelength modulated Raman spectra (WMR spectra) zero-crossings are equivalent 
to peak positions in standard Raman spectra and the peak-to-valley corresponds to the peak intensity in standard 
Raman spectra. The two phenotypes mainly differ in two lipid peaks at 1300 cm−1 (designated lipid band A) and 
at 1440–1450 cm−1 (designated lipid band B), see Supplementary Fig. 1 (see Supplementary Section 4 for the peak 
assignment). LR cells showed higher Raman peak intensity in both lipid bands (A and B) compared to LP cells. 
The two phenotypes are distinguished with high specificity and sensitivity, M. smegmatis (93.8%/96.8%), BCG 
(100%/96.8%) and M. tuberculosis (92.6%/96.1%) (see Supplementary Fig. 1).
Identification of M. tuberculosis in unstained infected lung tissue sections. Having created a tool 
to determine the lipid status of mycobacterial cells non-destructively we applied the technique to unstained, 
formaldehyde-fixed guinea pig lung tissue infected by M. tuberculosis to understand the cell state of the bacteria 
at the site of disease (see Methods section for more details). Guinea pig tissue was used in the analyses because 
the lesions which develop during pulmonary tuberculosis in guinea pigs are histologically similar to the disease 
seen in humans17. In total, 107 single M. tuberculosis cells were interrogated by WMR spectroscopy from the 
lung alveoli (Figs 1c and 2b). An example of a single bacillus in an alveoli is shown in Fig. 1a. The tissue section 
is attached to a quartz coverslip. The background of the lung alveoli was compared to the signal from a clean 
quartz slide. The two signals were found very comparable and no significant signal is attributed to the lung alveoli 
itself (Fig. 1b). The Fig. 1c shows the average WMR spectrum of the bacteria acquired in the alveoli with the two 
background signals.
It was not possible to relate our in-vitro and ex-vivo data directly as it was noted that lipid bands A and B 
were impacted differently by formalin fixation and freezing11, 18 (Fig. 2a and b). In M. tuberculosis lipid band 
A, intensity is much lower when acquired in tissue as compared to in-vitro. In contrast, there is less variation 
in lipid band B intensity between in-vitro and ex-vivo samples. Lipid band B was therefore used in subsequent 
examinations (Fig. 2c). To compare in-vitro with ex-vivo data we needed to establish a ratio between a band that 
varies and one that varies very little. Moreover, when in-vitro data are compared (Fig. 2a) similar peak intensities 
are found in the band between 1050 cm−1 and 1070 cm−1 (see Supplementary Section 4, peak assignments) for 
both M. tuberculosis LR and LP phenotypes. This was also true for M. tuberculosis in ex-vivo samples. Thus, this 
band is ideal as an internal reference. We, therefore calculated the peak-to-peak ratio (R band B/Ref band) between 
the maximum peak intensity of lipid band B and the maximum peak intensity in the internal reference band 
(1050 cm−1 and 1070 cm−1) for each WMR spectrum acquired from M. tuberculosis in lung tissue (Fig. 2b) and 
also for each WMR spectrum acquired from M. tuberculosis in-vitro (Fig. 2a). A higher ratio indicates a higher 
lipid concentration in the cell.
Using this technique it is notable that the distribution of values for LR and LP cells in-vitro overlaps, but 
the peak of the distributions are clearly separated (Fig. 2c). We are able to observe a lipid ratio value R band B/Ref 
band analogous to both LP and LR among cells in tissue. The R band B/Ref band obtained from WMR spectra of cells 
in infected lung tissue shows a wide distribution confirming the presence of both LR and LP phenotypes. It is 
notable that the distribution of cell state in tissue is skewed towards LR phenotype (Fig. 2c). A similar result was 
obtained when (R band A/Ref band), with band A adjusted for the losses associated with fixation and freezing was used 
(see Supplementary Section 3).
Identification of LR and LP single bacterium in the M. tuberculosis infected tissue. To ensure 
that the match between in-vitro and ex-vivo cells that we demonstrate is not an in-vitro artefact, we obtained an 
alternative measure of lipid cell state from tissue in parallel with WMR spectroscopy. To do this we used our 
previously published staining method9. As shown in Fig. 3, all LP cells appear only red caused by excitation 
from cell wall polar lipids. LR bacteria are red from polar cell wall lipids and are distinguished from LP by green 
fluorescence emission caused by the non-polar lipid body. We studied in-vitro stained cells and stained cells in 
guinea pig infected lung. Nile red staining does not impact significantly the WMR spectrum of bacteria as shown 
in Supplementary Section 6. We scored the Nile Red stained bacilli as either LR or LP as previously described and 
recorded the Raman spectrum from these defined cells (Fig. 4). This showed that, for both in-vitro cells and cells 
in tissue that the main source of variability is found in bands A and B. We also showed that in-vitro LR and LP 
cells could be discriminated by WMR spectroscopy (sensitivity (84.0%) and specificity (80.2%)) (Fig. 4a and b). 
LP cells cluster closely but LR are more dispersed. The presence of green fluorescence emission coming from 
intracellular lipid bodies correlates with higher Raman lipid peaks (in both lipid band A and B).
We then applied this method to M. tuberculosis cells (93 in total) in infected lung tissue sections. 56 cells were 
classified LR by Nile Red staining and 37 as LP (Fig. 3e–l). Using PCA LR and LP cells clustered together although 
there is a wider distribution for the LR cells as had been noted in-vitro (Fig. 4d). As in the case of our in-vitro 
data, green fluorescence correlates with higher lipid peaks in lipid bands A and B. A broader cluster in LR group 
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observed in Fig. 4d also shows higher variability among the LR population than the LP population in tissue. Thus, 
it was possible to discriminate between LR and LP cells with high sensitivity (92.6%) and specificity (84.6%) 
(Fig. 4c and d). This is illustrated by combining the figures to demonstrate the overlap between the differing cell 
types in-vitro and ex-vivo which cluster together (Fig. 4e and f). Using this measure, we are able to demonstrate 
that M. tuberculosis cells in the lung are predominately LR (60%).
Discussion
Preventing relapse is the main reason for prolonged treatment in tuberculosis, yet the causes are still not fully 
understood1, 4. In particular we have shown that some patients who become sputum culture negative rapidly still 
go on to relapse4. Our research provides a new tool to unravel this problem. This is the first time the label-free 
vibrational spectroscopy has been used to study the pathogenesis of tuberculosis in situ. Whilst Raman has been 
used previously to distinguish bacterial genus and species10, 11, our work makes a major leap forward giving us the 
ability to distinguish bacterial cell state at the site of disease. Reducing the Raman signal window size may affect 
the results slightly but does so within a small standard deviation of 0.044 in the obtained sensitivity and specificity 
(see in Supplementary Section 2 for more details). The possibility of this window reduction with a similar perfor-
mance actually gives us a way to make our system more compact and to have higher resolution, i.e. using a grating 
Figure 1. Investigation of the impact of the lung alveoli to the bacterial Raman spectrum. (a) shows an example 
of single bacillus in a lung alveoli interrogated by WMR spectroscopy. The scale bar corresponds to 5 µm. 
(b) presents the average Raman spectrum of the quartz slide surface (red line) and the average Raman spectrum 
of the lung alveoli (background)(green line). The tissue section like any other preparation interrogated with 
WMR spectroscopy is on a quartz coverslip. (c) the average spectrum of M. tuberculosis cells acquired in tissue 
are added (blue line) and compared with the lung alveoli and the quartz slide background. In both Fig. 1b and c 
the shaded coloured areas represent the standard deviation. In Fig. 1b and c the x-axis is in wavenumbers. The 
y-axis represents the differential intensity in arbitrary units.
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only over a range of 1400–1500 cm−1 and a shorter acquisition time. Future developments of our work there-
fore could lead to wide field video-rate acquisition in-vivo with non-linear vibrational spectroscopy approaches 
using suitable tuneable lasers for coherent anti-Stokes Raman scattering or stimulated Raman scattering19, 20. This 
confirms that vibrational spectroscopy can be a powerful methodology that can be applied to pathogenesis and 
pharmacodynamics studies.
The study of the physiological status of M. tuberculosis bacteria has been limited to the sputum while may not 
fully represent the cells responsible for relapse. The physiological state of the bacteria that never get into the spu-
tum are missed by such approaches21. Using WMRS we have been able to differentiate lipid rich from lipid poor 
mycobacteria in tissue and consequently our data bridges the gap between tissue and sputum. Importantly, cur-
rent methods, for example Nile Red staining (see in Supplementary Section 5 for more details), require destruc-
tive techniques, which means that no additional studies can be performed22. The preparations that we have used 
could be re-examined with, for example, immunohistochemical methods to differentiate macrophage activation 
Figure 2. (a) WMR spectra of LR and LP M. tuberculosis cells. Mean spectra of both LR (red curves) and LP 
(green curves) cells are calculated from ~60 WMR spectra are taken from single bacteria cells. The shaded area 
represents one standard deviation. The x-coordinate corresponds to the Raman shift (in wavenumber, cm−1) 
and the y-coordinate the differential Raman intensity in arbitrary units. (b) WMR spectra from M. tuberculosis 
cells in the infected lung tissue. The solid red line shows the mean WMR spectrum averaged over from all 
spectra of 107 cells taken at the single bacterium cell level. The colour-shaded area represents the associated 
single standard deviation. The acquisition time for each single bacterium was 150 seconds in total (see Methods 
section for more details). (c) Percentage of M. tuberculosis in-vitro LR, LP and form tissue with a given peak-to-
peak ratio (Rband B/Ref band) calculated by dividing the lipid band B intensity value by an internal reference band 
(Ref band: 1050 cm−1 to 1070 cm−1) peak intensity for each in-vitro M. tuberculosis WMR spectra (Fig. 2a) and 
each M. tuberculosis acquired in the lung tissue (Fig. 2b). The x-coordinate corresponds to Rband B/Ref band between 
0.5 and 3 and the y-coordinates represent the percentage of the bacterial population for each specific lipid ratio 
value. The blue, green and yellow bars correspond to the in-vitro LP, the in-vitro LR and the ex-vivo populations 
respectively. The lines in Fig. 2c are included to illustrate the shape of the distribution.
www.nature.com/scientificreports/
5SCIENTIFIC REPORTS | 7: 9844  | DOI:10.1038/s41598-017-10234-z
near to M. tuberculosis for which the metabolic state is now known. This opens up a wide range of new research 
possibilities that we will explore in future experiments.
The distinction between LR and LP is important as the LR phenotype has been associated with a reduced 
metabolic activity and down regulation of a series of enzymes6. More importantly, such LR cells have been shown 
to be phenotypically resistant to anti-tuberculosis antibiotics7, 23. Antibiotic susceptibility testing of purified popu-
lations of LR and LP cells suggest that the resistance can increase from between 3–5 times (ciprofloxacin) to more 
than 20 times for isoniazid and rifampicin9. We have now shown that in tissue the majority of the cells that we 
examined had a LR phenotype that implies a significant degree of phenotypic resistance. Our confidence in this 
result is increased by the concordance of in-vitro and ex-vivo clustering as demonstrated in Fig. 4f; confirming as 
well that no significant signal from the lung is participating to the WMR spectra (Fig. 1). Thus, our observation 
may throw some light on the mismatch between standard anti-tuberculosis susceptibility testing and the outcome 
of treatment in patients and the overall result of clinical trials. Many patients relapse after apparently successful 
treatment and this is thought to be due to dormant bacteria able to survive treatment and regrow4. The presence 
of lipid bodies positive bacteria in TB infected patients’ sputum has been linked to a higher risk of poor out-
come24. However sputum data might not be representative of the bacterial population living in patient lungs. Our 
data derived from lung tissue supports the idea that relapses may be caused by LR M. tuberculosis with phenotypic 
resistance to the prescribed treatment. It should be noted, however, that we characterised bacteria in the alveoli 
and not in the complex structure within solid tissue. Future developments will enable us to achieve this. Thus, 
using Raman spectroscopy we have shown that lipid rich bacteria are present in the lung at the site of disease and 
are the predominant cell type (Figs 2c and 4c and d). This observation suggests that this characteristic may allow 
LR cells to survive antibiotic chemotherapy.
Methods
Bacterial culture conditions. M. bovis (BCG, NCTC 5692), M. smegmatis (NCTC 8159), M. tuberculosis 
(NCTC7416) were grown at 37 °C in Middlebrook 7H9 medium (Sigma-Aldrich) supplemented with 4 ml of 50% 
glycerol (for 450 ml) (Sigma-Aldrich) and 0.05% tween80 (Fisher BioReagents). BCG and M. tuberculosis culture 
medium were also supplemented with 1 vial of Middlebrook ADC enrichment (Sigma-Aldrich).
Figure 3. M. tuberculosis in-vitro and from frozen lung tissue section stained with Nile red and observed on the 
fluorescence-Raman combined system (more details in the method section). (a–d) show in-vitro M. tuberculosis 
and (e–l) show M. tuberculosis in lung tissue. (a,e,i) show the red fluorescence (polar lipids) and (b,f,j) show the 
green fluorescence emission (non-polar lipids). (c,g,k) represent the pseudo images made by combining red and 
green fluorescence emissions images. Bright field images (White light) are shown in (d,h and l). Both red and 
green fluorescence emissions can be observed in LR cells encircled in blue,while only red fluorescence emission 
is presented in LP cells encircled in yellow. The size of bacteria can be calculated from the scale bar shown in l 
(typically between 0.5–1 µm in width and 2–4 µm in length).
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Animal infection. The lung sample analysed in these studies were from specific pathogen-free guinea pigs 
infected with an aerosol dose of 10–50 CFU (retained dose in the lung) of M. tuberculosis H37Rv (NCTC cat. no. 
7416)25. Nose-only aerosol challenge was performed using a fully contained Henderson apparatus as previously 
described26 and27 in conjunction with the AeroMP (Biaera) control unit28.
Guinea pig experimental work was conducted according to UK Home Office legislation for animal experimen-
tation and was approved by the UK Home Office. All animals were weighed weekly and observed daily in order 
to monitor any adverse effects.
Four weeks post-challenge, animals were killed by an overdose of sodium pentobarbital. At necropsy, the lung 
was immediately excised and sections of the left and right cranial lobes and right caudal lobes were fixed in 10% 
neutral buffered formalin for up to 18 months.
Figure 4. M. tuberculosis in-vitro and from infected lung tissue WMR spectra and PCA clusters. LR and LP 
bacteria are pre-assigned by fluorescence signals from Nile red stained bacteria. (a) Mean spectra of both LR 
(red curve) and LP (green curve) cells averaged over 100 WMR spectra taken in-vitro. The light coloured area 
represents the associated single standard deviation. The first three PCs for both LR and LP cells form two 3D 
clusters in (b). The LR cluster shows a broader cluster compared to LP group. (c,d) M. tuberculosis from lung 
tissue WMR spectra and PCA clusters. (c) Mean spectra of both LR (red curve) and LP (green curve) cells. 
The first three PCs for both LR and LP cells form two 3D clusters in (d). The LR cluster shows a broader cluster 
compared to LP group similarly than in-vitro. (e) Comparison of in-vitro and lung tissue M. tuberculosis LR 
and LP cells. In-vitro LR (red) and in-vitro LP (green) were compared to the ex-vivo LR (blue) and ex-vivo LP 
(yellow) bacilli acquired in infected lung tissue. (e) Mean spectra of both lipid rich and lipid poor cells acquired 
with WMR spectroscopy. (f) 3D clusters are plotted with the first three PCs for LR and LP in-vitro cells and the 
cells from infected tissue.
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Frozen section. Following fixation, the lung tissue was placed into OCT (optimal cutting temperature) solu-
tion (30% sucrose in PBS) to embed and freeze the tissue on dry ice. The fixed and frozen tissue was sectioned 
into 5 µm slices using a cryostat by Amsbio Ltd, UK (AMS Biotechnology (Europe) Limited/Registered office: 184 
Park Drive, Milton Park, Abingdon OX14 4SE/Registered in England & Wales: Company number 2117791/ISO 
9001:2008 registered firm). In this study three serial lung sections coming from one guinea pig were interrogated.
Nile Red staining of Bacterial culture. The bacteria were stained using a Nile Red stock solution at 
250 µg/ml diluted in DMSO (Sigma-Aldrich) and a 1 µl aliquot added to 100 µl of bacterial suspension, vortexed 
and left for ten minutes in the dark at room temperature. The tubes were spun down at 20,000 g for 3 minutes the 
supernatant was discarded. The bacteria were washed twice using PBS. The bacterial pellet was resuspended in 
20 µl of PBS and 10 µl heat fixed on a glass slide for light microscope or a quartz slide for Raman spectroscopy.
Nile Red staining of guinea pig lung tissue section. A 5 µm thick guinea pig frozen lung section 
mounted on quartz coverslip (SPI Supplies, 01015T-AB) was stained using 2 µl of Nile red diluted in PBS, 25 µg/
ml final concentration. The 2 µl were placed on the tissue section and the coverslip was then placed on top of a 
thick quartz slide (SPI Supplies, 01016-AB). The mount was sealed as noted previously. The sample was then 
interrogated by WMR spectroscopy.
Combined Raman-fluorescence spectroscopy setup. WMR spectra were recorded by a combined 
confocal Raman-fluorescence imaging system based on a Nikon microscope (Nikon TE2000-E). A tunable Ti:Sa 
laser (M2 SolsTis lasers, 1 W@785 nm) was focused by a microscope objective (Nikon Plano, 40x, oil) onto a single 
cell using the arrangement illustrated in Fig. 5. Excited Raman photons were then collected by a spectrometer 
formed with a monochromator (Andor Shamrock SR303i, 400 lines/mm grating @850 nm) and a cooled CCD 
camera (Andor Newton, CCD3). With this configuration, the confocal diameter and depth of the system are 5 µm 
and 4.68 µm respectively. In order to obtain a sufficient Raman signal from a single cell, we apply a laser dosage 
of 150 mW at the sample plane. Over a long period of exposure time, this focused laser power didn’t show any 
damage to the cells.
The system is able to switch from Raman spectroscopy to fluorescence imaging by placing FITC/TRITC 
cubes into the microscope and flipping the flip mirror (FM) to CCD1 (Hamamatsu ORCA-ER). Fluorescence 
images were taken via standard Nikon fluorescence cubes (FITC and TRITC) using a Nikon fluorescence white 
light source (Lamp2). Red fluorescence emission (580~620 nm) of Nile red stained samples excited by a green 
wavelength (545~565 nm) light shows the signals from the polar lipids whereas green fluorescence emission 
(500~540 nm) excited by a blue wavelength (475~490 nm) light shows the signals from the non-polar lipids (lipid 
bodies).
WMR spectra. In order to obtain the WMR spectrum from a single cell, five spectra were recorded contin-
uously over 2.5 minutes with a 30 seconds integration time for each spectrum. During acquisition, the laser line 
was tuned continuously over a total modulation range of ∆λ = 1 nm. A single WMR spectrum can be produced 
Figure 5. System setup for a combined Raman-fluorescence microscope: SF: single-mode fibre; MF: multi-
mode fibre (200um core diameter); LF: Laser line filter (Semrock LL01-785); EF: Edge filter (Semrock LPD02-
785RU); NF: Notch filter (Semrock NF03-785E); TRITC/FITC: Fluorescence Filter cubes (FITC: excitation 
475–490 nm/emission 500–540 nm, TRITC: excitation 545–565 nm/emission 580–620 nm); FM: flip mirror; 
CCD1: Hamamatsu ORCA_ER; CCD2:Imaging Source USB camera (DFK 42AUC03); CCD3:Andor Newton 
Camera (cooled to −70 °C); L1~L6: lenses; F/#: F number matcher.
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from these five spectra with all background fluorescence being removed essentially. In the WMR spectrum, all 
Raman peaks will locate at the zero crossings while their peak intensity will be reflected by the peak-to-valley 
value around the zero crossing.
Raman calibration and spectra processing. Raman spectra were taken from polystyrene beads (1µm 
in diameter) as a control to calibrate the laser line and the drift in the system. The known Raman peak position 
(1001.4 cm−1) of polystyrene bead was used for calculate the laser line. In this way, the drift in the laser line can 
be monitored during the whole data acquisition procedure. Suppose the drift is very slow (typically <0.2 nm 
over a day), we can calibrate the laser line used for each Raman spectrum from cells through an interpolation. 
Each Raman spectrum was also normalized by its total intensity (i.e. the integration over the area covered by the 
spectrum) in order to avoid any fluctuation in the laser power during wavelength modulation. The spectral region 
between 1000 cm−1 and 1800 cm−1 was used for the data analysis.
Principal component analysis (PCA). WMR spectra were collected from 60~100 cells from each cell 
phenotype. PCA was then applied to these training dataset in order to reduce the dimensionality. To distinguish 
between each two different cell phenotypes, the first seven principal components were taken into account, as they 
accounted for more than 70% of variances in these training dataset. This algorithm was written in Matlab codes.
Leave-one-out cross validation (LOOCV). The ability of distinguishing between each two different cell 
subsets was estimated by the method of leave-one-out cross validation. A multiple-dimensional space was defined 
by the principle components from the training dataset without one Raman spectrum. This leave-out spectrum 
was then classified in this space with the nearest neighbor algorithm. With this LOOCV method, correct or incor-
rect predictions for lipid rich and lipid poor cells in the training dataset were then used to estimate the specificity 
and sensitivity. Confusion matrix can also be estimated from correct and incorrect predictions for more than 
three cell subsets in the training dataset. This algorithm was written in Matlab codes.
Data Availability. Part of experimental datasets are available at http://dx.doi.org/10.17630/4be70c0f- 
7f62-45e5-9b94-a717c2b6e061.
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Abstract
Raman spectroscopy is a non-destructive and label-free technique. Wavelength-modulated Raman
(WMR) spectroscopy was applied to investigate Mycobacterium tuberculosis cell state, lipid rich (LR)
and lipid poor (LP). Compared to LP cells, LR cells can be up to 40 times more resistant to key
antibiotic regimens. Using this methodology single lipid rich (LR) from lipid poor (LP) bacteria can be
differentiated with both high sensitivity and specificity. It can also be used to investigate experimentally
infected frozen tissue sections where both cell types can be differentiated. This methodology could be
utilized to study the phenotype of mycobacterial cells in other tissues.
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1.  Introduction
Tuberculosis is a major health issue worldwide and a major cause of death due to infectious disease.
Treatment of tuberculosis has not improved in the past 50 years. Shortening therapy would make an
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important step forward to reducing the global burden of tuberculosis. Recent clinical trials using more
bactericidal regimens to shorten TB therapy to 4 months failed to do so due to higher relapse rate after
successful treatment [1, 2, 3]. Those observations confirmed that relapse is the main barrier to shorter
tuberculosis treatment. The bacteriology of relapse remains largely unknown and due to its importance
represents a key research area in tuberculosis. Patients that clear Mycobacterium tuberculosis from their
sputum rapidly during treatment can still undergo relapse [4]. In order to improve our knowledge of
relapse and its bacteriology, we need nondestructive methods to study bacteria directly at the site of the
disease. Relapse could be linked to bacteria that survive therapy, and several studies have shown that
mycobacteria accumulate lipid in intracellular bodies and these cells exhibit a lower metabolic rate [5, 6,
7, 8]. Recently lipid body positive mycobacteria were shown to be much more resistant to key
components of the tuberculosis therapy, up to 40 times more resistant to rifampicin [9]. Both phenotypes,
lipid rich (LR) and lipid poor (LP), can be observed in any mycobacterial population in a range of species.
To study the lipid content of Mycobacterium tuberculosis, we describe a novel method consisting of an
all-optical label-free Raman spectroscopy based system that can be applied to bacteria directly in tissue.
Raman spectroscopy has been applied previously to discriminate cultured bacteria and mycobacteria
species but never discriminate between two phenotypes or target mycobacteria in tissue [10, 11, 12]. We
use wavelength modulated Raman (WMR) spectroscopy to improve both sensitivity and specificity.
Rather than using a single excitation wavelength, WMR spectroscopy scans over a small range of the
laser wavelengths. Combined with subsequent multivariate statistical analysis, all background
fluorescence from biological samples can be removed. Importantly, WMR spectroscopy is a label-free
technology and can be therefore combined with other techniques such as immunostaining.
2. Materials
2.1.  In-Vitro Investigation
1. Test organism in this case: Mycobacterium tuberculosis (NCTC7416).
2. Growth medium: Middlebrook 7H9 medium (Sigma-Aldrich, UK).
3. Glycerol (Sigma-Aldrich, UK).
4. Tween 80 (Fisher BioReagents, UK).
5. Middlebrook ADC enrichment (Sigma-Aldrich, UK).
6. Bacterial culture tube.
7. Incubator set at 37 °C.
8. ​Phosphate-buffered saline​ (PBS)PBS.
9. Quartz coverslip (01015T-AB, SPI Supplies, PA, USA).
10. Quartz slide (01016-AB, SPI Supplies, PA, USA).
11. Transparent nail polish.
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2.2.  Tissue Investigation
1. Frozen infected tissue to investigate: in this example infected guinea pig (Specific pathogen-free
Dunkin Hartley strain guinea pigs) lung sections.
2. Cryostat to produce 3–5 μm thick frozen tissue sections (see Note 1).
3. Formalin solution.
4. Sucrose.
5. PBS.
6. Quartz coverslip (01015T-AB, SPI Supplies, PA, USA).
7. Quartz slide (01016-AB, SPI Supplies, PA, USA).
8. Transparent nail polish.
2.3.  Raman System
An example of the Raman system design is presented in Fig. 1.
1. Tunable laser that can generate light at 785 nm (see Note 2).
2. Microscope objective (Nikon, 50×, oil immersion).
3. Spectrometer: formed with a monochromator (Andor Shamrock SR303i, 400 lines/mm grating at
850 nm) and a cooled CCD camera (Newton 920, Andor Technology, UK).
4. A computer linked to the Ramen system and connected to the Internet.
5. Software list: Matlab, Andor Solis.
Fig. 1
Schematic diagram of the first experimental setup. The system is using a tunable Ti:Sapphire laser
(Spectra-Physics 3900 s, 785 nm, 1 W) pumped by a green laser (Verdi V6, 532 nm, 5 W). L , L , and
L  are lens. LF denotes line filter. EF denotes edge filter and NF denotes notch filter. The laser is
focused on the sample using a microscope objective (Nikon, 50×, oil). The spectrometer is composed of
a monochromator (Andor Shamrock SR303i, 400 lines/mm grating at 850 nm) and a cooled CCD
camera (Andor Newton).
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List of optics:
6. LF: Laser line filter (LL01-785, Semrock, USA).
7. EF: Edge filter (LPD02-785RU, Semrock, USA).
8. NF: Notch filter (NF03-785E, Semrock, USA).
9. FM: flip mirror.
10. CCD : Imaging Source USB camera (DFK 42AUC03, Imaging Source, Germany).
11. CCD : Andor Newton Camera (cooled at −70 °C).
12. L1–L36: lenses; F/#: F number matcher.
3. Methods
3.1. Bacteria from Culture
3.1.1.  Culture
Perform all steps before the heat killing of bacilli in a level 3 laboratory facility (or equivalent). Grow M.
tuberculosis (NCTC7416) at 37 °C in Middlebrook 7H9 medium supplemented with 0.05% (v/v) tween
80 and 24 mL of 50% glycerol (for 450 mL of medium). Add one vial of Middlebrook ADC supplement
(M0678, FLUKA) to the 450 mL.
1
2
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3.1.2.  Heat Killing of Bacilli
Harvest 1 mL of M. tuberculosis culture and place it at 80 °C for 20 min to heat inactivate the bacteria.
Take the inactivated bacteria out of the Cat3 facility (see Note 3).
3.1.3.  Wash
Take 100 μL of bacterial suspension and spin it at 20,000 × g for 3 min at room temperature. Discard the
supernatant. Wash the cells twice with 100 μL of PBS.
3.1.4.  Raman Slide Preparation from In-Vitro Cell
Resuspend the bacteria in 20 μL of PBS, take 10 μL out and heat fix onto a quartz coverslip (SPI
Supplies). Mount the fixed bacteria that are on the coverslip, on top of a quartz slide (SPI Supplies). The
cells end up between the quartz slides and coverslip. Seal mount using a transparent nail polish (leave to
air-dry for an hour before use). Interrogate the sample with WMR spectroscopy.
3.2. Tissue Sample Preparation
3.2.1.  Tissue Sectioning
AQ2
Treat the tissue to investigate with 10% neutral buffered formalin for an appropriate amount of time if it is
infected with M. tuberculosis (or another pathogen). Remove the tissue from the formalin solution and
freeze the tissue sample on a bed of dry ice in OCT (optimal cutting temperature) solution (30% sucrose
in PBS) for future Raman investigation. From the OCT block cut 3–5 μm sections using a cryostat. Place
the tissue section on the quartz coverslip.
3.2.2.  Tissue Section Mounting
Mount the frozen tissue section that is on the quartz coverslip (SPI Supplies, 01015T-AB), directly on top
of a quartz slide (SPI Supplies, 01016-AB). Seal the mount with transparent nail polish (leave to air-dry
for an hour before use). Interrogate the tissue sample with WMR spectroscopy. An example of single M.
tuberculosis bacillus in guinea pig lung tissue section observed under the Raman system is shown in Fig.
2 (see Note 4).
Fig. 2
M. tuberculosis in infected guinea pig lung tissue section observed under the Raman system (bright
field). A single bacillus can be observed (black arrow) in alveoli. The scale bar represents 5 μm
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3.3. Raman Microscopy Methods
3.3.1.  Raman System
Use your Raman system to acquire the spectra, an example of a confocal Raman system shown in Fig. 1.
This system uses a green laser (Verdi V6, 532 nm, 5 W) to pump a tunable Ti:Sapphire laser (Spectra-
Physics 3900 s, 785 nm, 1 W). To focus the laser on the bacteria use an oil immersion objective a Nikon,
50×, oil for example. A spectrometer with a monochromator (Andor Shamrock SR303i, 400 lines/mm
grating at 850 nm) with a cooled CCD camera (Andor Newton) is used to collect the Raman photons.
Determine the laser power to use according to the sample type being investigated (see Note 5).
3.3.2. Acquisition
3.3.2.1.  Standard Raman Spectra
Use for each single bacteria a 30 s integration time with a stable excitation laser wavelength at 784.6 nm.
Record a separate background Raman spectrum with the same condition from a (bacteria-free position)
position near the bacteria. Use it to subtract the background signals afterward. Determine the integration
time you need to obtain an optimal signal-to-noise ratio; this could vary depending on your system, the
organism under investigation and the power on the sample plane (see Note 6).
3.3.2.2.  WMR Spectra
Record five spectra continuously, with 30 s of integration each, while the laser is tuning over a small
range of 1 nm. From these five original spectra calculate a single WMR spectrum with the
autofluorescence background removed. Compare to the standard Raman spectrum; all Raman peaks will
locate at the zero crossings while their peak intensity corresponds to the peak-to-valley value (see Note 7).
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3.3.3.  Raman Calibration and Spectra Processing
Use control Raman spectra from polystyrene beads (1 μm in diameter) to monitor any possible drift in the
laser wavelength or the optical system. Acquire the Raman spectra of the polystyrene beads with the same
integration time as the experimental conditions.
The laser wavelength may vary during the experiments. We use a standard chemical, polystyrene, to
monitor this variation. As the known largest peak position of polystyrene is at 1001.4 cm , the actual
laser wavelength can be calculated (see Note 8).
If the drift in laser wavelength is very small (typically <0.2 nm over a day) and slow, the actual laser line
used to acquire each Raman spectrum can be calculated using an interpolation.
To avoid any influence from laser power fluctuation during wavelength tuning, normalize each Raman
spectrum by its total intensity (i.e., the integration over the area covered by the spectrum). To compare
your data sets and do the data processing use mainly the fingerprint region from 1000 cm  to 1800 cm
(see Note 9).
After Raman investigation, the tissue sample can be used for another method (see Note 10).
3.3.4.  Principal Component Analysis
To distinguish between two different cell phenotypes or species, apply principal component analysis
(PCA) to each training dataset containing standard Raman spectra or WMR spectra. Use approximately
60–80 cells for each phenotype or specie.
Use a number of principal components (PCs) that corresponds to more than 70% of variances in the
training dataset. In this example, the first seven principal components (PCs) have been used (see Note 11).
3.3.5.  Leave-One-Out Cross Validation
Use the method of leave-one-out cross validation (LOOCV) to estimate the ability of classification for the
different cell phenotypes or species. Without considering one Raman spectrum, a multiple-dimensional
space is defined by all the PCs in the training data set. This leave-out spectrum is then classified to be a
spectrum taken from either of your cell types based on its position in the multiple-dimensional space.
With this LOOCV for each spectrum in the data set, the specificity and sensitivity for a data set containing
two cell types are calculated (see Note 11).
4.  Notes
1. Frozen tissue slicing
We have used 5 μm thick formalin-fixed, frozen tissue sections successfully. However, the tissue
thickness can be adjusted according to the experiment. Commercial companies can slice fixed,
frozen tissue and mount onto quartz slides if cryostat equipment is not available.
2. Laser
−1
−1 −1
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A laser that can generate light at 785 nm and its wavelength can be tuned over 1 nm. For example,
a tunable Ti:Sapphire laser (Spectra-Physics 3900 s, 1 W at 785 nm) pumped by a green laser
(Coherent Verdi V6, 532 nm, 5 W) or a tunable Ti:Sa laser system (SolsTis M Squared lasers, 1
W at 785 nm).
3. Heat killing
To heat kill mycobacteria prior to the transfer of material from level 3 containment to a lower
level for analysis, 1 mL of cell culture (up to 10  cfu.mL ) is placed in a heat block for 20 min at
80 °C. This protocol was validated as follows:
After heat killing, M. tuberculosis was plated onto 7H10 (Sigma-Aldrich, UK) supplemented with
0.05% glycerol (Sigma-Aldrich, UK) and 10% OADC (Sigma-Aldrich, UK) and no growth was
observed after 4 weeks. Completion of this protocol allows transfer of fixed M. tuberculosis out of
the containment level 3 (CL3) laboratory to be analyzed at a lower containment level.
4. Preparation storage
Store tissue sections at −80 °C before use. Once sliced and mounted onto quartz slides store the
frozen tissue section preparation at −20 °C between two experimental days.
5. Laser power adjustment
Adjust the power on the sample plane to obtain an optimal signal-to-noise ratio. The power used
will depend on the sample being targeted. In the case of single mycobacterial cells, you can use
150 mW on the sample plane. This condition does not produce any damage to the cells during the
acquisition of the spectra. However, the integration time and laser power can be adjusted
depending on the cell size, specie or if a group of bacteria is targeted instead of a single cell. It is
important to optimize these parameters on the different organisms in advance.
6. Standard Raman acquisition
The acquisition time set to obtain a standard Raman spectrum is 30 s, 6 s five times accumulated.
The laser wavelength is constant through the measure and set at 784.6 nm. To produce a final
spectrum, a background Raman spectrum is first acquired next to a single bacterium. Once the
background is taken the signal from the single cell is recorded, and the background signal is
subtracted afterward. It takes 30 s to have the background signal and 30 s of acquisition to obtain
the bacterial spectrum. So, in this case, it takes around 1 min in total per single bacterium
standard Raman spectrum.
7. WMR spectroscopy acquisition
During acquiring WMR spectra, each spectrum was taken at an integration time of 30 s that
accumulates 6 s for five times. Five spectra were acquired continuously over 150 s when the laser
was tuning over a range of 1 nm around 785 nm. So, in this case, it takes around two and a half
minutes in total per single bacterium to acquire a WMR spectrum.
8. Laser wavelength calibration
8 −1
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To calculate the laser wavelength using the known position of the main polystyrene peak
(∆ω = 1001.4 cm ) use the following equation:
where ∆ω corresponds to the Raman shift, λ  (nm) is the laser wavelength to calculate and λ  (nm) the
measured wavelength of the main polystyrene peak in the Raman spectrum.
9. Raman spectra analysis
We observed that both standard and WMR spectroscopy could discriminate LR and LP cells.
However, WMR spectroscopy brings both higher sensitivity and specificity [13]. The
autofluorescence background is completely removed by the use of the modulation method
showing the spectrum with only the Raman peaks and with the accurate ratio between peaks [14,
15]. LR mycobacteria display higher intensity in the Raman bands associated with lipids mainly
at 1300 cm  and around 1440–1450 cm . [16](Paper title: “Label-free optical vibrational
spectroscopy to detect the metabolic state of M. tuberculosis cells at the site of disease”
submitted).
10. Raman spectroscopy a label-free and non-destructive methodology
Raman spectroscopy is label-free and non-destructive; therefore the tissue sample investigated
can be used again to perform another test such as immunostaining [16](cite our paper here). If
the tissue is studied with a staining method, the sample can be damaged meaning that it cannot
be reused. However, Raman spectroscopy is an interesting method to study single bacteria both
in vitro and in tissue especially if the sample is to be analyzed further using another method.
11. PCA LOOCV and Matlab
Additional information on PCA can be found in this article [1617]. We used Matlab to run the
PCA and the LOOCV analysis (MathWorks, UK, version R2014b).
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